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Abstract 
 
Up to 7-10% of the pregnant women receive at least one dose of 
synthetic glucocorticoids (GC) in order to promote fetal lung maturation 
and, despite animal and human data suggesting growth restriction and 
other deleterious effects on the developing brain and other organs, the 
use of repeated doses still occurs in clinical practice. Moreover, it is 
established that early life adverse events can shape physical and mental 
health in adulthood. In fact, there is accumulating evidence that 
exposure to stress or elevated levels of GC during crucial stages of 
development contributes for the appearance of neurospyschiatric 
conditions, such as anxiety and depression. 
In the present work, we assessed the impact of exposure to 
dexamethasone (DEX), a synthetic GC widely used in clinics, during 
gestational days 18-19 on the adult progeny. Following an initial 
endocrine and behavioral characterization, a neuroanatomical 
assessment of brain areas implicated in anxiety and fear conditioning, 
the bed nucleus of stria terminalis (BNST) and amygdala, respectively, 
was carried out; in these brain regions molecular and neurochemical 
assessments were also performed. In parallel, and since brain sexual 
differentiation begins during late gestation, we also aimed to evaluate 
the implications of antenatal DEX exposure on adult male sexual 
behavior and to establish possible molecular and neurochemical 
correlates, namely on the nucleus accumbens (NAcc) and the 
hypothalamus. To assess the differential the impact of the activation of 
glucocorticoid or mineralocorticoid receptors, whenever possible, we 
also included an additional group exposed to a natural GC at the same 
gestational period. 
Our data showed that prenatal DEX triggers a hyperanxious phenotype 
and alters fear behavior in adulthood. These behavioral traits correlated 
with hypothalamus-pituitary-adrenal (HPA) axis hyperresponsiveness 
and increased volume of the BNST, particularly the anteromedial 
! viii 
subdivision, whose bipolar neurons displayed increased dendritic length; 
in addition, we also found increased expression of the synaptic 
plasticity-related genes synapsin and NCAM in this brain region. 
Notably, the effects of antenatal DEX exposure were opposite in the 
amygdala, which displayed reduced volume due to dendritic atrophy. 
Despite the absence of differences in dopamine (DA) and its metabolite 
levels in the BNST, the levels of this neurotransmitter were substantially 
reduced in the amygdala, where an up-regulation of the DA receptor 2 
was also found.  
Regarding the impact of prenatal DEX on adult male sexual behavior, 
decreased number and increased mounts and intromissions latencies 
were observed. Reduced serum testosterone and increased 
hypothalamic expression of the androgen receptor (AR) correlated with 
these changes; additionally, reduced DA levels and increased dopamine 
receptors expression were observed in both hypothalamus and NAcc. 
Interestingly, exposure to equipotent doses of corticosterone, a natural 
corticosteroid, resulted in milder phenotypical changes.  
In summary, our data support that in utero DEX exposure differentially 
modulates anxiety and fear behavior through distinct morphological, 
neurochemical and molecular changes. Moreover, adult male sexual 
behavior is also affected through modification of specific neuronal and 
endocrine mediators. Importantly, a less detrimental phenotype seems 
to result from exposure to equipotent doses of natural GC, which points 
to the mediating role of mineralocorticoid and glucocorticoid receptors 
in these processes and calls for a reappraisal and judicious use of these 
drugs in the clinics. 
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Resumo 
 
Cerca de 7-10% das mulheres grávidas recebem, pelo menos, uma dose 
de glucocorticóides (GC) sintéticos para acelerar a maturação pulmonar 
fetal e, apesar de estudos em animais e humanos apontarem para  
atraso de crescimento e outros efeitos nefastos no cérebro e outros 
órgãos em desenvolvimento, o recurso a várias doses persiste na clínica. 
É reconhecido que eventos adversos durante fases precoces da vida 
podem moldar a saúde física e mental do adulto. De facto, existe 
evidência crescente de que a exposição a stress ou níveis elevados de 
GC durante etapas cruciais do desenvolvimento contribuem para o 
aparecimento de distúrbios neuropsiquiátricos, como ansiedade e 
depressão.  
No presente trabalho, avaliámos o impacto da exposição a 
dexametasona (DEX), um GC sintético amplamente utilizado na prática 
clínica, durante os dias de gestação 18-19, na descendência adulta. 
Após caracterização endócrina e comportamental, procedeu-se à 
avaliação neuroanatómica de áreas cerebrais implicadas na ansiedade e 
medo condicionado, o núcleo da estria terminal (NET) e a amígdala, 
respectivamente; também se efectuaram análises moleculares e 
neuroquímicas nestas regiões. Paralelamente, e uma vez que a 
diferenciação sexual cerebral se inicia durante a fase final da gravidez, 
quisemos também avaliar as consequências da exposição pré-natal a 
DEX no comportamento sexual masculino e estabelecer possíveis 
correlações moleculares e neuroquímicas, nomeadamente no núcleo 
accumbens (NAcc) e hipotálamo. De modo a avaliar o diferente impacto 
decorrente da activação do receptores glucocorticóides ou 
mineralocorticóides, incluímos, quando possível, um grupo 
experimental adicional exposto a GC naturais durante o mesmo período. 
Os nossos dados revelaram que a DEX pré-natal desencadeia um 
fenótipo de hiperansiedade e altera o comportamento relacionado com 
o medo na idade adulta. Estes traços comportamentais 
! x 
correlacionaram-se com uma resposta exacerbada do eixo hipotálamo-
pituitária-suprarrenal (HPS) e um aumento do volume do NET, 
particularmente da divisão anteromedial, cujos neurónios bipolares 
exibiam um aumento do comprimento dendrítico; nesta região cerebral 
também se observou aumento da expressão dos genes relacionados 
com a plasticidade sináptica, sinapsina e molécula de adesão celular 
neuronal (MACN). De destacar que os efeitos da exposição pré-natal a 
DEX foram opostos a nível da amígdala, com redução de volume devido 
a atrofia dendrítica. Apesar de não se terem encontrado diferenças nos 
níveis de dopamina (DA) e respectivos metabolitos no NET, os níveis 
deste neurotransmissor encontravam-se consideravelmente reduzidos 
na amígdala, onde se observou um aumento do receptor 2 da DA.  
Relativamente ao impacto da DEX pré-natal no comportamento sexual 
masculino do adulto, observou-se uma redução do número e aumento 
da latência para cópula com ou sem penetração. Estas alterações 
correlacionaram-se com diminuição da testosterona sérica e aumento 
da expressão hipotalámica do receptor dos androgénios (RA); observou-
se ainda redução dos níveis de DA e aumento da expressão dos 
receptores da dopamina no hipotálamo e no NAcc. De realçar que a 
exposição a doses equipotentes de corticosterona, um corticosteróide 
natural, originou alterações fenotípicas mais ténues.  
Em resumo, os nossos dados sugerem que a exposição intra-uterina a 
DEX modula de forma diferente a ansiedade e o medo através de 
distintas alterações morfológicas, neuroquímicas e moleculares. 
Também o comportamento sexual masculino do adulto é afectado 
através da modificação de mediadores neuronais e endócrinos 
específicos. De destacar que, da exposição a doses equipotentes de GC 
naturais, parece resultar um fenótipo menos afectado, o que aponta 
para o papel mediador dos receptores mineralocorticóides e 
glucocorticóides nestes processos e reclama para a necessidade de uma 
reavaliação e uso sensato destas substâncias na prática clínica. 
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Chapter 1 
 
 
Introduction 
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2
!1. INTRODUCTION 
 
 
1.1 The clinical application of corticosteroids during late gestation 
 
Corticosteroids are involved in the development and maturation of 
several fetal organs (Miller, 1998). These processes may be hastened by 
exogenous administration of these hormones, typically used to promote 
lung maturation in preterm labours (Crane et al., 2003). Liggins first 
described the major benefit of exogenous glucocorticoids (GC) 
administration in the prevention of the respiratory distress syndrome in 
premature infants (Liggins and Howie, 1972). The benefits of these 
drugs, whose efficiency is present through a wide range of gestational 
ages (24 to 34 weeks), comprise the reduction of mortality, respiratory 
distress syndrome, and intraventricular hemorrhage (NIH, 1994). Thus, 
in clinical practice, the prescription of corticosteroids became a 
common recommendation during late pregnancy, when at risk of 
premature labour (NIH, 1995). In Europe and North America, it is 
estimated that up to 7-10% of the pregnant women receive at least one 
dose of synthetic GC in order to promote fetal lung maturation 
(Matthews et al., 2004). Antenatal dexamethasone is also an option in 
the management of congenital adrenal hyperplasia, protecting female 
fetuses from virilization (Riepe, 2011), though in more prolonged 
therapeutic schemes. 
In daily practice, the use of repeated doses of prenatal glucocorticoids is 
frequent, despite data showing growth restriction and other deleterious 
effects on the developing brain and other organs (Newnham and Jobe, 
2009). Clinical guidelines on antenatal corticotherapy recommend 
administration of a total of 24mg of beta- or dexamethasone in a course 
of two or four doses (Miracle et al., 2008); however, multiple courses of 
GC are still often administered (Brocklehurst et al., 1999), regardless of 
the concerns on its potential deleterious effects. A consensus by the 
3
!National Institutes of Health Consensus Panel recommended the 
restriction of the use of repeated GC courses for controlled trial studies 
and highlighted the need of animal studies in order to assess its 
potential risks and benefits to the fetus (NIH, 2001). 
 
In fact, a correlation between GC exposure during early life and several 
metabolic (Barker, 1995; Lindsay et al., 1996), emotional and mood 
disorders in both animal models and humans in adulthood is now 
established (Weinstock, 2001; Mesquita et al., 2009; Appendix 3), 
stressing the need to fully clarify its effects and avoid unnecessary 
treatments.  !!
1.2 Hypothalamus-pituitary-adrenal (HPA) axis and the developing 
brain 
 
1.2.1 The HPA axis 
 
The hypothalamus-pituitary-adrenal (HPA) axis plays a major role in the 
stress response (Sapolsky et al., 1986), which aims to ease adaptation 
and restore homeostasis. In brief, stress sensitive neurosecretory 
neurons from the medial parvocellular division of the hypothalamic 
paraventricular nucleus (PVN), synthesize corticotrophin-releasing 
hormone (CRH) and arginine-vasopressin (AVP) among other 
secretagogues, which are released into hypophysial portal circulation 
and stimulate adrenocorticotrophic hormone (ACTH) production and 
release to circulation by anterior pituitary corticotropes (Whitnall, 
1993). At the adrenal cortex, ACTH promotes glucocorticoid production 
and release (Figure 1). 
The activation of the PVN may be triggered through (1) systemic 
stressors, that exert their effect through brainstem cathecolaminergic 
projections (Sawchenko et al., 1996), or (2) processive stressors, which 
4
!require higher order sensory processing in limbic circuits. The major 
projection converging in the PVN arises from the bed nucleus of stria 
terminalis (BNST), preoptic area and other hypothalamic sites (Herman 
and Cullinan, 1997). In particular, it is known that the BNST projections 
to the PVN are modulated by inhibitory GABAergic afferents from central 
and medial nuclei of the amygdala (Herman et al., 2005) and excitatory 
CRH projection from the central nuclei of the amygdala and 
glutamatergic afferents from prefrontal cortex (PFC) and ventral 
subiculum (Cullinan et al., 1993) (Figure 2).  
Following release into systemic circulation, GCs exert a wide spectrum 
of effects that are critical in stress adaptative response. These include 
cardiovascular activation (hypertension and positive inotropic effect), 
suppression of immunity and inflammation, but also metabolic actions 
(lipolysis, proteolysis, and gluconeogenesis), and effects on the 
reproductive system (Munck et al., 1984; Sapolsky et al., 2000). To 
control these effects, a mechanism of negative feedback through which 
corticosteroids act in the PVN and anterior pituitary gland, regulates 
their production and thus avoids the deleterious effects of chronic 
exposure to high levels of corticosteroids (De Kloet and Reul, 1987).  
 
 
 
Figure 1. Illustration of the HPA axis circuitry and feedback mechanisms of regulation. 
5
! 
1.2.2 Corticosteroid receptors 
 
Glucocorticoids exert their effects in the brain by binding to two types of 
nuclear receptors, the type 1 or mineralocorticoid receptor (MR) and the 
type 2 or glucocorticoid receptor (GR) (McEwen et al., 1986; De Kloet 
and Reul, 1987). While natural corticosteroids (cortisol in the human 
and corticosterone in the rat) bind to both despite displaying a greater 
affinity to MR (10-fold higher), synthetic corticosteroids (such as DEX or 
betamethasone) bind almost exclusively to GR (Reul et al., 1987). 
Concerning brain distribution of corticosteroid receptors, while MR are 
restricted predominantly to the lateral septum and hippocampus, GR 
have a more widespread distribution, with a higher density in lateral 
septum, dentate gyrus, nucleus of tractus solitarius and central 
amygdala, but also PVN and locus coeruleus (Reul and de Kloet, 1985). 
Studies on mature brains have shown opposing actions of MR and GR on 
neuronal survival in the dentate gyrus. While GR exclusive occupation 
results in permanent neuronal damage, MR does not (Sousa and 
Almeida, 2002). Moreover, a protective role has been attributed to MR 
occupancy, since simultaneous binding to both types of receptors 
resulted in less deleterious effects (Hassan et al., 1996). Of notice, there 
is also evidence of hippocampal neuronal death following prenatal 
administration of DEX (Uno et al., 1990). 
 
 
1.2.3 Accessibility of GCs to the fetus and fetal brain 
 
Corticosteroids are involved in the development and maturation of 
several fetal organ systems including the brain, lungs and liver (Miller, 
1998). In the same way as most fetal tissues, the placenta expresses 
glucocorticoid receptors as from mid-gestation (Johnson et al., 2008). 
The endogenous production of corticosteroids by the mesoderm derived 
6
!zona fasciculata/reticularis of the adrenal cortex (cortisol in the human 
and corticosterone in the rat) occurs late in gestation (Mesiano and 
Jaffe, 1997; Wotus et al., 1998). Nonetheless, maternal corticosteroids 
can access the fetal circulation (Dalle and Delost, 1979), with up to 80-
90% suffering metabolism by 11b-hydroxysteroid dehydrogenase type 2 
(11b-HSD2), during passage through the placenta (Murphy et al., 1974; 
Gitau et al., 2001).  
In contrast to natural corticosteroids which display high affinity to the 
corticosteroid binding globulin (CBG), synthetic corticosteroids, which 
are poor substrates for the 11b-HSD2, can also cross the placenta but 
remain unbound (Cooke et al., 1996), being less amenable to buffering. 
Additionally, corticosteroids, including dexamethasone can cross the 
blood brain barrier and access the brain (McEwen et al., 1976; Meijer et 
al., 1998). Of notice, previous data showed that 11b-HSD2 is highly 
expressed in the fetal brain during mid-gestation, protecting the 
developing brain from activation of GR (Diaz et al., 1998). Afterward, 
levels decline in most brain areas, allowing neuronal and glial 
maturational events induced by corticosteroids. 
 
 
1.2.4 Impact of antenatal corticosteroids in neurodevelopment  
 
The in utero environment determined by passage of chemical signals 
across the placenta is crucial to fetal development. Growing evidence 
suggests that adverse conditions during early life influence growth and 
brain development and, thus, predispose individuals to mood and 
anxiety disorders in adulthood (Heim and Nemeroff, 1999; Kaufman and 
Charney, 2001; Vythilingam et al., 2002). Of relevance for this thesis is 
the fact that fetal exposure to high levels corticosteroids, either 
endogenous or exogenous, appears to program the HPA axis and impair 
mood and emotional behavior in adulthood (Weinstock, 2005). However, 
the nature of the corticosteroid, the dosage and the period of exposure 
7
!are determinant for the outcome (Welberg and Seckl, 2001). 
Specifically, prenatal exposure to DEX has been shown to increase the 
messenger RNA (mRNA) levels of corticotropin releasing hormone (CRH) 
in the central nucleus of the amygdala (CeA) and of GR and MR in the 
basolateral division of the amygdala (BLa) (Welberg et al., 2001), while 
endogenous corticosteroids do not seem to affect the latter (Welberg et 
al., 2000); importantly, the former triggers at the long-term an 
overactivation of the HPA. In fact, an impairment in the MR/GR balance 
has been associated with an hyperactivation of the HPA axis (De Kloet, 
2003), which was correlated with the development of depression 
(Holsboer, 2000; Gold and Chrousos, 2002). In addition, HPA axis 
hyperactivity was associated with morphologic effects in the 
hippocampus (Sousa et al., 2000; Sousa and Almeida, 2002), prefrontal 
cortex (Cerqueira et al., 2007), ventral tegmental area (VTA), nucleus 
accumbens (NAcc) (Leao et al., 2007; Appendix 1), extended amygdala 
(Pego et al., 2008), and dorsal striatum (Dias-Ferreira et al., 2009) in 
several rodent models. 
Nonetheless, and despite these compelling evidence of extensive 
activational effects of glucocorticoids, much less is known on the impact 
of prenatal short-term exposure to corticosteroids in the neuronal 
networks controlling emotional and sexual behaviors. 
 
 
1.3 The neuronal network regulating emotional behavior 
 
The amygdala and the bed nucleus of stria terminalis (BNST) exhibit a 
significant amount of corticosteroids receptors (De Kloet et al., 1998) 
and are, thus, possible targets of prenatal GC. The knowledge on the 
amygdala has largely evolved in the last two decades. Challenged the 
concept of a unique entity (Swanson, 1998), the amygdala is known to 
be related with diverse functions, including emotion, fear, attention and 
learning. An adjacent nuclear complex, the BNST, has been recognized 
8
!in the vicinity of the stria terminalis. Importantly, for the present thesis, 
a double dissociation between the involvement of the amygdala and 
BNST in fear and anxiety has been reported (Davis, 1992b, a, 1998, 
2006), with the former being largely implicated in fear processing, 
whereas the BNST is largely related with anxiety behavior.  
 
 
1.3.1 The amygdala  
 
The term amygdala was initially used to describe an almond shaped 
nucleus in the inner temporal lobe (Burdach, 1819). Johnston 
subsequently reviewed its extension and divisions (Johnston, 1923), and 
the amygdala to be composed by an archaic group of nuclei related to 
the olfactory system (central, medial and cortical nuclei, and nucleus of 
the lateral olfactory tract) and a more recent group of nuclei (lateral and 
basal). More recently, the concept of the “extended amygdala” emerged, 
following observations on the topographical and functional similarities 
between central and medial nuclei of the amygdala and the BNST 
(Alheid and Heimer, 1988; Alheid et al., 1998). New developments were 
established on the knowledge of the structural and functional 
organization of the amygdala (Swanson and Petrovich, 1998), 
suggesting that it is composed of three main regions: (1) a specialized 
ventromedial extension of the striatum, (2) a caudal olfactory cortex, 
and (3) a temporal extension of the claustrum. 
Besides its topographic relationship, both morphologic and 
histochemical similitude support the concept that striatal amygdala 
consists of a specialized extension of the striatum, being formed by the 
central and medial nuclei, and anterior area (Alheid and Heimer, 1988; 
Esclapez et al., 1993; McDonald and Augustine, 1993; Sun and Cassell, 
1993). Supporting this idea is the fact that the central (CeA) and medial 
nuclei of the amygdala (MeA) have GABAergic extrinsic projections, in 
the same way as the adjacent caudate-putamen (Davis et al., 1994). 
9
!Conversely, extrinsic projections from the remaining amygdala are 
presumed to be mainly glutamatergic, supporting its cortical nature. 
In contrast to the somatic motor information modulated by dorsal 
striatum (caudate-putamen), most information processed in the 
amygdala is relayed by its major output, the CeA, to several autonomic-
related centers, namely in the brainstem and hypothalamus in response 
to emotional stimuli (Hopkins and Holstege, 1978; Rosen et al., 1991; 
Bandler and Shipley, 1994). The MeA receives its major sensory input 
from the accessory olfactory bulb and projects massively to the medial 
preoptic nucleus and other sexually dimorphic hypothalamic nuclei 
thought to play key roles in mediating steroid sensitive reproductive 
functions. Sensory input from the vomeronasal organ, transporting 
pheromonal information, is projected to the accessory olfactory bulb 
and then relayed in the MeA, which then projects to the BNST and 
hypothalamic areas related with reproductive function (Scalia and 
Winans, 1975; Simerly et al., 1989). 
 
The amygdalar olfactory cortical group consists of the nucleus of the 
lateral olfactory tract (NLOT), the cortical amygdalar nucleus (COA) and 
the postpiriform and piriform–amygdalar areas (Swanson and Petrovich, 
1998). The former two are considered different areas since the NLOT, 
and anterior and posterolateral COA receive projections from the main 
olfactory bulb, while the posteromedial COA receives inputs from the 
accessory olfactory bulb (Scalia and Winans, 1975). Both the 
postpiriform and piriform-amygdalar areas receive input from the main 
olfactory bulb and project to the CeA and several amygdalar regions, 
respectively (Pitkanen et al., 1997). 
 
The temporal extension of the claustrum is formed by the lateral, basal 
and posterior nuclei. Consisting of the deepest layers of temporal, 
piriform and frontal cortex, it forms a frontotemporal system (Swanson 
and Petrovich, 1998), and is separated from the superficial cortical 
10
!layers by the amygdalar capsule, a division of the extreme capsule 
(Swanson, 1998).  
 
While local circuits are mostly constituted by spine-sparse non-
pyramidal neurons containing GABA, acetylcholine and a variety of 
neuropeptides (McDonald and Pearson, 1989), projections to CeA, 
ventral caudate-putamen, nucleus accumbens, and frontal cortex are 
assured by glutamatergic pyramidal neurons (McDonald, 1991). 
Whereas frontal cortex connections probably take part in the awareness 
of fear and anxiety, projections to the CeA are essential for autonomic 
and somatic responses to adverse stimuli. On the other hand, outputs to 
ventral caudate-putamen and nucleus accumbens convey motivational 
information to motor areas, permitting avoidance or approach in 
response to aversive or reinforcer related stimuli, respectively. 
 
 
1.3.2 The bed nucleus of stria terminalis (BNST) 
 
The BNST is one of the relay stations that conveys inputs from stress-
sensitive areas of the cortex and limbic system both to the HPA axis 
(Figure 2) but also to brain stem nuclei implicated in several emotional 
behaviors (Herman and Cullinan, 1997). Following initial descriptions on 
the gray matter surrounding the stria terminalis (Ramón y Cajal, 1911), 
the expression bed of the stria terminalis was later used to name a region 
comprised between the temporal pole caudally and the base of the 
olfactory peduncle rostrally (including part of the head of the caudate 
nucleus) (Johnston, 1923). 
 
Subsequent studies using cyto- and chemoarchitectonic criteria both in 
developing and adult models suggested the division of the BNST into 
anterior and posterior components, separated by the vertical fibers of 
11
!the stria terminalis (Bayer, 1987; Ju and Swanson, 1989; Ju et al., 
1989).  
 
The anterior division comprises ventral, dorsal, and lateral areas, each 
consisting of several nuclei (Dong et al., 2001). The posterior division 
contains at least five nuclei: principal, interfascicular, transverse, dorsal, 
and premedullary. The information on cyto- and chemoarchitectonic 
characteristics permitted a more precise determination of regional 
boundaries: a) between the anterior and posterior divisions of the BNST; 
b) among the several nuclei or cell groups in each division, and c) 
between the BNST and the ventrally adjacent preoptic region.  
 
Based on projection studies, the ventral and dorsal areas of the anterior 
division have been arranged in a medial group. This anteromedial 
division receives inputs from both the MeA and CeA, and from main and 
accessory olfactory system components of the amygdala (Krettek and 
Price, 1978; Weller and Smith, 1982; Dong et al., 2001; Dong and 
Swanson, 2006). This division densely projects to hypothalamic regions 
strongly related with the neuroendocrine system (Cullinan et al., 1993; 
Moga and Saper, 1994; Spencer et al., 2005).  
Conversely, the lateral (or anterolateral) division receives projections 
from the CeA and amygdalar components of the main olfactory system 
(Krettek and Price, 1978; Weller and Smith, 1982; Dong et al., 2001) 
and participates in the expression of ingestive behaviors and 
homeostasis through projections to areas related with central autonomic 
control and midbrain structures coordinating visceral and somatic 
motor responses (Dong and Swanson, 2003, 2004a, 2006). Besides 
establishing reciprocal projections with MeA and amygdalar components 
of the accessory olfactory system (Dong et al., 2001), neurons from the 
posterior division project to hypothalamic areas that modulate 
reproductive and defensive behaviors (Dong and Swanson, 2004b, 
2006). 
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Figure 2. Simplified schematic representation of the extended amygdala circuitry and its modulatory action 
over the HPA axis. 
 
 
1.4 Neurobiology of sexual behavior 
 
When describing the patterns of male sexual behavior, motivation to 
engage in sexual activity and sexual performance may be distinguished. 
These two aspects of sexual behavior find parallel in the more classic 
description of appetitive and consummatory behaviors (Ball and 
Balthazart, 2008). Briefly, there are three major systems regulating 
sexual motivation and genital and motor responses (Hull et al., 2004): 
a) the mesolimbic system is critical for appetitive behavior and 
reinforcement; b) the medial preoptic system contributes to genital 
reflexes, sexual motivation and motor patterns of copulation; c) the 
nigrostriatal system enhances the motoric readiness to respond to 
stimuli (Figure 3).  
 
Dopamine is the common key player in all three systems, easing sexual 
motivation, copulatory proficiency, and genital reflexes (Giuliano and 
Allard, 2001). The recognized facilitating effects of DA on male sexual 
function date from evidence of increased libido and sexual potency as a 
side-effect in Parkinson patients treated with L-Dopa (Barbeau, 1969; 
Bowers et al., 1971; Kofman, 1971). More recently, the use of the 
D1/D2 agonist, apomorphine, to treat erectile dysfunction has achieved 
13
!some degree of success (Heaton, 2000; Giuliano and Allard, 2001; 
Montorsi et al., 2003).  
 
The pathways for sexual excitation involve the activation of 
incertohypothalamic and mesolimbic dopamine transmission that 
targets the hypothalamic medial preoptic area (mPOA) and nucleus 
accumbents (NAcc), respectively (Pfaus, 2009). Conversely, the 
nigrostriatal dopaminergic pathway, whose cell bodies in the zona 
compacta of the substantia nigra project to the dorsal striatum (Moore 
and Looklingland, 1995), has a predominant role in the motor aspects 
of sexual behavior, as supported by the fact that DA is released only 
during copulation (Damsma et al., 1992).  
 
 
Figure 3. Illustration of brain dopaminergic systems controlling sexual behavior. VTA, ventral tegmental area; 
mPFC, medial prefrontal cortex; SN, substantia nigra; mPOA, medial preoptic area; NAcc, nucleus 
accumbens. From Pfaus JG (2009). Pathways of sexual desire. J Sex Med 6:1506-33.  
 
 
1.4.1 The role of the hypothalamus, the BNST and the amygdala in 
male sexual behavior  
 
Two cell groups of the mPOA appear to be of particular relevance in the 
modulation of male sexual behavior in gerbils: the medial and lateral 
14
!sexually dimorphic areas, homologous to the rats’ medial portion of the 
medial preoptic nucleus (MPN) and magnocellular MPN, respectively 
(Yahr, 1995). Diverse mating eliciting sensory stimuli indirectly relay in 
the mPOA, while reciprocal connections modulate its processing 
(Simerly and Swanson, 1986). The dopaminergic input to the mPOA 
originates from the periventricular system, including cell bodies in the 
medial portion of the mPOA (Simerly and Swanson, 1986; Moore and 
Looklingland, 1995). In turn, projections from mPOA to other 
hypothalamic, midbrain, and brainstem nuclei, are known to regulate 
somatomotor or autonomic patterns and to contribute for sexual 
motivation (Simerly and Swanson, 1988; Yahr, 1995). It is also 
important to highlight the efferents to the paraventricular nucleus of the 
hypothalamus which are critical in the regulation of non-contact 
erections and copulation. 
 
The modulation of sexual behavior in hypothalamic sites is known to be 
influenced by hormones, in particular testosterone, and 
neurotransmitters, namely dopamine. Testosterone is thought to 
centrally mediate most hormonal effects on male sexual behavior. These 
hormonal effects are conveyed through androgen receptors present in 
brain areas relevant for male sexual behavior, including the mPOA or 
mPOA-anterior hypothalamus (AH) continuum (Yahr, 1995). The effects 
of testosterone binding may be either long-lasting through promoting 
protein transcription (McGinnis and Kahn, 1997) or faster, being 
mediated by membrane receptors affecting ion-channel activity or 
second-messenger systems (Moore and Evans, 1999; Shakil et al., 
2002). 
 
As in other brain regions, two main families of DA receptors in the 
mPOA differentially affect sexual behavior: a) the D1-like family which 
includes D1 and D5 subtypes and activate adenylyl-cyclase, and b) the 
D2-like family which consists of D2, D3 and D4 subtypes and inhibits 
15
!the adenylyl-cyclase (Civelli et al., 1993). While it has been shown that 
an increase in the D2/D1 ratio in the mPOA results in a delay in the 
onset of copulation and in a reduction of the ejaculatory threshold, 
possibly by altering autonomic control of penile reflexes (Hull et al., 
1989), selective stimulation of D1 receptors increases the rate of 
copulation and the number of ejaculations (Markowski et al., 1994). 
 
The amygdala and BNST, particularly its posteromedial division, are 
also of particular relevance in the control of male rodent sexual behavior 
(Alheid et al., 1995). In the corticomedial region of the amygdala, 
chemosensory, somatosensory, and hormonal stimuli are integrated and 
then projected to the mPOA and other central regulatory areas (Hull, 
2010). Morevoer, somatosensory afferents from the genitals reach the 
MeA via the subparafascicular nucleus, which then projects either 
directly to the mPOA or via the BNST. Interestingly, despite lacking 
dopaminergic neurons, the MeA seems to facilitate DA release by 
cellular bodies or terminals in the mPOA, promoting mating behavior 
(Dominguez and Hull, 2001). 
 
 
1.4.2 The mesolimbic system  
 
Behavioral data suggest that male rodent sexual behavior is a rewarding 
and reinforcing behavior. In the mesocorticolimbic circuit, dopaminergic 
projections from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAcc) and medial prefrontal cortex (mPFC) play a crucial 
role in motivation (Alcaro et al., 2007); importantly, for the present 
context is the fact that DA is released in the NAcc of male rats upon 
female presentation and during sexual behavior (Pfaus et al., 1990). The 
disinhibition of dopaminergic projection neurons of the VTA and 
subsequent release of DA into NAcc is attained following stimulation of 
mu opioid receptors which block their tonic inhibition by local 
16
!GABAergic interneurons (Klitenick et al., 1992; Ikemoto et al., 1997). 
Interestingly, in prenatally stressed male rats, the absence of copulatory 
behaviors was associated with a failure to increase extracellular levels of 
dopamine and its metabolites in the NAcc (Wang et al., 1995). Such 
data, obtained through simultaneous sexual behavior testing and 
concomitant microdialysis sampling, suggested that intense 
environmental stressors might impair NAcc dopamine release (Wang et 
al., 1995). 
 
A final note, to note that during copulation, in response to the VTA 
dopaminergic innervation via the mediodorsal thalamus, the mPFC 
exerts a positive feedback through glutamatergic projections, further 
promoting the excitation of VTA dopaminergic neurons (Tzschentke, 
2000; Balfour et al., 2006). In addition to the VTA, other areas relevant 
for sexual behavior receive input from the mPFC, namely mPOA, NAcc, 
and BNST, thus showing that the mPFC also plays a modulatory role in 
male sexual behavior (Figure 4).  
 
 
 
 
Figure 4. Simplified representation of mesolimbic dopamine system circuitry in the rat brain highlighting the 
major projections to the nucleus accumbens (NAc) and ventral tegmental area (VTA). AMG, amygdala; BNST, 
bed nucleus of the stria terminalis; LDTg, laterodorsal tegmental nucleus; LH, lateral hypothalamus; PFC, 
prefrontal cortex; VP, ventral pallidum. Adapted from Kauer JA, Malenka RC (2007). Synaptic plasticity and 
addiction. Nat Rev Neurosci 8:844-58. 
 
17
!1.5 Aims of the study 
 
While the use of antenatal GCs triggers long-term gains in several 
clinical conditions, evidence highlights several undesired “programming 
effects” that need to be clarified. 
 
The present thesis aims to: 
 
- Characterize the potential effects of brief antenatal exposure to 
corticosteroids on emotional behavior in adulthood (Chapters 2.1 and 
2.2). 
- Assess the impact of this prenatal glucocorticoids on the structure of 
the BNST and amygdala, brain regions implicated in anxiety and fear 
behaviors, and establish its molecular and neurochemical correlates 
(Chapter 2.2). 
- Establish the impact of antenatal corticosteroids exposure on adult 
male sexual behavior and on its hormonal and neurochemical mediators 
(Chapter 2.3). 
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Induction of a Hyperanxious State by Antenatal
Dexamethasone: A Case for Less Detrimental
Natural Corticosteroids
Mário Oliveira, João M. Bessa, Ana Mesquita, Hugo Tavares, André Carvalho, Rui Silva, José M. Pêgo,
João J. Cerqueira, Joana A. Palha, Osborne F.X. Almeida, and Nuno Sousa
Background: Synthetic glucocorticoids are commonly prescribed during pregnancy, despite a lack of systematic investigations of their
potential impact on the developing brain and neurological and behavioral performance.
Methods: Neuroendocrine parameters and behavior in the adult offspring of pregnant Wistar rats treated antenatally with either
dexamethasone (DEX) or corticosterone (CORT) were monitored; DEX (.1 mg/kg and 1 mg/kg) and CORT (25 mg/kg) were given to
pregnant rat dams on gestation days 18 and 19.
Results: Despite normal basal levels of corticosterone, the adult offspring of mothers given DEX or CORT displayed abnormal responses
in the dexamethasone-suppression test. Neither treatment influenced spatial memory performance, but both DEX and CORT facilitated
development of depressionlike behavior following chronic stress. The latter finding demonstrates that high-dose antenatal cortico-
therapy can impair the organism’s resilience to stress in adulthood. Interestingly, comparison of the progeny of CORT-treated and
DEX-treated mothers revealed that the latter were more anxious.
Conclusions: Since DEX and CORT differ in their affinity for glucocorticoid and mineralocorticoid receptors and corticosteroid-
binding globulin, our findings emphasize the need to consider the pharmacologic properties of antenatal corticotherapies and
demonstrate the potential long-term benefits of ligands that can bind to both receptors.
KeyWords:Neurodevelopment, corticosteroids, antenatal cortico-
therapy, anxiety, depression, cognition
Glucocorticoids are prescribed during late gestation insome 10% of risk pregnancies to promote fetal lungmaturation (Crane et al 2003; Crowley 1995; National
Institutes of Health 1995). Frequently, synthetic glucocorticoids,
such as dexamethasone (DEX) or betamethasone, are used rather
than cortisol (the natural glucocorticoid in humans) or hydrocor-
tisone (Jobe et al 2003). Chronic antenatal dexamethasone is also
the treatment of choice for reducing genital masculinization in
female fetuses with congenital adrenal hyperplasia (Forest et al
1998; New et al 2001).
Corticosteroids exert their long-term actions by binding to
nuclear receptors whose actions result from the regulation of
transcription of corticosteroid-responsive target genes. Two
types of receptors, the high-affinity mineralocorticoid receptor
(MR) and the low-affinity glucocorticoid receptor (GR), mediate
corticosteroid actions in the brain and periphery (Reul et al
1987). Dexamethasone binds exclusively to GR in vivo. In
contrast, corticosterone (CORT) (the dominant endogenous glu-
cocorticoid in rodents) binds to both receptors but shows a
higher affinity for the MR. Glucocorticoid receptors become
activated when endogenous corticosteroid secretion is elevated
(e.g., during stress) and chronic GR activation deleteriously
affects both peripheral tissues (e.g., bone and muscle atrophy,
glucose intolerance) and the brain (Sapolsky 1999). Studies on
the mature brain have shown that DEX causes irreversible
neuronal damage or even death in the striatum and hippocam-
pus (Almeida et al 2000; Haynes et al 2001; Sousa et al 1998). In
contrast, MR occupancy has been reported to confer neuropro-
tection, and interestingly, concomitant activation of GR and MR
by high levels of CORT results in only transient dendritic atrophy
and synaptic loss (Sousa and Almeida 2002; Sousa et al 2000).
One study in the Rhesus monkey reported the neuronal death-
inducing effects of antenatal DEX (Uno et al 1990). Given the
relatively common use of glucocorticoid therapy in obstetrics, it
seemed prudent to make a systematic reappraisal of the potential
harmful effects of antenatal glucocorticoid therapy on the devel-
oping brain; additionally, in light of the differing pharmacologi-
cal profiles of various glucocorticoids, we also considered it
worthwhile to compare the effects of different glucocorticoid
analogs.
Normal development of the fetal hypothalamic-pituitary-ad-
renal (HPA) axis is essential for normal growth, organogenesis,
and immunity. Recent studies have shown that HPA axis function
can be programmed in early life, or even prenatally, by stress, a
condition characterized by elevated corticosteroid secretion
(Huot et al 2002; Liu et al 2001; Weaver et al 2004). This
programming includes permanent alterations to the thresholds
for glucocorticoid negative feedback (Bakker et al 1995; Jacob-
son and Sapolsky 1991; Levitt et al 1996), with resulting basal
hypercortisolemia (Huot et al 2002; Levitt et al 1996) and
exaggerated HPA responses to subsequent stressors. Besides
increasing susceptibility to a number of systemic pathologies
such as hypertension, autoimmune disorders, and diabetes
(Munck and Guyre 1986; Sapolsky et al 2000), chronic exposure
to high levels of glucocorticoids is causally linked to the devel-
opment of emotional and mood disorders in both experimental
animals and humans (Charney and Manji 2004; McEwen 2000).
In this study, either CORT (25 mg/kg) or DEX (Sigma-Aldrich,
St. Louis, Missouri) (1 mg/kg or .1 mg/kg) were administered to
rat dams in late pregnancy; cognition, emotionality, and suscep-
tibility to display depressionlike behavior were examined in their
adult offspring. These measures were complemented by the
assessment of HPA axis function, including the efficiency of
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glucocorticoid negative feedback; impairments of the latter are
observed in a significant proportion of patients with major
depression (Evans and Nemeroff 1987; Holsboer 1983; Holsboer
et al 1995).
Methods andMaterials
Animals and Treatments
Pregnant female Wistar rats (Charles River Laboratories, Bar-
celona, Spain) were individually housed under standard labora-
tory conditions (light/dark cycle of 12/12 hours, with lights on
at 8:00 AM; 22°C ambient temperature; ad libitum food and
water). Subcutaneous injections of 1 mg/kg of dexamethasone
(DEX1, n ! 4), 25 mg/kg of corticosterone (CORT, n ! 4), or
saline solution (CONT, n ! 3) were administered on pregnancy
days 18 and 19 (parturition in the rat occurs on pregnancy day
21) (Figure 1). An additional group of pregnant dams (n! 3) was
treated with a lower dose (.1 mg/kg) of dexamethasone
(DEX0.1). Progeny (n ! 8 per group) were separated and
housed according to gender and antenatal treatment on postnatal
day 21. Experiments were conducted in accordance with local
regulations (European Union Directive 86/609/EEC) and Na-
tional Institutes of Health (NIH) guidelines on animal care and
experimentation.
One major aim of this study was to compare the effects of
prenatal exposure to different glucocorticoid receptor ligands
(DEX and CORT). Accordingly, drug dosages were chosen to
achieve similar transrepressive potencies at the GR (DEX 1
mg/kg vs. CORT 25 mg/kg) (Buttgereit et al 1999; Schimmer and
Parker 2001) and the induction of equivalent somatic changes
(DEX .1 mg/kg vs. CORT 25 mg/kg). The somatic changes
monitored were body weight (at various postnatal intervals), age
at eye opening, and thymus and adrenal weights (at sacrifice), as
well as various parameters reflecting the activity of the HPA axis
(see below).
Neuroendocrine Function Tests
Blood samples were collected by tail venipuncture between
7:00 AM and 9:00 AM when offspring were 2 and 10 months old;
additionally, blood samples were collected from offspring aged 2
months for the assessment of basal nighttime serum CORT levels
by radioimmunoassay (RIA) (ICN Biomedicals, Costa Mesa,
California).
A dexamethasone suppression test (DST) was performed
when animals were 10 months old. Briefly, animals were injected
subcutaneously with either vehicle or DEX (30 "g/kg) at 9:00 AM
and blood samples for CORT determination were obtained at
7:00 PM.
Behavioral Tests
Behavioral evaluation was performed when animals were 2
months old (n ! 8 per experimental group), and a subgroup of
female rats (n ! 6 per experimental group) was tested at 8
months of age. All tests were conducted during the daily light
phase (9:00 AM–6:00 PM).
Open Field
Exploratory behavior was investigated using the open field
test in a brightly illuminated (white light) room. Briefly, rats were
placed in the center of an arena (43.2 # 43.2 cm; transparent
acrylic walls and white floor) (MedAssociates Inc., St. Albans,
Vermont) and position was monitored online over a period of 8
minutes with the aid of two 16-beam infrared arrays. Total
distances traveled were used as indicators of locomotor activity.
Time and distances in the central and predefined peripheral
areas were recorded and used to calculate the ratio of time spent
in the central quadrant of the platform and the distance traveled
in this central area (versus rest of the open field platform). The
number and duration of rearings were also recorded.
Elevated Plus Maze
This test was used to assess emotionality (degree of anxious-
ness); all investigations were carried out under bright white light.
Animals were placed (5 minutes) on a black polypropylene
plus-shaped platform elevated 72.4 cm above the floor; the maze,
consisting of two open arms (50.8 # 10.2 cm) and two closed
arms (50.8 # 10.2 # 40.6 cm), was supplied by MedAssociates
Inc. The number of entries into each of the arms and the time
spent therein were recorded online. Data were processed to
yield the ratio of time spent in the open arms versus total time
and the number of entries into each arm of the maze.
Morris Water Maze
This maze consisted of a black tank (diameter: 170 cm; depth:
50 cm), divided into quadrants by imaginary lines and filled with
water (22°C) to a depth of 31 cm. During testing, a black platform
(12# 12 cm; invisible to the rats) was placed at a height of 30 cm;
this platform was placed in a different quadrant of the maze in
each test session. The room was dimly lit and extrinsic visual
clues were glued to the walls. Data were collected using a
video-tracking system (Viewpoint, Champagne au Mont d’Or,
France). We used a place-learning task to assess the ability of rats
to learn the position of the invisible escape platform. Animals
were tested for 5 consecutive days (four trials per day, with a
maximum of 2 minutes per trial). The escape platform was
placed in the center of an arbitrarily defined quadrant assigned to
a specific test subject. To avoid possible bias effects due to
geographic preference, “animal-platform position” was paired
between the different treatment groups. Test sessions were
begun with rats being placed facing the wall of the maze in a
defined start position. In the first trial of each day, rats were
placed in the quadrant immediately to the right of that containing
the escape platform; this procedure was continued in a clockwise
Figure1. Schematic representationof the experimental design. Subcutane-
ous injections were administered to pregnant rats at gestation days 18 and
19. Maternal separation was performed at postnatal day 21 (PND21). Ele-
vated plusmaze (EPM) andMorris watermaze (MWM) testswere performed
in two separate sets of animals. In another cohort of animals, the forced
swimming test (FST)wasperformedbeforeor after exposure to chronicmild
stress (CMS). Activity of the hypothalamic-pituitary-adrenal (HPA) axis was
monitored by assays of basal and stress-induced corticosterone secretion
and after the dexamethasone suppression test (DST).
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fashion over the subsequent test days. The path described and
time spent to reach the platform (latency time) were recorded in
the consecutive trials, terminated when the escape platform had
been reached; in cases where the escape platform had not been
reached within 2 minutes of placing the rat in the maze, the
experimenter guided the animal to the platform. In either case,
animals were dried and allowed to rest for 30 seconds before
being returned to the maze for the remaining test sessions of that
day.
Depressionlike Behavior
Learned helplessness, as a measure of susceptibility to de-
pression-related behavior, was assessed in a subgroup of animals
using the forced swim test (FST) before and after exposure to a
chronic mild stress (CMS) protocol. The first FST was performed
in animals aged 8 months; animals were then subjected to CMS
for 6 weeks when they were put through a second FST.
The CMS paradigm consisted of a battery of insults based in
previously described protocols (Willner et al 1992).
For the FST, rats were placed in cylinders filled with water
(25°C) to a depth such that the animals had no solid support for
their rear paws. After a 10-minute pretest session, animals were
rested for 24 hours before being subjected to the actual tests,
which lasted 5 minutes. At the end of each test session, animals
were placed on a heating pad (15 minutes) before being returned
to their home cages. The cylinders were filled with fresh water
after each trial. A video camera placed at the top of the cylinder
was used to record test sessions; video recordings were later
scored by an investigator blind to the experimental details. Time
of immobility (passiveness; defined as time spent either immo-
bile or making righting movements to stay afloat) and latency to
immobility were computed.
Data Analysis
Initially, one-way analysis of variance (ANOVA) on ranks
(Kruskal-Wallis) was performed to evaluate overall treatment
effects on behavioral analysis. Differences between groups were
determined by appropriate post hoc pairwise comparisons.
Place-learning task performance was analyzed on the average
values from blocks of four consecutive trials. A two-factor
analysis of learned helplessness in the FST before and after
exposure to CMS was performed (considering prenatal expo-
sure ! trial), followed by one-way ANOVA to assess between-
subject effects. Biometrical data were analyzed by one-way
ANOVA, followed by post hoc pairwise comparisons to establish
differences between groups. All results are expressed as group
means " SEM. Differences were considered to be statistically
significant when p # .05.
Results
Antenatal Corticosteroids Affect BirthWeight,
Neurodevelopmental Milestones, and HPA
Responsiveness in Adulthood
The progeny of animals treated with both DEX and CORT
displayed reduced birth weight (p $ .0001; Table 1); .1 mg/kg of
DEX and 25 mg/kg of CORT proved equipotent in this respect.
Differences in body weight (CORT-treated and DEX0.1-treated
vs. control offspring) were abolished with increasing maturity,
whereas body weights in the animals exposed to the high dose
(1 mg/kg) of prenatal DEX remained significantly reduced.
In accordance with previous studies (Neal et al 2004), we also
observed a trend for an advance in the day of eye opening in the
progeny of mothers treated with corticosteroids: postnatal day
(PND)13 in the control group versus PND12 in 50% of the high
DEX, 37.5% of the low DEX, and 12.5% of the CORT-treated
groups.
Basal diurnal and nocturnal corticosterone determinations
failed to reveal any significant differences among experimental
groups (Figure 2), even though there was a trend for basal
nighttime levels of corticosterone to be higher in animals that had
been prenatally exposed to DEX at 1 mg/kg. Despite a significant
gender effect, with female animals displaying higher corticoste-
rone levels than male animals (p $ .001), variations among
experimental groups were similar between sexes. Importantly,
data derived from dexamethasone suppression tests demon-
strated an impaired shutoff response in the progeny of both
CORT-treated and DEX1-treated animals (p $ .02).
Progeny of DEX-TreatedMothers Display Reduced
Locomotion and Exploratory Activity
Open field testing at 2 months of age demonstrated that
several parameters were affected by corticosteroid treatment.
The ratio of time spent in central area over total time (Figure 3A)
was affected by treatment both in male animals (H $ 12.43; p $
.006) and female animals (H $ 10.56; p $ .014). The progeny of
DEX-treated animals spent proportionately less time in the
central area than the control group, both in male animals and
female animals. Corticosterone-exposed rats displayed interme-
diate scores that were not significantly different from control in
female animals but differed from DEX groups. This parameter did
not differ between animals exposed to 1 versus .1 mg/kg DEX.
Table 1. Body Weight Evolution During the First 60 Days of Life
Treatment PND 1 PND 10 PND 21 PND 30 PND 60
CONT male animals 6.9 (.2) 30.3 (1.4) 60.9 (1.3) 110.9 (1.0) 267.5 (7.5)
CORT male animals 5.6 (.1)a 26.4 (1.5)b 56.0 (1.9)b 111.8 (4.4)b 280.5 (6.6)b
DEX 1 mg/kg male animals 5.2 (.2)a 20.5 (1.5)a 48.4 (3.4)a 97.5 (4.3)a 234.1 (8.5)a
DEX .1 mg/kg male animals 5.6 (.1)a 27.3 (.3)b 54.0 (.3)b 107.1 (1.4)b 278.0 (6.3)b
CONT female animals 6.7 (.1) 29.3 (1.7) 64.3 (.9) 100.9 (1.4) 186.9 (3.7)
CORT female animals 5.4 (.1)a 25.0 (1.4)a 59.1 (1.9)b 100.4 (2.1)b 187.0 (3.9)b
DEX 1 mg/kg female animals 5.2 (.1)a 20.3 (.9)a 48.1 (2.7)a 93.4 (2.2)a 166.9 (5.0)a
DEX .1 mg/kg female animals 5.4 (.1)a 23.3 (.2)a 58.8 (.8)b 98.3 (.9)b 184.5 (2.0)b
Body weights (g) at PND 1, 10, 21, 30, and 60 of offspring of vehicle (CONT), corticosterone (CORT), and high-dose
dexamethasone (DEX; 1mg/kg) treated pregnant rats. Values representmean (SEM). Animals exposed to lowdoses of
DEX (.1 mg/kg) do not differ from CORT-exposed animals. PND, postnatal day; CONT, vehicle; CORT, corticosterone;
DEX, dexamethasone.
aSignificantly different from control animals, p# .05.
bSignificantly different from DEX, p# .05.
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Female animals had significantly higher values than male animals
(p ! .001).
Analysis of total distance traveled (Figure 3B), an index of
global locomotor activity, revealed a significant effect of treatment
for bothmale animals and female animals (male animals: H" 18.27,
p " .001; female animals: H " 11.48, p " .009). The male and
female offspring of DEX1-treated mothers traveled less distances
on the test arena than control animals and CORT. Progeny from
DEX0.1-exposed mothers did not differ from DEX1 in male
animals, but in female animals the progeny of DEX0.1 traveled
longer distances than DEX1. Importantly, DEX0.1 displayed
decreased locomotor activity when compared with CORT-ex-
posed rats. Overall, female animals traveled greater distances than
male animals (p " .001).
Figure2.Antenatal corticosteroids affectHPA responsiveness in adulthood.
(A) Diurnal quiescent levels of corticosterone at 2 and 10 months of age
(bottom left) and after the DST (top right) in the female progeny of vehicle-
(CONT), corticosterone- (CORT), and dexamethasone- (DEX) injected preg-
nant rats. (B)Nocturnal quiescent levels of corticosteroneat 2monthsof age
in the male and female progeny of vehicle- (CONT), corticosterone- (CORT),
high dexamethasone- (DEX1), and low dexamethasone- (DEX0.1) injected
pregnant rats. Results are expressed in ng/mL. Error bars represent SEM. The
DST results reveal bluntedglucocorticoidnegative feedback in theoffsrping
of CORT- andDEX-exposedmothers. *p! .05. HPA, hypothalamic-pituitary-
adrenal axis; DST, dexamethasone suppression test.
Figure 3. Progeny of DEX-treatedmothers display reduced locomotion and
exploratory activity.Data collected in theopenfield test performedat 2 (2m)
and 8 months (8m) of age in male and female offspring of vehicle- (CONT),
corticosterone- (CORT), and dexamethasone- (DEX) treated pregnant rat
dams. (A) Percentage of time spent in central area of the open field arena.
(B) Total distance travelled in centimetres. (C) Number (left) and duration
(right) of rearings. Error bars represent SEM. *p! .05.
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Regarding rearing count and duration (Figure 3C), a signif-
icant effect of treatment was observed both for male animals
(count: H ! 8.69, p ! .034; duration: H ! 9.34, p ! .025) and
female animals (count: H ! 11.26, p ! .01; duration: H !
10.94, p ! .012). On both parameters, results of the male and
female progeny of DEX-treated animals were significantly
different from those of vehicle- and CORT-treated mothers.
The results for the progeny of CORT-treated rats were not
significantly different from those found in control animals
except in the number of rearings in male animals. Animals
exposed to high or low doses of DEX during the antenatal period
did not differ on these parameters, but DEX0.1 female animals
displayed decreased rearing activity when compared with CORT-
treated animals. Duration of rearing was longer in female than in
male subjects (p ! .02).
Data from 8-month-old rats showed that impaired exploratory
activity was retained in older rats. In fact, all parameters analyzed
were affected by treatment (H ! 7.62, p ! .022; H ! 8.24, p !
.016; H ! 7.79, p ! .02; H ! 8.02, p ! .018, respectively, for
percentage of time in central area, total distance traveled, rearing
count, and duration). Comparisons between groups revealed that
the progeny of DEX-treated animals displayed significantly less
time in the center of the arena and decreased locomotion and
rearing activity when compared with control animals and CORT-
exposed animals.
DEX Treatment in Late Gestation Triggers a High-Anxiety
Phenotype in Adulthood
Analysis of variance revealed that the ratio of time spent in
open arms (vs. total time) in the elevated plus maze (Figure 4A)
was significantly affected by antenatal treatment in both male (H !
18.83, p ! .001) and female (H ! 12,84, p ! .005) animals.
Treatment of mothers with DEX significantly reduced the per-
centage of time spent in the open arms as compared with control
animals and CORT-treated rats in both sexes. Progeny of CORT-
treated rats displayed scores that also differed from DEX0.1 in
male animals but not in female animals; no significant differences
were found between animals treated with high versus low doses
of DEX.
Analysis of the number of open arm entries (Figure 4B)
revealed a significant effect of treatment in male animals (H !
12.07, p ! .007) and female animals (H ! 16.28, p ! .001).
Offspring of DEX-treated mothers showed a lower number of
entries into the open arms compared with control animals.
Offspring of CORT-treated dams differed from DEX1 and DEX0.1
in male animals, while DEX0.1 and DEX1 did not differ in both
male animals and female animals.
Groups did not differ in the number of closed arm entries in
both male animals and female animals (Figure 4C).
Similar behavioral patterns were observed when the offspring
of CORT- and DEX-treated mothers were tested at 8 months of
age; notably, however, none of the parameters analyzed reached
statistical significance.
Spatial Memory Is Not Influenced by
Antenatal Corticotherapy
In the place-learning task of the Morris water maze, all
animals improved their performance throughout the 5 days of
testing (Figures 5A, 5B). Repeated measures analysis of the data
on mean escape latency failed to reveal significant differences
between any of the experimental groups.
Figure 4.Dexamethasone treatment in lategestationproduces ahigh-anxiety
phenotype in adulthood. Results of the elevated plusmaze test at 2 (2m) and 8
months (8m) of age in the male and female progeny of vehicle- (CONT), corti-
costerone- (CORT), and dexamethasone- (DEX) treated pregnant rats. (A) Ratio
of time spent in open arms over closed arms. (B)Number of open arm entries.
(C)Number of closed arm entries. Error bars represent SEM. *p" .05.
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Antenatal Corticotherapy Increases Susceptibility
to Depressivelike Behavior
Duration of immobility and latency to immobility in the FST
were significantly affected by the factor “trial number” (p ! .001,
Figure 6A and p ! .001, Figure 6B, respectively). None of the
experimental groups differed on any of the parameters measured
when the FST was applied in basal conditions. However, be-
tween-group differences became evident when the FST was
applied to animals that were previously exposed to the CMS
paradigm (H " 6.63, p " .036 for immobility time and H " 7.63,
p" .02 for latency to immobility): notably, antenatal exposure to
either CORT or DEX1 resulted in a significant increase in
immobility in the FST, and the latency to display of immobility
was also significantly reduced in rats exposed to DEX1 and
CORT.
Comparison between the FST before and after exposure to
CMS revealed that prenatal treatments with DEX1 and CORT
were associated with significantly increased immobility in the
FST and decreased latency to display immobility. No significant
differences were found in the FST between the CORT and DEX1
groups or between the genders.
Discussion
Fetal development is, in part, determined by the maternal
environment through the passage of chemical signals across the
placenta. Moreover, in utero experience strongly influences
growth and brain development in later life. Of particular rele-
vance to psychiatry is the increasing evidence that adverse
conditions during early life can predispose individuals to mood
and anxiety disorders in adulthood (Heim and Nemeroff 1999;
Kaufman and Charney 2001; Vythilingam et al 2002). The data
presented here clearly show that corticosteroid treatment during
pregnancy increases anxietylike behavior in adult offspring.
They also show that exposure to corticosteroids during prenatal
life can program the brain such that it becomes more likely to
express depressionlike behavior following exposure to stressful
experience. Both the increased anxiety and vulnerability to
succumb to lifetime stressors may be related to the fact that
antenatal corticosteroids interfere with the mechanisms govern-
ing glucocorticoid negative feedback at the neural and/or hypo-
physeal levels (Charmandari et al 2005; Welberg and Seckl 2001;
Weaver et al 2004).
While fetal production of glucocorticoids occurs relatively late
in gestation, maternal corticosteroids can cross the placental
barrier (Dalle and Delost 1979; Gitau et al 2001). Synthetic
corticosteroids such as dexamethasone also have access to the
fetus, but unlike their endogenous counterparts, they do not bind
to corticosteroid binding globulin (CBG) and, as such, neither the
mother nor fetus can buffer their actions. Our findings that
prenatal administration of either CORT or DEX results in accel-
erated eye opening (a measure of neurological development)
and retarded body growth are in keeping with the view that
corticosteroids can act permissively to accelerate some develop-
mental processes (cf. Gransbergen and Mulder 1998; Neal et al
2004; Slotkin et al 1992), while transiently or permanently
delaying others (cf. Gransbergen and Mulder 1998). Interestingly,
impeded somatic growth, one of the best-known deleterious
effects of antenatal corticosteroid exposure, was here found to be
more prominent after antenatal treatment with DEX, as com-
pared with CORT, even when administered at equivalent doses
(in terms of gene transrepressive potency). Within the context in
which the present work was done, it is important to note that the
similarity of the behavioral phenotypes of the high-dose and
low-dose DEX-treated animals was greater than that between
animals treated with low-dose DEX versus CORT.
Corticosteroids differ in their quality and magnitude of effects
according to whether they activate MR, GR, or both of these
receptors. In biological assays, DEX displays up to 25-fold greater
selectivity for GR as compared with CORT, which elicits both
mineralocorticoidlike and glucocorticoidlike effects. Chronic GR
activity is associated with numerous peripheral and central
pathologies. In contrast, a “yin-yang” relationship between MR
and GR is thought to help maintain homeostasis and health.
Stress can disrupt the subtle mechanisms governing the MR/GR
Figure 5. Spatial memory is not influenced by antenatal corticotherapy. Results of the place-learning task on the Morris water maze performed at 2 months
of age inmale and female offspringof vehicle- (CONT), corticosterone- (CORT), anddexamethasone- (DEX) treated rats ongestationdays 18 and19. Data from
each day were grouped and learning analyzed in blocks of trials. Error bars represent SEM.
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balance and lead to chronic hyperactivity of the HPA axis due to
an impairment of glucocorticoid negative feedback mechanisms
(De Kloet 2003). Hypersecretion of corticosteroids is strongly
linked with depressive illness (Gold and Chrousos 2002; Hols-
boer 2000). The corticosteroid hypothesis of mood disorders is
centered on the finding of aberrant responses to the DST or
DEX/CRH tests (Evans and Nemeroff 1987; Holsboer 2000) in a
sizeable proportion of patients suffering from major depression.
Increased anxiety can predispose an individual to develop
depression, and it is therefore interesting to note that impaired
glucocorticoid feedback also seems to underlie anxiety disorders
(Reul and Holsboer 2002; Strohle and Holsboer 2003).
The present observations that antenatal DEX, but not CORT,
produces persistent effects on emotionality are important in light
of the above-mentioned associations between the HPA axis,
emotionality, and mood. On the other hand, although control,
antenatal CORT-treated, and DEX-treated animals showed equal
rates of acquisition of learned helplessness (FST), we observed
that animals treated during prenatal life with either CORT or DEX
were more susceptible to the development of depressionlike
symptoms (performance in FST) if they had additionally been
exposed to chronic mild stress. Interestingly, animals exposed to
antenatal CORT and DEX also showed similar impairments in the
DST.
How can the similar responses of the CORT and DEX groups
in the DST and FST (after stress) be reconciled with their differing
emotional states? One potential explanation may be found in the
fact that anxiety and depression result from changes in distinct
neurochemical and anatomical substrates; each of these sub-
strates are likely to display differing sensitivity to corticosteroids,
reflecting their differing rates of development and relative ex-
pression of GR and/or MR (Jutapakdeegul et al 2003; McCormick
et al 2000; Owen and Matthews 2003; Rosenfeld et al 1993). Thus,
brain structures governing emotionality (primarily, the amyg-
dala) versus spatial memory (primarily, the hippocampus) may
be subject to differential programming by corticosteroids during
specific time windows (cf. Brabham et al 2000; Weinstock 1997).
In addition, the possibility that individual brain areas may only
become vulnerable after certain thresholds (magnitude and/or
duration of hypercortisolism) have been reached should be
considered.
The pronounced differences between the emotional states of
animals exposed to antenatal CORT versus DEX deserve consid-
eration of the likely underlying neurobiological mechanisms.
The hyperanxiety induced by antenatal DEX points to the
amygdala (or its regulatory circuits) as a key target(s) of this
GR-selective corticosteroid. Concordant with this, it is pertinent
to note that DEX has been previously shown to increase the
messenger RNA (mRNA) levels of corticotropin releasing hor-
mone (CRH) in the central nucleus of the amygdala (CeA) and of
GR and MR in the basolateral division of the amygdala (BLA)
(Welberg et al 2001), while endogenous corticosteroids do not
seem to affect the latter (Welberg et al 2000).
Sex-specific neuroendocrine alterations in response to the
prenatal corticosteroid milieu, as shown by Dean and Matthews
(1999), may also indirectly impact on the expression of emo-
tional and cognitive behaviors. The basal corticosterone secre-
tion profiles in animals exposed to antenatal corticosteroids
confirmed previous studies showing that such antenatal treat-
ments do not interfere with gender differences in HPA axis
activity (Kitay 1961; Critchlow et al 1963). Interestingly, gender
did not prove to be a significant factor in any of the behavioral
measurements in the present study. However, we observed that
changes in emotional behavior were generally more pronounced
in female animals, in agreement with a previous report that the
behavioral effects of prenatal stress are more profound in female
subjects (Bowman et al 2004). Thus, it is important to consider
cyclic changes in ovarian activity in future work on this issue,
especially in light of a report showing that corticosteroid-induced
prenatal programming includes effects on ovarian cyclicity (Liu
et al 2001) and the fact that there are profound male-female
Figure 6. Antenatal corticotheraphy increases susceptibility to depressive-
like behavior. Susceptibility to depressivelike behavior in the progeny of
vehicle- (CONT), corticosterone- (CORT), anddexamethasone- (DEX) treated
pregnant rats was assessed in forced swimming tests before or after expo-
sure to a chronicmild stress (CMS) paradigm. (A)Duration of immobility. (B)
Latency to immobility. Error bars represent SEM. *p! .05.
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differences in anxiety-like behavior under basal conditions (cf.
Mitev et al 2003).
The present study demonstrates that prenatal exposure to
glucocorticoids leads to long-lasting effects on brain function and
that these effects vary according to the pharmacological profile of
the drug used. Interestingly, while exposure to DEX and CORT
do not differ in their ability to influence cognitive processes and
susceptibility to stress-induced depressionlike behavior, animals
exposed to antenatal DEX show a hyperanxious phenotype.
Although caution should be exerted in extrapolating these
findings in the rat to humans, they provide an impetus for clinical
investigations on this topic, given that glucocorticoids are usually
administered during equivalent (late) phases of human preg-
nancy (Jobe 2003). We propose that cortisol/hydrocortisone
might be a better alternative to DEX therapy during pregnancy.
This view is bolstered by reports showing that cortisol (1 g/kg)
has the same therapeutic efficacy as DEX and other closely
related potent GR agonists such as betamethasone during preg-
nancy (Crowley 1995) and neonatal life (Watterberg 2004). The
fact that DEX (unlike natural corticosteroids) does not bind to
CBG allows this glucocorticoid to easily cross the placenta; thus,
the lack of endogenous buffering capacity most likely contrib-
utes to the programming of hyperemotionality by antenatal DEX.
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Abstract
Rationale Several human and experimental studies have
shown that early life adverse events can shape physical and
mental health in adulthood. Stress or elevated levels of
glucocorticoids (GCs) during critical periods of develop-
ment seem to contribute for the appearance of neuro-
spyschiatric conditions such as anxiety and depression,
albeit the underlying mechanisms remain to be fully
elucidated.
Objectives The aim of the present study was to determine the
long-term effect of prenatal exposure to dexamethasone- DEX
(synthetic GC widely used in clinics) in fear and anxious
behavior and identify the neurochemical, morphological and
molecular correlates.
Results Prenatal exposure to DEX triggers a hyperanxious
phenotype and altered fear behavior in adulthood. These
behavioral traits were correlated with increased volume of
the bed nucleus of the stria terminalis (BNST), particularly
the anteromedial subdivision which presented increased
dendritic length; in parallel, we found an increased
expression of synapsin and NCAM in the BNST of these
animals. Remarkably, DEX effects were opposite in the
amygdala, as this region presented reduced volume due to
significant dendritic atrophy. Albeit no differences were
found in dopamine and its metabolite levels in the BNST,
this neurotransmitter was substantially reduced in the
amygdala, which also presented an up-regulation of
dopamine receptor 2.
Conclusions Altogether, our results show that in utero DEX
exposure can modulate anxiety and fear behavior in parallel
with significant morphological, neurochemical and molec-
ular changes; importantly, GCs seem to differentially affect
distinct brain regions involved in this type of behaviors.
Keywords Anxiety . Fear . Amygdala . Glucocorticoid .
Prenatal . BNST. Stereology . Neurodevelopment .
Corticosteroids . Dopamine
Introduction
Since the initial evidence on its benefit in the prevention of
respiratory distress syndrome in preterm infants (Liggins
and Howie 1972), antenatal glucocorticoids (GCs) have
gained wide clinical use in the enhancement of fetal lung
maturation in pregnancies at risk of preterm delivery (Crane
et al. 2003; Crowley 1995; NIH 1995). In fact, accumulat-
ing evidence shows a substantial decrease in neonatal
morbidity and mortality, which strongly supported the
recommendations for its clinical use (Hofmeyr 2009; NIH
1995). Additionally, antenatal GCs have been use to treat
other conditions such as congenital adrenal hyperplasia
(Speiser et al. 2010).
GCs act predominantly through intracellular receptors
which control the transcription of GC-responsive target
genes (Matthews 2001). While endogenous GCs (cortico-
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sterone in rats and cortisone in humans), at basal levels,
display higher affinity to the mineralocorticoid receptors
(MR), leaving glucocorticoid receptors (GR) receptors
largely unoccupied (De Kloet et al. 1998), synthetic GCs
such as dexamethasone (DEX) can readily cross the
placenta and bind almost exclusively to GR (Reul et al.
1987). GRs can also be activated when endogenous GC
secretion is elevated and this chronic activation is noxious
for both the periphery and the brain (Sapolsky 1999). One
relevant finding is that despite both being efficacious in
preventing respiratory distress syndrome (Crowley 2000),
synthetic GCs effects seem to be more deleterious than
endogenous GCs (Oliveira et al. 2006).
While the use of antenatal GCs triggers long-term gains
in several clinical conditions, evidence is also revealing the
detrimental effects of antenatal exposure to these hormones;
in fact, it is now established a correlation between GC
exposure in early life with several metabolic (Barker 1995;
Lindsay et al. 1996) and emotional and mood disorders in
both animal models and humans in adulthood (Mesquita et
al. 2009; Weinstock 2001). These so-called “programming
effects” of GCs may result from endocrine, morphological,
neurochemical, and molecular changes in specific brain
regions; as examples, we have shown that antenatal
exposure to DEX significantly changes the mesolimbic
circuit (Leao et al. 2007) while others have shown
deleterious effects in the prefrontal cortex (Diaz Heijtz et
al. 2010), amygdala and hypothalamus (Nagano et al.
2008). Importantly, previous studies from our lab have
shown that antenatal exposure to GCs induces a hyperemo-
tional phenotype in adulthood (Oliveira et al. 2006). Given
the established role of the amygdala and bed nucleus of
stria terminalis (BNST) in fear and anxiety (Davis 1992a, b,
1998, 2006), herein we decided to perform an extensive
morphological and molecular analysis of these brain
regions in adult animals exposed to antenatal DEX and to
search for correlations with fear and anxiety behaviors.
Materials and methods
Animals and treatments
Experiments were conducted in accordance with European
Union regulations (Directive 86/609/EEC) and National Insti-
tutes of Health guidelines on animal care and experimentation.
Fourteen pregnant Wistar rats (Charles River Laboratories,
Barcelona, Spain) were individually housed under standard
laboratory conditions (room temperature 22°C; 12/12 h light/
dark cycle; food and water ad libitum). Subcutaneous
injections of dexamethasone (DEX, 1 mg/kg;N=7) or vehicle
(CONT, 1 mL/kg; N=7) were administered on embryonic
(ED) 18 and 19 of pregnancy, as previously described
(Oliveira et al. 2006; Oliveira et al. 2011). Weaning was
carried out at postnatal day 21; male offspring was randomly
distributed in groups of two animals per cage according to
treatment. Ten males from 4 to 5 different litters of each
treatment were tested for behavior at 3 months age.
Elevated plus maze
The elevated plus maze test, used to assess the degree of
anxiousness, was performed on a black polypropylene plus-
shaped platform elevated 72.4 cm above the floor (ENV-
560; MedAssociates Inc, St Albans, VT, USA). The maze
consisted of two open arms (50.8×10.2 cm) and two closed
arms (50.8×10.2×40.6 cm). Animals were tested over a
period of 5 min, under bright white light. The number of
entries into each of the arms and the time spent therein were
recorded using a system of infrared photobeams. Data were
processed to obtain the ratio of time spent in the open arms
versus total time and the number of entries into each arm of
the maze.
Acoustic startle as a function of stimulus intensity
Acoustic startle reflex was measured in a startle response
system (SR-LAB, San Diego Instruments, San Diego, CA,
USA). The apparatus consisted of a non-restrictive Plexiglas
cylinder (inner diameter 8.8 cm, length 22.2 cm), mounted on
a Plexiglas platform and placed in a ventilated, sound-
attenuated chamber. A piezoelectric element detected cylinder
movements. Background white noise (intensity 63 dB) was
used to minimize the impact of external acoustic stimuli.
Animals were habituated to the apparatus (5 min daily)
for 2 days before testing. In the trial day, following a 5-min
acclimatization to the chamber, rats were presented five
baseline startle stimuli (50 ms pulse of white noise at
120 dB) at a 30 s inter-stimulus interval, in order to become
familiarized with the startle stimuli. Then, 60 startle stimuli
were randomly presented (50 ms duration and variable
intensity between 70 and 120 dB at 10 dB increments).
Startle magnitude was assessed at 1 ms intervals, during the
200 ms period following stimulus. Chambers were cleaned
between tests (70% ethanol and water) in order to remove
olfactory cues.
Prepulse inhibition
The test lasted 20 min, following a 5 min acclimatization
period. A white background noise (70 dB) was provided.
Following five introductory 120-dB startle trials (noise lasting
40 ms), a total of 35 test trials were pseudo-randomly
delivered as follows: (a) five trials with background noise
only, (b) 10 startle trials of 120 dB and (c) five prepulses of
each of four different intensities preceding a startle trial.
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Prepulse intensities of 2, 4, 8, and 16 dB above the
background noise level lasted 20 ms and preceded the
120 dB startle presentation in 100 ms. Intertrial intervals
ranged from 10 to 20 s. The average startle response (AVG)
was assessed in the 100 ms period following the onset of the
startle stimulus presentation. The mean AVG for the ten
120 dB startle trials was employed in the formula used to
assess the percentage of reduction in AVG compared to startle
trials alone: % PPI=100 X [1−(AVG at prepulse plus startle
trial)/(AVG at startle trial)].
Fear-potentiated startle
A stainless steel grid was adapted to the floor of the testing
chamber, through which an electric current could be passed
under software control. Following a 5-min acclimatization
period, 20 light-shock pairings were presented at 30 s
intervals. The shock (0.6 mA) was presented during the last
500 ms of the 5 s light pulse (3 W incandescent light bulb).
Following conditioning, animals were returned to their
home cages.
On the testing day, the steel grid used during conditioning,
was maintained. After a 5-min acclimatization, 20 baseline
startle stimuli were presented. Startles were measured. Then,
animals were randomly presented 10 startle stimuli (intensity
120 dB, duration 50 ms), five of them during the last 50 ms of
the delivery of a 5 s luminous conditioned stimulus (CS).
Histological procedures
Following behavioral assessment, eight male animals (derived
from four to five different litters) of each group were placed
under deep pentobarbital anesthesia and transcardially per-
fused with either 4% paraformaldehyde solution (N=4) or
0.9% saline (N=4).
Brains from the former set of subjects were embedded in
glycolmethacrylate (Tecnovit 7100; Heraeus Kulzer, Wer-
heim, Germany) and 30 μm coronal sections were obtained
by microtome (Cerqueira et al. 2005). These were placed on
a gelatinized slide, stained with Giemsa, mounted with
Entellan (Merck, Darmstadt, Germany) and coverslipped.
Shrinkage factor was calculated according to previous
studies (Madeira et al. 1990).
Brains from animals perfused with 0.9% saline were
processed for Golgi–Cox staining as previously described
(Gibb and Kolb 1998); details are given in Electronic
supplementary material (ESM).
Regional boundaries
We analyzed stereological parameters in three regions of
the amygdaloid complex, namely the basolateral anterior
(BLa), lateral (La) and central (CeA), as previously outlined
(Paxinos and Watson 2005). CeA and La nuclei were
differentiated using prior definitions (De Omlos et al. 2004)
and the BLa division was distinguished from surrounding
areas on the basis of cell size and staining intensity (De
Omlos et al. 2004; Krettek and Price 1978). In accordance
with a recent revision of anatomical and projection studies
of the BNST (Dong et al. 2001), three divisions were
considered, the anteromedial (BNSTam), anterolateral
(BNSTal), and posterior (BNSTp). In order to avoid
observer bias and to permit comparison between groups,
the same observer drew all regional boundaries.
Stereological procedures
Volume and cell number estimations were obtained using
StereoInvestigator® software (MicroBrightField, Williston,
VT, USA) and a motorized microscope (Axioplan 2, Carl
Zeiss, Hamburg, Germany) attached to a camera (DXC-
390, Sony Corporation, Tokyo, Japan). The Cavalieri’s
principle (Gundersen et al. 1988) was applied to evaluate
the volume of each region. Average cell numbers were
estimated using the optical fractionator method (West et al.
1991). Coefficients of error were computed according to
previously published formulas for cell numbers (Gundersen
et al. 1999) and volume estimates (Gundersen and Jensen
1987). Detailed methods are provided in the ESM.
Dendritic tree analysis
BLa pyramidal-like, CeA multipolar, and BNSTam bipolar
neurons were chosen as described elsewhere (McDonald
1982a, b, 1983). For each selected neuron, all branches of
the dendritic tree were reconstructed at 600x magnification
using a motorized microscope (Axioplan 2, Carl Zeiss),
with oil-immersion objectives, and attached to a camera
(DXC-390, Sony Corporation) and Neurolucida software
(MicroBrightField). A 3-D analysis of the reconstructed
neurons was performed using NeuroExplorer software
(MicroBrightField). Dendritic branches were sampled in
order to estimate spine density; spines in the selected
segments were classified in thin, wide, ramified and
mushroom categories (Harris et al. 1992). Thin spines were
considered immature, while the other spine types were
classified as mature. A total of 20 neurons/group/area were
drawn (total 120 neurons).
Brain catecholamines
A different set of males was sacrificed by decapitation (n=6
animals derived from three different litters per group). After
brain snap freezing, macrodissection of the amygdala and
bed nucleus of stria terminalis was rapidly performed under
a stereomicroscope (Model SZX7, Olympus America Inc.,
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Center Valley, PA, USA). Whole brains were placed upside
down and, using delicate forceps (Dumont #7 forceps, Fine
Science Tools USA Inc., Foster City, CA, USA), the areas
of interest were dissected according to stereological
coordinates (Paxinos and Watson 2005). Samples were
frozen in liquid nitrogen (overnight at −20°C) after adding
perchloric acid 0.2 M; then, samples were briefly sonicated,
centrifuged and 50 μl aliquots of the supernatant injected
on a high performance liquid chromatography (HPLC)
combined with electrochemical detection system. A mobile
phase of 0.7 M aqueous potassium phosphate (monobasic;
pH 3.0) in 10% methanol, 1-heptanesulfonic acid (222 mg/
l), and Na-EDTA (40 mg/l) was used.
Levels of dopamine, 3,4-dihydroxyphenylacetic acid and
4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid)
were determined using a Gilson instrument (Gilson Inc.,
Middleton, WI, USA), fitted with an analytical column
(Supelco Supelcosil LC-18 3 M; 7.5 cm×4.6 mm; flow
rate: 1.0–1.5 ml/min; Supelco, Bellefonte, PA, USA). A
standard curve was then obtained and data presented as
concentration (nanograms per milligram of tissue protein).
Molecular correlates
In order to establish molecular correlates, the mRNA
expression of dopamine D1 and D2 receptors (Drd1 and
Drd2, respectively) was assessed in the BNST and
amygdala. Moreover, we evaluated the expression of
several synaptic plasticity-related genes, including synapsin
(Syn), brain-derived neurotrophic factor (BDNF) and neural
cell adhesion molecule (NCAM). The amygdala and bed
nucleus of stria terminalis of an additional set of animals (N
=8 animals derived from four different litters/group) were
isolated as described above. For real-time PCR analysis,
total RNA was isolated from frozen areas using Trizol
(Invitrogen) and DNase treated (Fermentas), according to
manufacturer. Two micrograms of RNA were converted
into cDNA using the iSCRIPT kit (Biorad). RT-PCR was
performed using SyberGreen (Qiagen) and the Biorad q-
PCR CFX96 apparatus. HPRT was used as a housekeeping
gene. We used relative quantification to determine the fold
change difference between control and DEX animals, using
the ΔΔCT method as described before (Pfaffl 2001).
Primer sequences available in the ESM.
Statistical analysis
Results are presented as mean ± SEM. A repeated measures
test was used to analyze data from acoustic startle, prepulse
inhibition and fear-potentiated startle; Greenhouse-Geissser
and Huynh–Feldt’s corrections were applied for acoustic
and fear-potentiated startle data, respectively. The compar-
ison of means between groups was performed using the
Student’s t test for the remaining variables. Statistical
significance was considered for P<0.05.
Results
Brief antenatal exposure to DEX triggers hyperanxiety
and impairs fear conditioning
Animals exposed to either DEX 1 mg/kg or vehicle
(controls) at embryonic day 18 and 19 were tested at
3 months of age. Antenatal exposure to DEX resulted in
a significant reduction on the ratio of time spent in open
arm when compared to controls (t=3.636, P=0.004;
Fig. 1a); these results confirm our previous findings
(Oliveira et al. 2006). Furthermore, while the number of
open arm entries was also decreased following DEX
exposure (t=2.424, P=0.026; Fig. 1b), there were no
significant differences between groups in the number of
closed arm entries (t=0.340, P=0.738), thus showing that
the increased anxiety behavior should not be attributed to
locomotory differences.
In the acoustic startle test, startle amplitudes for DEX-
exposed subjects increased more rapidly as a function of
stimulus intensity when compared to controls (F(3,47)=
4.036, P=0.016; Table 1). When comparing responsiveness
to individual noise intensities between groups, DEX-
exposed rats displayed significantly increased startle ampli-
tudes at 70 (t=5.121, P<0.001), 80 (t=4.252, P=0.001), 90
A BFig. 1 Elevated plus maze data.
a Ratio of time spent in open
arm over total time. b Number
of open and closed arm entries.
Data presented as mean ± SEM.
*Different from controls,
P<0.05
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(t=3.537, P=0.006), 100 (t=3.045, P=0.012) and 110 dB
(t=2.452, P=0.025).
Interestingly, the acoustic startle response to inhibitory
prepulses was not affected by exposure to antenatal DEX, as
shown by the analysis of treatment×prepulse intensity
interaction (F(3,54)=3.858, P=0.994; Fig. 2). Moreover,
comparison between groups failed to reveal significant
differences at any prepulse intensity. The fact that all groups
had similar percentages of reduction in the average of startle
response, supports the absence of sensorimotor deficits.
Startle amplitude varied as a function of the treatment×
stimulus interaction in the fear-potentiated startle (F(1,18)=
8.379; P=0.01; Table 2). While controls displayed enhanced
startle amplitude after being presented a conditioned stimulus
startle, DEX exposure resulted in an impaired fear condi-
tioning in the acoustic startle, as shown by the significantly
decreased ratio of conditioned stimulus/basal startle respon-
siveness in the DEX group (t=−2.602, P=0.018; Fig. 3).
Antenatal DEX exposure promotes dendritic remodeling
in the BNST and in the amygdala
To further understand the behavioral findings, we have
performed a detailed morphological characterization of
the BNST and amygdala brain regions, known to be
involved in fear and anxiety, respectively (Walker and
Davis 1997).
Volumetric determinations reveal that antenatal exposure
to DEX resulted in an increase in BNST total volume (t=
3.841, P=0.009; data not shown). This effect was largely
due to increased volumes in anteromedial division of the
BNST of DEX-exposed animals (t=5.887, P=0.001;
Fig. 4a); conversely, the volumes of BNSTal and BNSTp
were not influenced by such antenatal exposure (t=−0.484,
P=0.646 and t=0.718, P=0.500, respectively). DEX
exposure during pregnancy did not affect the total number
of cells in the BNST (t=1.595, P=0.162) nor in its
divisions (BNSTam: t=1.475, P=0.191; BNSTal: t=
−1.506, P=0.183; BNSTpost: t=0.946, P=0.381; Fig. 4b).
The volumetric increase in the BNST was further
scrutinized through a 3-D morphological analysis of
dendritic arborizations of neurons in the BNSTam; the
neurons in this brain region were previously described as
cells with ovoid soma, moderate polarized dendritic
Fig. 2 Prepulse inhibition test. Percentages of reduction in average
startle response compared with startle trials at prepulse intensities of 2,
4, 8, and 16 dB above background noise level
Table 1 Acoustic startle data
Noise (dB) Controls DEX
70 dB 30.51±3.03 97.50±15.07 *
80 dB 32.50±4.72 291.17±86.56 *
90 dB 145.19±21.39 561.26±115.66 *
100 dB 1203.54±168.88 3126.46±608.44 *
110 dB 4645.30±461.93 6221.83±447.09 *
120 dB 6358.69±257.17 7101.62±519.47
Startle amplitude (arbitrary units) in response to acoustic stimulus.
Data presented as mean ± SEM
*P<0.05, different from controls
Fig. 3 Fear-potentiated acoustic startle data. Data presented as the
average of ratios between conditioned stimulus/basal startle respon-
siveness ± SEM. *Different from controls, P<0.05
Table 2 Fear-potentiated acoustic startle data
Controls DEX
Startle 5290.89±658.66 5252.08±716.75
CS+startle 6229.04±425.83 4554.13±577.61*
Startle amplitude (arbitrary units) in response to acoustic stimulus with
or without previous conditioned stimulus (CS). Data presented as
mean ± SEM
*P<0.05, different from controls
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branching, with sparse spines (McDonald 1983). Data
revealed that antenatal exposure to DEX resulted in a
significant increase of total dendritic length when compared
to controls (t=4.498, P<0.001; Table 3). Spine densities
were not affected by antenatal DEX treatment (t=−1.779, P=
0.085), even when a separate analysis of mature (t=−1.825,
P=0.076) and immature forms (t=−0.534, P=0.0596) was
performed.
In contrast to the BNST, antenatal exposure to DEX
resulted in a decreased volume of BLa and CeA divisions
of the amygdala (BLa t=−3.564, P=0.02; CeA t=−3.072,
P=0.027) but not in the La division (t=−0.561, P=0.605)
(Fig. 4c). No effect was observed on the estimated number
of cells in the BLa, CeA and La divisions of the amygdala
(t=1.457, P=0.196; t=−1.383, P=0.216; t=−0.725, P=0.496,
respectively; Fig. 4d).
The analysis of the dendritic arborizations of pyramidal-
like neurons in the BLa region of the amygdala, which
represent the predominant cell type in the area (70%; type I)
(McDonald 1982b; Sah et al. 2003), revealed a reduction in
total and basal dendritic lengths following DEX treatment
(t=−2.471, P=0.018 and t=−3.252, P=0.002, respectively;
Table 3); however, apical dendritic length was not affected
(t=−0.832, P=0.411) by antenatal DEX exposure. The
density of spines in these neurons was not affected by
antenatal exposure to DEX (t=0.165, P=0.870), even when
assessing mature and immature spines separately (t=−0.122,
P=0.903 and t=0.598, P=0.555, respectively).
Treatment also affected the CeA predominant cell type,
previously called medium spiny neurons (by comparison
with neurons in the striatum; Sah et al. 2003). These
neurons have an ovoid or fusiform soma and three to five
nonspiny primary dendrites from which moderately spiny,
sparsely branching secondary and tertiary dendrites arise.
These neurons in the DEX progeny displayed a significant
A B
C D
Fig. 4 a Estimated volumes of
anterolateral (BNSTal), antero-
medial (BNSTam) and posterior
(BNSTpost) divisions of the bed
nucleus of stria terminalis. Data
presented in cubic millimeters, as
mean ± SEM. b Estimated total
number of cells in the antero-
lateral (BNSTal), anteromedial
(BNSTam) and posterior
(BNSTpost) divisions of the bed
nucleus of stria terminalis. c
Estimated volumes of BLa, CeA,
and La divisions of the amygda-
la. Data presented in cubic milli-
meters, as mean ± SEM. d
Estimated total number of cells in
the BLa, CeA, and La divisions
of the amygdala. Data presented
as mean ± SEM; *Different from
controls, P<0.05
Table 3 Dendritic length and spine density of bipolar neurons of
anteromedial region of the bed nucleus of stria terminalis (BNSTam),
pyramidal-like neurons of basolateral amygdaloid nucleus (BLa), and
multipolar neurons of the central nucleus of the amygdala (CeA)
Controls DEX
BNSTam (bipolar)
Dendritic length (μm) 395±17 511±19*
Density of spines (n/μm) 0.58±0.042 0.49±0.027
Mature 0.47±0.035 0.39±0.026
Immature 0.10±0.015 0.09±0.016
BLa (pyramidal)
Dendritic length (μm) 1969±128 1506±137*
Basal dendrites 1088±87 721±72*
Apical dendrite 881±80 785±83
Density of spines (n/μm) 0.95±0.046 0.95±0.027
Mature spines 0.71±0.037 0.70±0.026
Immature spines 0.24±0.022 0.26±0.012
CeA
Dendritic length (μm) 818±38 670±19*
Density of spines (n/μm) 0.45±0.043 0.47±0.037
Mature 0.35±0.039 0.36±0.032
Immature 0.09±0.009 0.12±0.015
Data presented as mean ± SEM
*P<0.05, different from controls
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dendritic atrophy when compared to controls (t=−3,491,
P=0.002; Table 3). No effect was found on the densities of
total, mature and immature spines (t=0.435, P=0.666,
t=0.023, P=0.982 and t=1.332, P=0.191, respectively).
Neurochemical and molecular correlates
To complement the behavioral and morphometric analysis,
we decided to measure dopamine levels and its metabolites.
Antenatal DEX exposure had no effect on the concentration
of dopamine in the BNST, nor its turnover (dopamine
t=0.026, P=0.980; dopamine turnover t=0.291, P=0.777;
Fig. 5a–b).
In contrast, the neurochemical analysis in the amygdala
revealed a decrease in dopamine concentration following
antenatal exposure to DEX (t=5.006, P=0.001; Fig. 5c).
Moreover, dopamine turnover was significantly increased
in these subjects (t=−4.405, P=0.001; Fig. 5d).
At a molecular level, and given the impact of antenatal
DEX exposure on dendritic arborization, we assessed the
expression of the synaptic plasticity-related genes in the
BNST and amygdala, namely a synaptic gene (synapsin
(Syn)), a neurotrophin (brain-derived neurotrophic factor
(BDNF)) and a cell adhesion molecule (neural cell adhesion
molecule (NCAM)), all known to be involved in synaptic/
dendritic plasticity. Moreover, as the dopaminergic innerva-
tion of the BLa is considered to facilitate amygdala-dependent
functions (Asan 1997), and since a hypodopaminergic status
was previously associated with DEX exposure (Leao et al.
2007; Rodrigues et al. 2010), the expression of dopamine D1
and D2 receptors (Drd1 and Drd2, respectively) was also
evaluated.
In the BNST, DEX-exposed animals displayed increased
expression of synapsin (t=−2.418, P=0.030) and NCAM
(t=−2.032, P=0.045) (Table 4). No significant differences
between groups were found in the expression of the
remaining genes analyzed (Drd1 t=−0.663, P=0.514;
Drd2 t=−0.881, P=0.386; BDNF t=−0.214, P=0.832).
In the amygdala, Drd2 mRNA levels were significantly
increased in the DEX-exposed subjects (t=−3392, P=0.008),
while Drd1 were not affected (t=0.370, P=0.717; Table 4).
The expression levels of the synaptic plasticity-related genes,
namely synapsin, BDNF and NCAM were not significantly
different between groups (t=0.546, P=0.594, t=−1.457,
P=0.167 and t=−0.376, P=0.713, respectively).
Discussion
In utero and early postnatal environment, namely the GC
milieu, is crucial for neurodevelopment not only through its
activational effects, but also through important program-
ming effects. Increasing evidence suggests that early life
exposure to GC triggers undesired metabolic, cardiovascu-
lar, neuroendocrine and behavioral phenotypes in adulthood
(Mesquita et al. 2009). Both synthetic (such as DEX) and
naturally occurring GCs are able to exert a programming
effect in the brain; however, it is important to remember
that their effects can be quite distinct (Oliveira et al. 2006)
as endogenous GCs preferentially bind to MR, whereas
A B
DC
Fig. 5 Neurochemical analysis
by HPLC of the bed nucleus of
stria terminalis (BNST) (a–b) and
the amygdala (c–d). a, c Concen-
tration of each neurotransmitter
(nanograms per milligram of pro-
tein) is presented. 3,4-dihydroxy-
phenylacetic acid (DOPAC) and
4-hydroxy-3-methoxyphenylacetic
acid (homovanillic acid, HVA). b,
d Dopamine turnover assessed by
the ratio between dopamine
metabolites and dopamine con-
centrations. Data presented as
mean ± SEM
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DEX binds almost exclusive to GR (Reul et al. 1987), the
receptors that mediate most of the detrimental effects of
GCs. Although it has been argued that synthetic GCs have a
limited capacity to reach the brain in mice (De Kloet et al.
1975), its deleterious effects in the central nervous system
are undeniable (Cerqueira et al. 2005; Cerqueira et al. 2007;
Leao et al. 2007; McArthur et al. 2005; Yu et al. 2010),
specially in rats, and may arise from the use of higher
dosages which can indeed pass the barriers and activate
brain GC receptors (Miller et al. 1992; Reul et al. 1987).
Moreover, in the context of the present study, it is important
to highlight the fact that the exposure to DEX has occurred
during a period in which the brain barriers are still
immature (Saunders et al. 2000).
The data herein presented extends our previous obser-
vations that antenatal exposure to DEX results in anxiety-
like behavior in adult animals (Oliveira et al. 2006). In fact,
while we confirmed a hyperanxious phenotype in the
elevated plus maze, we also found an increased acoustic
startle response (ASR) in DEX-exposed rats. The startle, a
fast protective response from the organism to a sudden and
intense stimulus (Koch 1999), is considered an indicator of
anxiety-like behavior. The ASR results from the activation
of a trisynaptic circuit, where auditory inputs from several
brainstem nuclei (dorsal cochlear nucleus, cochlear root
nucleus, ventral cochlear nucleus, lateral superior olive and
ventrolateral tegmental nucleus) are conveyed to a main
sensorimotor interface, the caudal pontine reticular nucleus,
which then projects to spinal motor neurons to trigger the
motor response (Koch 1999; Lee et al. 1996). Importantly,
it was demonstrated that a direct projection from the BNST
to the caudal pontine reticular nucleus, but also an indirect
one via the CeA, are responsible for the modulatory
response of stressors upon the ASR (Davis et al. 1997).
The BNST is one of the relay stations that conveys
inputs from stress-sensitive areas of the cortex and limbic
system both to the HPA axis but also to brain stem nuclei
implicated in several emotional behaviors (Herman and
Cullinan 1997). Here, we show a hypertrophy of the BNST,
due to the enlargement of its anteromedial region. Interest-
ingly, this region presented alterations in the expression
levels of NCAM, a molecule important for neuronal
plasticity (Bisaz and Sandi 2010; Nacher et al. 2002).
Augmented levels of synapsin, a protein involved in the
regulation of neurotransmitter release (Rosahl et al. 1995),
also suggest increased synaptic activity of this brain region
in DEX-exposed animals, which is in line with the
increased dendritic arborization of these animals. Such
plastic changes are paralleled with an increased startle
response, thus supporting the idea of an overactivation of
this brain subregion. This increased activity of the BNSTam
is also in accordance with our previous observation of a
hyperresponsive HPA axis in these subjects (Oliveira et al.
2006). Importantly, the activational increase of circulating
corticosteroids might further promote the activation of the
BNST as it is known that these hormones are implicated in
the neuroanatomical changes observed in this brain region
(Pego et al. 2010).
Several projections to the caudal pontine reticular
nucleus are considered responsible for the increase in
startle amplitude induced by fear conditioning to a previous
neutral stimulus. These include projections from the CeA,
either direct or via mesencephalic reticular formation and
deep layers of superior colliculus, but also indirect
projections from the medial amygdala via ventromedial
hypothalamus and ventral periaqueductal gray (Davis
2006). Previous data supports that while baseline startle
amplitudes are not affected by interference with these
connections, the response to fear conditioning is. Interest-
ingly, we here show that antenatal DEX exposure impairs
fear conditioning in adulthood, which is consistent with
deficits in amygdalar function and memory consolidation
for emotionally arousing experiences. These results, togeth-
er with previous data showing that early life stress (neonatal
isolation) resulted in impairment of context-induced fear
conditioning in adult male rats (Kosten et al. 2006),
Table 4 Gene expression analysis (measured by real-time PCR) in amygdala and bed nucleus of stria terminalis (BNST)
Treatment Drd1 Drd2 Syn BDNF NCAM
BNST
Controls 0.950±0.12 1.070±0.12 0.918±0.05 1.127±0.14 0.987±0.04
DEX 1.229±0.21 1.226±0.13 1.200±0.11* 1.196±0.27 1.318±0.25*
Amygdala
Controls 1.066±0.13 0.927±0.07 1.167±0.19 0.920±0.04 1.043±0.10
DEX 0.990±0.16 2.494±0.62* 1.060±0.04 1.102±0.12 1.115±0.17
The mRNA expression levels are presented as the fold change increase in relation to the respective control. Data presented as mean ± SEM.
Dopamine D1 receptor (Drd1), dopamine D2 receptor (Drd2), synapsin (Syn), brain-derived neurotrophic factor (BDNF) and neural cell adhesion
molecule (NCAM)
*P<0.05, different from controls
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confirms that fear conditioning can be modulated by
adverse early life events. The role of different divisions of
the amygdala in fear behavior, in particular the CeA and
BLa, has been extensively studied. Several forms of CeA
lesions have been correlated with disruption of fear-
potentiated startle (Campeau and Davis 1995; Hitchcock
and Davis 1987; Walker and Davis 1997). Electrolytic
lesions of the CeA completely blocked the expression of
fear-potentiated startle in rats (Kim and Davis 1993).
Conversely, inactivation of BNST did not disrupt fear-
potentiated startle (Gewirtz et al. 1998; Walker and Davis
1997); however, more recently, it has been suggested that
BNSTlat tonically inhibits fear-potentiated startle, probably
through projections to the CeA (Meloni et al. 2006). Thus,
the present observations of decreased volumes in the CeA
and BLa in DEX-exposed rats are likely to be implicated in
the changes in fear conditioning displayed by these
animals; once again, the volumetric decreases in these
amygdalar divisions result largely from dendritic atrophy—
which fits previous observations of the effects of chronic
unpredictable stress in the BLa (but not the CeA; Vyas et al.
2003; Vyas et al. 2002). It is relevant to stress at this point
that others have shown that a single course of betametha-
sone at postnatal day one failed to affect volumes of
cerebral cortex, corpus callosum, hippocampus, dentate
gyrus or amygdala (Yossuck et al. 2006), however, several
technical differences may explain this discrepancy. The
time of the exposure and the nature of insults seems to be
critical issues to consider, as several windows of vulnera-
bility to the programming effects of different stimuli seem
to occur. Indeed, stress effects in neuronal morphology of
specific brain regions are not necessarily equal across life
and depend on the type of stress. While stress effects in the
BNST morphology seem more similar, since different types
of stress induce a general hypertrophy of dendrites in the
neurons of this brain region (Pego et al. 2008; Vyas et al.
2003), the effects of stress in the amygdala are less
concordant to our present observation of dendritic atrophy.
Whereas chronic juvenile stress leads to a general hyper-
trophy of amygdalar dendrites (Eiland et al. 2011), others
failed to find any significant change in dendritic structure
after stress exposure in adulthood (Pego et al. 2008) and
others have shown remarkably divergent changes in
amygdalar neurons following different types of stress (Vyas
et al. 2003; Vyas et al. 2002).
Remarkably, such morphological effects in the amygdala
were accompanied by changes in dopamine but not other
catecholamines levels. Dopamine, arising mainly from the
VTA, plays a facilitative role in the function of the
amygdala (Asan 1997). In vitro studies also suggest that
the excitability of amygdalar, namely BLa, neurons is
modulated by dopamine (Kroner et al. 2005). In addition,
behavioral data showed that VTA lesion results in blocked
fear-potentiated startle (Borowski and Kokkinidis 1996). At
least in part, the facilitation of affective behaviors by DA
may be explained by actions at the cellular level on BLa
neurons. It has been suggested that DA receptor activation
could simultaneously facilitate the BLa output in response
to strong inputs that cause spike firing, while suppressing
weaker inputs via activation of GABAergic interneurons
(Kroner et al. 2005). Thus, the present observation of a
hypodopaminergic status in the amygdala seems to be of
relevance to the deficits in fear memory. In fact, it confirms
observations in models of dopamine deficient mice (Fadok
et al. 2010), in which the restoration of dopamine in the
BLa was shown to be required for the formation of fear-
related memory (Fadok et al. 2010). Dopamine levels in the
amygdala are also determinant for sensorimotor gating, as it
was shown that NAcc and amygdalar infusions of this
neurotransmitter significantly impair PPI (Swerdlow et al.
1992); surprisingly, we did not find any differences in PPI
in DEX-exposed animals, which is also in accordance with
another previous study (Hauser et al. 2006).
Herein, the decreased amygdalar levels of dopamine are
associated with increased expression of D2 receptor mRNA
in DEX-exposed subjects; such up-regulation could be seen
as a compensation mechanism. Remarkably, no differences
were found in D1 receptor expression, suggesting that D2
receptor has a prominent role in fear behavior. Indeed,
while D1 receptors may participate in recognition of
danger, D2 receptors seem to have a role in setting up
adaptive responses to adverse stimuli (de la Mora et al.
2010). Moreover, D2 (but not D1) antagonists injection in
the BLa impairs fear-potentiated startle probably due to
reduced dopaminergic tone (de Oliveira et al. 2011), which
is in agreement with the amygdalar hypodopaminergic
status seen in DEX-exposed animals. These findings are
consistent with recent data showing that D2 receptor
pathway connecting the VTA and BLa modulates condi-
tioned fear (de Oliveira et al. 2011).
The present findings unravel the impact of antenatal
exposure to DEX in the brain regions implicated in fear and
anxiety behaviors. We show that subjects exposed to GCs
during neurodevelopment present marked neuroanatomical,
neurochemical and molecular programming changes in the
BNST and amygdala, and are more vulnerable to anxiety
and fear pathology in adulthood. Thus, our findings further
support the concerns raised on the potential deleterious
effects of antenatal exposure to synthetic corticosteroids
(Rodrigues et al. 2010, 2011; Talge et al. 2007; Mesquita et
al. 2009) and call for the need of a parsimonious use of
these drugs.
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SUPPLEMENTARY,MATERIAL!
!
Histological,procedures,
Following!behavioral!assessment,!animals!were!placed!under!deep!pentobarbital!anesthesia!
and!transcardially!perfused!with!either!4%!paraformaldehyde!solution!(N=4/group)!or!0.9%!
saline!(N=4/group).!
Brains! from! the! former! set! of! subjects! were! embedded! in! glycolmethacrylate! (Tecnovit!
7100;!Heraeus! Kulzer,!Werheim,!Germany)! and! 30! µm! coronal! sections!were! obtained! by!
microtome! (Cerqueira!et!al.,!2005).!These!were!placed!on!a!gelatinized! slide,! stained!with!
Giemsa,!mounted!with!Entellan! (Merck,!Darmstadt,!Germany)!and!coverslipped.!Shrinkage!
factor!was!calculated!according!to!previous!studies!(Madeira!et!al.,!1990).!
Brains! from! animals! perfused! with! 0.9%! saline! were! processed! for! GolgiYCox! staining! as!
previously!described!(Gibb!and!Kolb,!1998).!In!brief,!brains!were!removed!and!immersed!in!
GolgiYCox! solution! [1:1! solution! of! 5%! potassium! dichromate! and! 5%! mercuric! chloride!
diluted! 4:10! with! 5%! potassium! chromate! (Glaser! and! Van! der! Loos,! 1981)]! for! 14! days;!
brains! were! then! transferred! to! a! 30%! sucrose! solution! (7! days),! before! being! cut! on! a!
vibratome.! Coronal! sections! (200! µm! thick)!were! collected! in! 6%! sucrose! and! blotted! dry!
onto! cleaned,! gelatinYcoated! microscope! slides.! They! were! then! alkalinized! in! 18.7%!
ammonia,! developed! in! Dektol! (Kodak,! LindaYaYVelha,! Portugal),! fixed! in! Kodak! Rapid! Fix!
(prepared!to!manufacturer’s! instructions),!dehydrated!through!a!graded!series!of!ethanols,!
and!cleared!in!xylene!prior!to!being!mounted!and!coverslipped.!!
!
Stereological,procedures,
Volume! and! cell! number! estimations! were! obtained! using! StereoInvestigator®! software!
(MicroBrightField,!Williston,! VT,! USA)! and! a!motorized!microscope! (Axioplan! 2,! Carl! Zeiss,!
Hamburg,!Germany)!attached!to!a!camera!(DXCY390,!Sony!Corporation,!Tokyo,! Japan).!The!
Cavalieri´s! principle! (Gundersen! et! al.,! 1988)!was! applied! to! evaluate! the! volume! of! each!
region.! Every! fourth! section!was!used! and! its! crossYsectional! area!was! estimated!by!point!
counting!at!a!final!magnification!of!112x.!A!testYpoint!system!with!an!interpoint!distance!at!
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the! tissue! level! of! 120! µm,! was! used.! The! volume! of! the! region! of! interest! was! then!
calculated! from! the! number! of! points! that! fell! within! its! boundaries! and! the! distance!
between!the!systematically!sampled!sections.!!
Average! cell! numbers!were! estimated! using! the! optical! fractionator!method! (West! et! al.,!
1991).! In! brief,! a! grid! of! equally! spaced! virtual! 3YD! boxes! (30! µm! x! 30! µm! x! 20! µm)!was!
superimposed! on! every! fourth! section,! as! for! volumetric! estimation.! The! number! of! cells!
falling! inside! the! boxes! was! counted,! according! to! standardized! stereological! procedures!
(Gundersen!et!al.,!1999;!Coulin!et!al.,!2001).! In!order! to!exclude!glial!cells! from!estimates,!
neuronal!and!glial!cell!body!profiles!were!considered,!based!on!criteria!described!elsewhere!
(Ling!et! al.,! 1973;!Peinado!et! al.,! 1997).!Coefficients!of! error!were! computed!according! to!
previously! published! formulas! for! cell! numbers! (Gundersen! et! al.,! 1999)! and! volume!
estimates!(Gundersen!and!Jensen,!1987).!!!
!
Dendritic,tree,analysis,
BLa!pyramidalYlike,!CeA!multipolar!and!BNSTam!bipolar!neurons!were!chosen!as!described!
elsewhere! (McDonald,! 1982b,! a,! 1983).! For! each! selected! neuron,! all! branches! of! the!
dendritic! tree! were! reconstructed! at! 600x! magnification! using! a! motorized! microscope!
(Axioplan!2,!Carl!Zeiss),!with!oilYimmersion!objectives,!and!attached!to!a!camera!(DXCY390,!
Sony! Corporation)! and! Neurolucida! software! (MicroBrightField).! A! 3YD! analysis! of! the!
reconstructed!neurons!was!performed!using!NeuroExplorer!software!(MicroBrightField).!The!
criteria!used!to!select!neurons!for!reconstruction!were:!a)!full!impregnation!of!the!neurons!
along! the! entire! length! of! the! dendritic! tree;! b)! dendrites! without! significant! truncated!
branches;!c)!no!morphological!changes!attributable!to!incomplete!dendritic!impregnation!of!
GolgiYCox!staining;!d)!relative!separation!from!neighboring! impregnated!neurons.!Dendritic!
branches!were!sampled!in!order!to!estimate!spine!density!(number!of!spines!per!micron!of!
dendritic! length),!using!the!following!method:!only!branches!that!were!either!parallel!or!at!
acute! angles! to! the! coronal! surface! of! the! section! and! did! not! show! overlap! with! other!
branches!that!would!obscure!visualization!of!spines!were!considered;!moreover,!segments!
were!randomly!selected! in! the!proximal!parts!of! the!tree;!spines! in! the!selected!segments!
were! classified! in! thin,!wide,! ramified!and!mushroom!categories! (Harris! et! al.,! 1992).! Thin!
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spines!were!considered!immature,!while!the!other!spine!types!were!classified!as!mature.!A!
total!of!20!neurons/group/area!were!drawn!(total!120!neurons).!
!
Molecular,correlates,
!
Primer,Name, Sequence,
Hprt_F, GCAGACTTTGCTTTCCTTGG,
Hprt_R, TCCACTTTCGCTGATGACAC,
NCAM_F, AAAGGATGGGGAACCCATAG,
NCAM_R, TAGGTGATTTTGGGCTTTGC,
Synapsin_F, CACCGACTGGGCAAAATACT,
Synapsin_R, TCCGAAGAACTTCCATGTCC,
Bdnf_F, GCGGCAGATAAAAAGACTGC,
Bdnf_R, GCAGCCTTCCTTCGTGTAAC,
Drd1_F, TCCTTCAAGAGGGAGACGAA!
Drd1_R, CCACACAAACACATCGAAGG!
Drd2_F, CATTGTCTGGGTCCTGTCCT!
Drd2_R, GACCAGCAGAGTGACGATGA!
Table! 1! Y! Primer! sequences! for! assessment! of! mRNA! expression! of! neural! cell! adhesion!
molecule! (NCAM),! synapsin,! brainYderived! neurotrophic! factor! (BDNF)! and! dopamine! D1!
(Drd1)!and!D2!receptors!(Drd2).!
!
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A B S T R A C T
Introduction. Brain regions implicated in sexual behavior begin to differentiate in the last trimester of gestation.
Antenatal therapy with corticosteroids is often used in clinical practice during this period to accelerate lung
maturation in preterm-risk pregnancies. Clinical and animal studies highlighted major behavioral impairments
induced later in life by these treatments, especially when synthetic corticosteroids are used.
Aim. To evaluate the implications of acute prenatal treatment with natural vs. synthetic corticosteroids on adult
male rat sexual behavior and its neurochemical correlates.
Methods. Twelve pregnant Wistar rats were injected with dexamethasone (DEX—1 mg/kg), corticosterone
(CORT—25 mg/kg), or saline on late gestation (pregnancy days 18 and 19). Following this brief exposure to
corticosteroids, we assessed the sexual behavior of the adult male progeny and subsequently associated these
behaviors with the levels of catecholamines and mRNA of dopamine and androgen receptors (AR) in brain regions
relevant for sexual behavior.
Main Outcome Measures. Sexual behavior of adult male offspring was assessed by exposure to receptive females.
This was associated with serum testosterone levels and levels of catecholamines (determined by high-performance
liquid chromatography) and dopamine and AR mRNA expression (real-time polymerase chain reaction [PCR]) in
brain regions implicated in sexual behavior.
Results. Prenatal DEX exposure resulted in a decreased number and increased mounts and intromissions latencies
in adulthood. These findings were associated with decreased levels of serum testosterone and increased hypothalamic
expression of AR mRNA. DEX animals also displayed lower dopamine levels and higher dopamine receptor mRNA
expression both in hypothalamus and nucleus accumbens (NAcc). The milder phenotype of CORT animals was
associated only with decreased dopamine levels in NAcc.
Conclusion. Antenatal corticotherapy programs adult male sexual behavior through changes in specific neuronal and
endocrine mediators. Importantly, equipotent doses of CORT trigger less detrimental consequences than DEX,
emphasizing the differential impact of activation of the different corticosteroid receptors. Oliveira M, Leão P,
Rodrigues A-J, Pêgo J-M, Cerqueira J-J, and Sousa N. Programming effects of antenatal corticosteroids
exposure in male sexual behavior. J Sex Med 2011;8:1965–1974.
Key Words. Antenatal Corticotherapy; Corticosteroids; Dopamine; Neurodevelopment; Sexual Behavior; Central
Neurochemichal Correlates
Introduction
The last trimester of gestation and early post-natal period are critical for brain sexual dif-
ferentiation [1]. Insults at this period, including
stress and prolonged exposure to corticosteroids,
have been shown to disrupt several behaviors in
adulthood, namely male sexual behavior [2–4].
Interestingly, exposure to corticosteroids during
late gestation has been correlated with a sustained
perturbation in male steroidogenesis [5] and an
impoverished dopaminergic innervation of the
nucleus accumbens (NAcc) [6], which is of particu-
lar relevance when considering the facilitatory role
1965
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of dopamine in the different aspects of sexual
behavior [7]. In contrast to dopamine, serotonin is
primarily inhibitory especially at the hypothala-
mus level [8–10]. In fact, it is the balance of sero-
tonin and dopamine levels at specific areas that
controls almost all aspects of sexual behavior
[8].
Importantly, the levels of dopamine and sero-
tonin can be modulated by testosterone [8]. Tes-
tosterone induces an up-regulation of nitric oxide
synthase [11] and, concomitantly, dopamine
release in preoptic area [12,13], which strongly
influences male sexual behavior. Testosterone
may also have a direct activational effect on
androgen receptors (AR) and an indirect one
(via estradiol formation) on estrogen receptors
[14], important mediators of sexual behavior
response.
In clinical practice, glucocorticoids are pre-
scribed in about 10% of pregnancies at risk of
preterm delivery in order to promote fetal lung
maturation [15–17]. Dexamethasone (DEX) and
betamethasone, the preferred drugs [18], are syn-
thetic corticosteroids that cross the placenta with
100% efficacy and have been shown to reduce the
morbidity and mortality of the preterm infant
after delivery [17]. Despite this, the safety of the
exposure of the developing fetal brain to gluco-
corticoids has been questioned as it might have
lifelong effects on adult behavior and neuroendo-
crine function [19–21]. Available data suggest
that the activity of the hypothalamic–pituitary–
adrenal (HPA) axis, which is vital to stress
response, might be reprogrammed by manipula-
tions in the corticosteroid milieu during late ges-
tation; this altered pattern of the HPA is believed
to be, at least in part, responsible for the behav-
ioral and neuroendocrine changes [22], as well as
for increased risk for hypertension, type 2 diabe-
tes [23–25], and neuropsychiatric disorders [21].
Of particular interest is the evidence suggesting a
less deleterious effect on adult emotional behav-
ior of the acute administration of endogenous
corticosteroids [20], especially in light of evi-
dence showing that cortisol displays similar
therapeutic efficacy to DEX during pregnancy
and neonatal life [16].
In light of this evidence, we decided to assess
the impact of short-term antenatal corticosteroid
exposure in male sexual behavior and search for its
neurochemical and endocrine correlates. Further-
more, we also wanted to compare natural and syn-
thetic corticosteroids in terms of long-term
adverse effects.
Methods
Animals and Treatments
Experiments were conducted in accordance with
local regulations (European Union Directive
86/609/EEC) and National Institutes of Health
guidelines on animal care and experimentation.
Twelve adult pregnant Wistar Han rats
(Charles-River Laboratories, Barcelona, Spain)
received at day 14 of gestation were individually
housed under standard laboratory conditions
(12/12 hours light/dark cycle, with lights on at 8
am; food and water ad libitum).
Subcutaneous injections of DEX (1 mg/kg,
Sigma-Aldrich, St. Louis, MO, USA; N = 4), cor-
ticosterone (CORT, 25 mg/kg, Sigma-Aldrich;
N = 4), or saline (controls, 1 mL/kg; N = 4) were
administered on embryonic days (ED) 18 and 19
of pregnancy [20]. Drug dosages were chosen to
achieve comparable transrepressive potencies at
the glucocorticoid receptors [26].
Weaning was performed at postnatal day 21 and
pups were pair-housed according to gender and
prenatal experimental procedures. Male offsprings
(two siblings per dam; N = 4 dams/group) were
tested at 3 months for sexual behavior.
Preparation of Sexually Receptive Females
Adult female rats (3 months) were individually
housed andovariectomized, as previously described
[27]. Sexual receptivity was induced by subcutane-
ous estradiol benzoate (20 mg/rat, Sigma-Aldrich)
and progesterone (1 mg/rat, Sigma-Aldrich) 52 and
4 hours before male exposure, respectively.
Male Sexual Behavior
The test arena consisted of a rectangular Plexiglas
box (40 ¥ 60 ¥ 40 cm) with a transparent top and a
video camera over it. Males were exposed to
females 2 hours after the onset of the dark phase,
in a quiet room, with a dim red light. Sexually
experienced males were placed in the arena 10
minutes before a receptive female was presented
and activity was recorded for 20 minutes; mount
and intromission latency and number of mounts
and intromissions (vaginal penetration) were reg-
istered manually by the observer and intromission
ratio calculated as intromissions/(intromissions +
mounts). Numbers of ejaculations were assessed
visually for each animal.
Biometric and Testosterone Measurements
Animals were sacrificed 1 week after behavior
assessment and blood collected for determination
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of serum total testosterone levels by electrochemi-
luminescense immunoassay (Elecsys Testosterone
II reagent kit, Roche Diagnostics, Indianapolis,
IN, USA; measuring range 2.5–1,500 ng/dL).
Testis wet weight was assessed and normalized to
the total weight of the animal.
Brain Catecholamines
After brain snap freezing, the regions of interest
were rapidly dissected under the scope usingmacro-
dissection of specific brain areas (Figure 1). The
hypothalamus was isolated by placing whole brains
upside down and using delicate forceps (Dumont #7
forceps, Fine Science Tools USA Inc., Foster City,
CA,USA) to detach it from the rest. The hypothala-
mus was identified as the round-shaped area in the
center of the brain. NAcc was isolated using punch
dissection in 2 mm sections of brains (AltoTM brain
matrix, Stoetling Co., Wood Dale, IL, USA) and
identified under a stereomicroscope (Model SZX7,
Olympus America Inc., Center Valley, PA, USA).
The NAcc was identified as the tissue in the vicinity
of the anterior branch of the anterior commissure,
according to stereological coordinates [28]. Samples
were frozen overnight at -20°C after adding perclo-
ric acid 0.2 M. Samples were briefly sonicated and
centrifuged, and 50 mL aliquots of the supernatant
was injected on a high-performance liquid chroma-
tography combined with electrochemical detection
system. Amobile phase of 0.7 M aqueous potassium
phosphate (monobasic) (pH 3.0) in 10% methanol,
1-heptanesulfonic acid (222 mg/L) and ethylenedi-
aminetetraacetic acid disodium salt (Na-EDTA)
(40 mg/L) was used.
Figure 1 Macrodissection of the nucleus accumbens (NAcc) and hypothalamus. (A) Schematic representation of the
beginning (beg) of the NAcc, at interaural 11.52 mm and bregma 2.52 mm and the end (end) of this area at interaural 9.60
and bregma 0.60. It is possible to distinguish the NAcc core (AcbC) and the shell (AcbSh). (B) Example of the NAcc
dissection. Brains were cut using brain slicer following adequate references and whole NAcc was removed using delicate
forceps. (C) Schematic representation of the rat brain with the hypothalamus highlighted. (D) Dissection of the hypothalamus.
Schemes on A and B were adapted from Paxinos and Watson [28].
Programming Adult Male Sexual Behavior 1967
J Sex Med 2011;8:1965–1974
69
Levels of 5-HT, 5-hydroxyindoleacetic acid,
dopamine, 3,4-dihydroxyphenylacetic acid, and
4-hydroxy-3-methoxyphenylacetic acid (homo-
vanillic acid) were determined using a Gilson
instrument (Gilson Inc., Middleton, WI, USA),
fitted with an analytical column (Supelco Supelco-
sil LC-18 3 M; 7.5 cm ¥ 4.6 mm; flow rate: 1.0–
1.5 mL/min; Supelco, Bellefonte, PA, USA). A
standard curve was then obtained and data pre-
sented as concentration (nanogram per milligram
of tissue protein).
Molecular Analysis
For real-time PCR analysis, total RNAwas isolated
from frozen areas using Trizol (Invitrogen, Heidel-
berg, Germany) and DNase treated (Fermentas,
Vilnius, Lithuania), according to the manufacturer.
Two micrograms of RNA were converted into
cDNA using the iSCRIPT kit (Bio-Rad, Hercules,
CA, USA). RT-PCR was performed using Syber-
Green (Qiagen, Valencia, CA, USA) and the
Bio-Rad q-PCRCFX96 apparatus. Hypoxanthine-
guanine phosphoribosyltransferase (HPRT) was
used as a housekeeping gene. We used relative
quantification to determine the fold-change differ-
ence between control, CORT, and DEX animals,
using the DDCT method as described before [29].
Primer sequences were AR_F:GGGTGACT
TCTCTGCCTCTG, AR_R:CCACAGATCAG
GCAGGTCTT(AR); ESR1_F:CAGGTGCCCT
ACTACCTGGA, ESR1_R:GGTAGCCAGAGG
CATAGTCG (estrogen receptor 1); ESR2_F:AA
CCGCCATGAGTATTCAGC, ESR2_R:GTAA
CAGGGCTGGCACAACT (estrogen recep-
tor 2); nNOS_F:GACAACGTTCCTGTGGTC
CT, nNOS_R:GAAGAGCTGGTCCTTTGT
GC (neuronal nitric oxide synthase [nNOS]);
D1R_F:TCCTTCAAGAGGGAGACGAA,D1R_
R:CCACACAAACACATCGAAGG (dopamine
D1 receptor); D2R_F:CATTGTCTGGGTCCT
GTCCT, D2R_R:GACCAGCAGAGTGACGA
TGA (dopamine D2 receptor); HPRT1_F:GC
AGACTTTGCTTTCCTTGG, HPRT1_R:TC
CACTTTCGCTGATGACAC.
Statistical Analysis
For statistical analysis, the “n” of each experiment
group was considered the number of litters from
which individuals were derived. Two males per
litter were averaged in order to represent each
litter. Results are presented as average ! standard
error. Data were analyzed by PASW Statistics 18.0
(SPSS Inc, Chicago, IL, USA), using analysis of
variance. Whenever appropriate, post hoc com-
parisons were performed using Tukey’s test; statis-
tical significance was considered when P < 0.05.
Results
Acute Antenatal DEX Exposure Affects Adult Male
Sexual Behavior
Treatment significantly affected sexual motivation
and the volitive aspects of copulatory behavior
(F(2,9) = 20.057, P < 0.001), as revealed by an
increased latency to mount in DEX-exposed
animals compared to controls (P < 0.001) and
CORT subjects (P = 0.029), respectively
(Figure 2) [30]. CORT animals were also different
from controls (P = 0.027).
Treatment also affected the number of mounts
(F(2,9) = 5.233, P = 0.031), another measure of
sexual motivation [27], which was significantly
decreased in DEX-exposed subjects when com-
Figure 2 Mount and intromission latencies were increased in dexamethasone (DEX) and corticosterone (CORT) exposed
animals when compared to controls (left); the number of mounts and intromissions was significantly reduced in DEX-exposed
rats (right). *P < 0.05.
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pared to controls (P = 0.027). Interestingly,
CORT rats were not different from the other
groups.
In contrast to mounts, intromissions are not
exclusively dependent on sexual motivation [27].
Treatment affected this parameter (F(2,9) = 23.081,
P < 0.001) as revealed by an increased latency of
DEX progeny in comparison to controls
(P < 0.001) and CORT subjects (P = 0.016). Again,
CORT animals also took more time to intromis-
sion than controls (P = 0.024).
Moreover, the number of intromissions was
affected by treatment (F(2,9) = 8.083, P = 0.010).
This indicator of the easiness in the activation of
ejaculatory reflexes [27] was found to be decreased
in DEX-exposed (P = 0.008) but not on CORT-
exposed subjects (P = 0.103).
Intromission ratio (Figure 3), an indicator of
the efficiency of penile erection, was also affected
by treatment (F(2,9) = 22.972, P < 0.001) [27].
DEX-subjects displayed significantly lower ratios
compared to controls (P < 0.001) and CORT-
exposed animals (P = 0.003). Ejaculation number
was similar between groups (data not shown).
Adult Testosterone Levels are Affected by
Antenatal DEX
Serum testosterone levels were significantly
reduced by antenatal DEX exposure (F(2,9) =
15.815, P = 0.001; vs. CORT P = 0.001; vs. con-
trols P = 0.004) but not by CORT (Figure 4).
Testis wet weight was similar between groups (data
not shown).
Antenatal Corticosteroids Influence Brain
Dopamine Levels
Antenatal corticosteroids exposure influenced the
levels of dopamine in NAcc (F(2,9) = 39.911,
P < 0.001; Table 1). Both progeny of CORT and
DEX dams displayed decreased levels of dopamine
in NAcc in comparison to controls (P < 0.001 and
P < 0.001, respectively). Treatment also affected
dopamine turnover (F(2,9) = 6.162, P = 0.021), with
an increase in DEX subjects when compared to
CORT (P = 0.026) and controls (P = 0.047).
Hypothalamic levels of dopamine were also
significantly affected by antenatal treatment
(F(2,9) = 5.817, P = 0.024), with a decrease only in
DEX-treated subjects (P = 0.022) when compared
to controls. Dopamine turnover in this area was
also affected (F(2,9) = 10.286, P = 0.005), with
CORT and DEX animals displaying a lower ratio
when compared to controls (P = 0.010 and 0.008,
respectively).
Treatment did not affect serotonin levels
(F(2,9) = 3.564, P = 0.072) nor its turnover
(F(2,9) = 1.076, P = 0.381) in the NAcc. However,
hypothalamic levels of serotonin were reduced
(F(2,9) = 14.050, P = 0.002), while its turnover was
increased (F(2,9) = 7.552, P = 0.012) in both DEX
(P = 0.003; P = 0.029) and CORT (P = 0.004;
P = 0.016) groups.
Molecular Correlates
In the NAcc, dopamine D1 (D1R) and D2 (D2R)
receptors mRNA levels were significantly
affected by prenatal exposure to corticosteroids
(F(2,9) = 111,471, P < 0.001 and F(2,9) = 76.383,
P < 0.001, respectively; Table 2), with an increase
in DEX group when compared to controls
(P < 0.001; P < 0.001, respectively) and CORT
(P < 0.001; P < 0.001, respectively). A similar
effect was also observed in the hypothalamus, but
only for D1R (F(2,9) = 7.868, P = 0.011; vs. controls
P = 0.009); CORT animals were not different
from any other group.
Figure 3 Intromission ratio, calculated as intromissions/
(intromissions + mounts), was diminished in dexametha-
sone (DEX)-exposed rats when compared to controls and
corticosterone (CORT) animals. *P < 0.05.
Figure 4 Antenatal dexamethasone (DEX) administration
led to diminished serum testosterone levels (ng/dL) in adult
male rats, when compared to corticosterone (CORT) and
controls. *P < 0.05.
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Levels of AR and nNOS mRNA were not dif-
ferent between groups in the NAcc. However, in
hypothalamus, there was a significant effect of
exposure on AR (F(2,9) = 13.049, P = 0.002) and
nNOS (F(2,9) = 27.056, P < 0.001) mRNA levels,
with an increase in DEX progeny when com-
pared to controls (P = 0.020; P < 0.001, respec-
tively) and CORT subjects (P = 0.002; P = 0.002,
respectively).
Levels of estrogen receptors 1 and 2 were not
affected by treatment in neither area.
Discussion
In rats, brain sexual differentiation occurs mainly
during late gestation (ED 14–21) and the first 2
weeks of postnatal life [1]. The vulnerability of this
time-window to several insults, including stress
and corticosteroid exposure, may thus lead to
long-term consequences on adult male sexual
behavior [2,3]. In fact, previous data suggest that
prenatal stress disrupts the normal maternal hor-
monal milieu and suppresses the fetal testosterone
peak on ED 18 and 19, required for later expres-
sion and maintenance of male sexual behavior
[31,32]. Such data sustain that interferences in
the maturation of the HPA axis, affect the
hypothalamic–pituitary–gonadal axis, since both
are regulated by common players both centrally
and at the periphery [5]. Following the initial
experimental evidence showing that late gestation
whole-body restraint under bright lights results in
delayed initiation of copulation [33], more recent
data correlated prolonged prenatal stress/
corticosteroids with impaired adult male sexual
behavior and reduced serum testosterone levels
[2,3]. However, no previous studies focused on the
potential effects of a short-term exposure which
better mimics the everyday clinical practice, nor
in the comparison between different types of
corticosteroids.
Appetitive behaviors are more variable than the
relatively stereotypic consummatory behaviors and
are thought to reflect an underlying, inferred
motivational state, leading an organism into
contact with a certain stimulus. Sexual motivation
includes sensory and motor processes that may be
sensitized by gonadal hormones, as well as more
general activational processes that may affect other
behaviors [34]. The analysis of several behavioral
parameters permitted us to distinguish between
appetitive and consummatory components of male
rat sexual behavior. Male rat sexual behavior is
characterized by a series of mounts, either with or
without vaginal penetration (intromission), ulti-
mately leading to ejaculation [35]. Latency until
Table 1 HPLC measurement of dopamine and serotonin (5-HT) levels and respective turnover in nucleus accumbens
and hypothalamus
Treatment Dopamine Dopamine turnover 5-HT 5-HT turnover
Nucleus accumbens Controls 319.53 (22.24)* 0.785 (0.023) 62.17 (1.54) 0.170 (0.018)
CORT 146.29 (0.76) 0.713 (0.030) 38.07 (4.19) 0.196 (0.915)
DEX 162.17 (13.93) 1.333 (0.234)† 49.82 (10.12) 0.215 (0.028)
Hypothalamus Controls 21.46 (2.82) 1.212 (0.095)* 30.31 (1.72)* 0.030 (0.014)*
CORT 15.33 (1.10) 0.825 (0.010) 22.34 (0.80) 0.075 (0.003)
DEX 12.82 (1.03)‡ 0.808 (0.078) 22.18 (1.01) 0.070 (0.007)
Values represent mean (SE). *Different from CORT and DEX (P < 0.05); †different from controls and CORT (P < 0.05); ‡different from controls (P < 0.05).
Dopamine and serotonin (5-HT) tissue concentration (ng/mg total protein) and respective turnover. Dopamine turnover assessed by the ratio between dopa-
mine metabolites and dopamine concentrations; Serotonin (5-HT) turnover assessed by the ratio between 5-hydroxyindoleacetic acid (5-HIAA) and 5-HT
concentrations.
HPLC = high-performance liquid chromatography; CORT = corticosterone-exposed animals; DEX = dexamethasone-exposed animals.
Table 2 Gene expression analysis (real-time PCR) in nucleus accumbens and hypothalamus
Treatment D1R D2R AR ESR1 ESR2 nNOS
Nucleus accumbens Controls 1.023 (0.019) 1.010 (0.002) 0.96 (0.11) 0.97 (0.11) 0.96 (0.13) 0.96 (0.12)
CORT 1.191 (0.067) 0.670 (0.015) 1.05 (0.11) 1.07 (0.05) 1.40 (0.21) 1.10 (0.04)
DEX 2.131* (0.070) 1.779* (0.112) 1.33 (0.14) 1.09 (0.14) 1.00 (0.03) 1.23 (0.25)
Hypothalamus Controls 1.010 (0.044) 0.944 (0.032) 0.949 (0.120) 0.888 (0.134) 1.088 (0.116) 0.805 (0.162)
CORT 1.230 (0.130) 0.820 (0.035) 0.779 (0.046) 1.358 (0.085) 1.259 (0.124) 1.133 (0.050)
DEX 1.570† (0.106) 0.938 (0.031) 1.308* (0.011) 1.421 (0.189) 1.485 (0.179) 1.886* (0.147)
Values represent mean (SE). *Different from controls and CORT (P < 0.05); †Different from controls (P < 0.05).
The mRNA expression levels are presented as the fold change increase in relation to the respective control.
D1R = dopamine D1 receptor; D2R = dopamine D2 receptor; AR = androgen receptor; ESR1 = estrogen receptor 1; ESR2 = estrogen receptor 2; nNOS = neuronal
nitric oxide synthase; CORT = corticosterone-exposed animals; DEX = dexamethasone-exposed animals.
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the first mount reflects some of the appetitive
aspects and sexual motivation; on the other hand,
intromission and ejaculation latencies, but also
mount and intromission frequencies, reproduce
consummatory components of copulatory behav-
ior [30,36]. Interestingly, the impairment of male
sexual behavior observed in this study was mainly
characterized by alterations in sexual motivation
(increase in mount and intromission latencies)
[34]; moreover, the reduced number of mounts
might also reflect decreased sexual motivation
[27]. Importantly, these differences are more strik-
ing in animals exposed to DEX than to CORT.
Regarding the neurobiology of sexual behavior,
three major integrative systems regulate sexual
motivation and genital and motor responses [8].
Whereas the mesolimbic system is critical for
appetitive behavior and reinforcement, the medial
preoptic system contributes to genital reflexes,
sexual motivation, and motor patterns of copula-
tion. Finally, the nigrostriatal system enhances the
motoric readiness to respond to stimuli. Dopam-
ine is the common key player in all three systems,
easing sexual motivation, copulatory proficiency,
and genital reflexes [7]. The pathways for sexual
excitation involve the activation of incertohypo-
thalamic and mesolimbic dopamine transmission
that targets the hypothalamic medial preoptic area
(MPOA) and NAcc, respectively [37]. As a result,
in the male rat, there is a slight increase in dopam-
ine release in NAcc following presentation to a
receptive female that is followed by a sharp
increase in dopamine transmission during copula-
tion, which gradually declines after the removal of
the female [38].
In prenatally stressed male rats, the absence of
copulatory behaviors is associated with a failure to
increase extracellular levels of dopamine and its
metabolites in the NAcc. Such data, obtained
through simultaneous sexual behavior testing and
concomitant microdialysis sampling, suggested
that intense environmental stressors might impair
NAcc dopamine release [39].
In our experiment, an interesting
neurochemical–behavioral link was established.
Serotonin levels in the NAcc and hypothalamus
were not increased in CORT or DEX progeny
when compared to controls, suggesting that the
sexual impairment observed is unlikely to be
related to the inhibitory effects of serotonin
[8,10,40]. On the other hand, we found decreased
dopamine in hypothalamus and NAcc of animals
briefly exposed to prenatal corticosteroids. Inter-
estingly, we had previously reported a reduced
dopaminergic innervation of the NAcc following
prenatal short-term exposure to DEX, revealed by
a reduced density of tyrosine hydroxylase-positive
fibers in these subjects [6]. In addition, the
decrease in dopamine levels in NAcc herein
reported is likely to be of relevance for the changes
in sexual behavior if one takes into account
descriptions correlating a delayed onset of copula-
tion and ejaculation with a diminished release of
this neurotransmitter in the mesolimbic tract [8].
Furthermore, the increase in dopamine D1 and
D2 receptors mRNA in the NAcc following DEX
exposure herein shown further supports the exist-
ence of a hypodopaminergic status in these
animals, and may appear as a compensatory
mechanism due to the low dopamine levels
observed.
Although we observed substantial differences in
the dopamine levels and receptors in theNAcc, one
limitation of this work is the fact that we did not
discriminate between its two functionally distinct
regions: the core and the shell. In fact, these two
regions of the NAcc display distinct c-fos expres-
sion during sexual behavior; whereas there is
increased c-fos in the core, its expression remains
unchanged in the shell [41]. On the contrary,
administration of drugs of abuse results in increased
dopamine levels in the shell of the NAcc [42–45].
This suggests that shell and coremight be activated
differently in response to natural reinforcers and
drugs of abuse. Indeed, NAcc neurons exhibit
similar neuronal activity when responding to two
natural rewards—food and water, but different
firing patterns when responding for a natural
reward vs. cocaine [46]. Therefore, considering the
different functional/activational roles of core and
shell, it would be interesting to analyze dopamine
metabolism and receptors in each subarea in order
to dissect what is the most affected area.
The hypodopaminergic status of DEX-exposed
animals in the NAcc might have other behavioral
consequences besides altered sexual behavior, con-
sidering the importance of correct dopamine input
for feeding, reward, and addiction, among others.
Dopamine is released in the NAcc in response to
not only drugs of abuse, but also to other consum-
matory behaviors such as sex and food; thus, the
ventral tegmental area (VTA)-NAcc pathway is
also known as the “reward pathway” [47]. Interest-
ingly, some studies have reported cross-
sensitization between repeated exposures to
pharmacological agents and natural motivated
behaviors such as sex [48–50]. For example, sexual
experience can cross-sensitize neuronal responses
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to amphetamine and this seems to be dependent
on dopamine release in the NAcc [41].
The intricately regulated balance between
hypo- and hyperdopaminergic states in the
mesolimbic circuit, especially in the NAcc area,
underlies an individual’s cycles of drug-seeking
behavior/abuse and response to natural rewards.
While a hyperdopaminergic state seems to
enhance the motivational or rewarding properties
of drugs of abuse, hypodopaminergic states appear
to enhance drug-seeking behavior in parallel with
reductions in the perceived motivational impact of
“natural” rewards such as food and sex [51–53].
This theory is in agreement with our behavioral
and neurochemical results, given the fact that
DEX animals have low dopamine levels in the
NAcc and, concomitantly, impaired appetitive
sexual behavior. Additionally, it suggests that these
animals might also display differential susceptibil-
ity to addiction, a phenomenon also observed in
other models of early life stress [54].
Dopamine in the hypothalamus, particularly in
the MPOA, is essential for genital reflexes, motor
patterns of copulation, and probably sexual moti-
vation [55]; several studies described the facilita-
tive role of increased levels in the MPOA on sexual
behavior, suggesting that testosterone might
mediate this effect [56]. In the present study, con-
clusions on the impact of prenatal exposure to
natural vs. synthetic corticosteroids are limited by
the fact that dissection of the whole hypothalamic
area was performed instead of isolating the
MPOA. Nonetheless, the decreased hypothalamic
levels of dopamine herein reported in the DEX
group, but not in the CORT group, is associated
with a significant effect on D1 receptors mRNA.
This fact is likely to be of significance to explain
the differential neuroendocrine and behavioral
effects of CORT from DEX.
Since testosterone can directly activate AR, or
indirectly via stimulation of estrogen receptors due
to its aromatization to estradiol [57], we also ana-
lyzed the levels of these receptors in DEX and
CORT progeny. Interestingly, an increase in AR
mRNA was observed in the hypothalamus of DEX
progeny, possibly reflecting a reduction in circu-
lating androgens, but no differences were found in
estrogen receptors. Interestingly, previous studies
showed that although normal basal levels of
dopamine in the MPOA are adequate to allow
some copulatory behavior, efficient mating
requires an androgen-dependent female-
stimulated increase [58]. Also, by upregulating
nNOS in the MPOA, testosterone enhances nitric
oxide production, which controls dopamine
release [59]. In the present study, we found
increased levels of nNOSmRNA in the hypothala-
mus of DEX subjects. It would be of added value
to assess if theses changes persist in MPOA
samples, which would be in accordance to previous
descriptions in the MPOA of gonadectomized rats
[60]. However, technical issues in the isolation of
the MPOA and the fact that neighbor hypotha-
lamic subareas might display different susceptibili-
ties to circulating androgens could justify why
other studies did not confirm the original findings
[61].
Thus, in order to draw further conclusions on
the impact of the in utero corticosteroids exposure
on the adult male MPOA, it would be of interest to
specifically analyze this hypothalamic area in
future studies.
Conclusions
Early life exposure to short-term glucocorticoid
ligands triggers lifelong programming effects in
brain regions implicated in distinct aspects of male
sexual behavior. The behavioral changes are par-
alleled with altered dopaminergic systems and
neuroendocrine markers. These findings are of
clinical relevance, as they provide support to
therapeutic interventions for sexual dysfunction
that modulate brain dopaminergic levels [62–65]
and peripheral levels of testosterone [66–68].
Noticeably, equipotent CORT administration
triggers a less detrimental impairment than DEX,
highlighting the role of the different corticoster-
oid receptors on the systems regulating sexual
behavior. Now, it is important to dissect and dis-
tinguish how exposure to different glucocorticoids
modulates the neuroendocrine, neurochemical,
and molecular environment and to identify the
changes directly relevant for the observed impair-
ment in sexual behavior.
Acknowledgments
This study was supported by a grant from the Institute
for the Study of Affective Neuroscience. The authors
would like to thank the Clinical Laboratory of Hospital
de Braga for technical support.
Corresponding Author:Mário Oliveira, MD, Life and
Health Sciences Research Institute (ICVS), School of
Health Sciences, University of Minho, Campus de
Gualtar, Braga 4710-057, Portugal. Tel: (351) 253-604-
929; Fax: (351) 253-604-820; E-mail: mariooliveira@
ecsaude.uminho.pt
1972 Oliveira et al.
J Sex Med 2011;8:1965–1974
74
Conflict of Interest: None.
Statement of Authorship
Category 1
(a) Conception and Design
Mário Oliveira; Nuno Sousa
(b) Acquisition of Data
Mário Oliveira; Pedro Leão; Ana-João Rodrigues;
José-Miguel Pêgo
(c) Analysis an Interpretation of Data
Mário Oliveira; Nuno Sousa; Ana-João Rodrigues
Category 2
(a) Drafting the manuscript
Mário Oliveira
(b) Revising it for intellectual content
Ana-João Rodrigues; João-José Cerqueira; Nuno
Sousa
Category 3
(a) Final approval of the completed manuscript
Mário Oliveira; Nuno Sousa
References
1 Segarra AC, Luine VN, Strand FL. Sexual behavior of male
rats is differentially affected by timing of perinatal ACTH
administration. Physiol Behav 1991;50:689–97.
2 Gerardin DC, Pereira OC, KempinasWG, Florio JC, Moreira
EG, Bernardi MM. Sexual behavior, neuroendocrine, and neu-
rochemical aspects in male rats exposed prenatally to stress.
Physiol Behav 2005;84:97–104.
3 Piffer RC, Garcia PC, Pereira OC. Adult partner preference
and sexual behavior of male rats exposed prenatally to
betamethasone. Physiol Behav 2009;98:163–7.
4 Holson RR, Gough B, Sullivan P, Badger T, Sheehan DM.
Prenatal dexamethasone or stress but not ACTH or corticos-
terone alter sexual behavior in male rats. Neurotoxicol Teratol
1995;17:393–401.
5 Page KC, Sottas CM, Hardy MP. Prenatal exposure to dex-
amethasone alters Leydig cell steroidogenic capacity in imma-
ture and adult rats. J Androl 2001;22:973–80.
6 Leao P, Sousa JC, Oliveira M, Silva R, Almeida OF, Sousa N.
Programming effects of antenatal dexamethasone in the devel-
oping mesolimbic pathways. Synapse 2007;61:40–9.
7 Giuliano F, Allard J. Dopamine and male sexual function. Eur
Urol 2001;40:601–8.
8 Hull EM, Muschamp JW, Sato S. Dopamine and serotonin:
Influences on male sexual behavior. Physiol Behav 2004;
83:291–307.
9 Verma S, Chhina GS, Mohan Kumar V, Singh B. Inhibition of
male sexual behavior by serotonin application in the medial
preoptic area. Physiol Behav 1989;46:327–30.
10 Fernandez-Guasti A, Escalante AL, Ahlenius S, Hillegaart V,
Larsson K. Stimulation of 5-HT1A and 5-HT1B receptors in
brain regions and its effects on male rat sexual behaviour. Eur
J Pharmacol 1992;210:121–9.
11 Du J, Hull EM. Effects of testosterone on neuronal nitric oxide
synthase and tyrosine hydroxylase. Brain Res 1999;836:90–8.
12 Dominguez JM, Muschamp JW, Schmich JM, Hull EM.
Nitric oxide mediates glutamate-evoked dopamine release in
the medial preoptic area. Neuroscience 2004;125:203–10.
13 Lorrain DS, Matuszewich L, Howard RV, Du J, Hull EM.
Nitric oxide promotes medial preoptic dopamine release
during male rat copulation. Neuroreport 1996;8:31–4.
14 Raskin K, de Gendt K, Duittoz A, Liere P, Verhoeven G,
Tronche F, Mhaouty-Kodja S. Conditional inactivation of
androgen receptor gene in the nervous system: Effects on male
behavioral and neuroendocrine responses. J Neurosci
2009;29:4461–70.
15 Crane J, Armson A, Brunner M, De La Ronde S, Farine D,
Keenan-Lindsay L, Leduc L, Schneider C, Van Aerde J. Ante-
natal corticosteroid therapy for fetal maturation. J Obstet
Gynaecol Can 2003;25:45–52.
16 Crowley PA. Antenatal corticosteroid therapy: A meta-analysis
of the randomized trials, 1972 to 1994. Am J Obstet Gynecol
1995;173:322–35.
17 NIH. Effect of corticosteroids for fetal maturation on perinatal
outcomes. NIH consensus development panel on the effect of
corticosteroids for fetal maturation on perinatal outcomes.
JAMA 1995;273:413–8.
18 Jobe AH, Newnham JP, Moss TJ, Ikegami M. Differential
effects of maternal betamethasone and cortisol on lung matu-
ration and growth in fetal sheep. Am J Obstet Gynecol
2003;188:22–8.
19 Matthews SG. Antenatal glucocorticoids and programming of
the developing CNS. Pediatr Res 2000;47:291–300.
20 Oliveira M, Bessa JM, Mesquita A, Tavares H, Carvalho A,
Silva R, Pego JM, Cerqueira JJ, Palha JA, Almeida OF, Sousa
N. Induction of a hyperanxious state by antenatal dexametha-
sone: A case for less detrimental natural corticosteroids. Biol
Psychiatry 2006;59:844–52.
21 Welberg LA, Seckl JR, Holmes MC. Prenatal glucocorticoid
programming of brain corticosteroid receptors and
corticotrophin-releasing hormone: Possible implications for
behaviour. Neuroscience 2001;104:71–9.
22 Welberg LA, Seckl JR. Prenatal stress, glucocorticoids and the
programming of the brain. J Neuroendocrinol 2001;13:
113–28.
23 Sapolsky RM, Romero LM, Munck AU. How do glucocorti-
coids influence stress responses? Integrating permissive, sup-
pressive, stimulatory, and preparative actions. Endocr Rev
2000;21:55–89.
24 Levitt NS, Lindsay RS, Holmes MC, Seckl JR. Dexametha-
sone in the last week of pregnancy attenuates hippocampal
glucocorticoid receptor gene expression and elevates blood
pressure in the adult offspring in the rat. Neuroendocrinology
1996;64:412–8.
25 Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR. Prenatal glu-
cocorticoid exposure leads to offspring hyperglycaemia in the
rat: Studies with the 11 beta-hydroxysteroid dehydrogenase
inhibitor carbenoxolone. Diabetologia 1996;39:1299–305.
26 Schimmer BP, Parker KL. Adrenocorticotropic hormone;
adrenocortical steroids and their synthetic analogues; inhibi-
tors of the synthesis and actions of the adrenocortical hor-
mones. In: Bruton LL, Lazo JS, Parker KL, eds. Goodman and
Gilman’s: The pharmacological basis of therapeutics. 11th
edition. New York: McGraw-Hill; 2005:1587–612.
27 Agmo A. Male rat sexual behavior. Brain Res Brain Res Protoc
1997;1:203–9.
28 Paxinos G,Watson C. The rat brain in stereotaxic coordinates.
San Diego: Academic Press; 2005.
29 Pfaffl MW. A new mathematical model for relative quantifica-
tion in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
30 Pfaus JG, Mendelson SD, Phillips AG. A correlational and
factor analysis of anticipatory and consummatory measures of
sexual behavior in the male rat. Psychoneuroendocrinology
1990;15:329–40.
31 Ward IL, Weisz J. Differential effects of maternal stress
on circulating levels of corticosterone, progesterone, and
Programming Adult Male Sexual Behavior 1973
J Sex Med 2011;8:1965–1974
75
testosterone in male and female rat fetuses and their mothers.
Endocrinology 1984;114:1635–44.
32 Lalau JD, Aubert ML, Carmignac DF, Gregoire I, Dupouy JP.
Reduction in testicular function in rats. II. Reduction by dex-
amethasone in fetal and neonatal rats. Neuroendocrinology
1990;51:289–93.
33 Ward IL. Prenatal stress feminizes and demasculinizes the
behavior of males. Science 1972;175:82–4.
34 Hull EM, Wood RI, McKenna KE. Neurobiology of male
sexual behavior. In: Neill JD, ed. Knobil and Neill’s physiology
of reproduction. Vol. 2. 2nd edition. St. Louis, MO: Elsevier;
2006:1729–824.
35 Hull EM, Dominguez JM. Sexual behavior in male rodents.
Horm Behav 2007;52:45–55.
36 Agmo A. Sexual motivation—An inquiry into events determin-
ing the occurrence of sexual behavior. Behav Brain Res
1999;105:129–50.
37 Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506–
33.
38 Pfaus JG, Damsma G, Nomikos GG, Wenkstern DG, Blaha
CD, Phillips AG, Fibiger HC. Sexual behavior enhances
central dopamine transmission in the male rat. Brain Res
1990;530:345–8.
39 Wang CT, Huang RL, Tai MY, Tsai YF, Peng MT. Dopamine
release in the nucleus accumbens during sexual behavior in pre-
natally stressed adult male rats. Neurosci Lett 1995;200:29–
32.
40 Chan JS, Snoeren EM, Cuppen E, Waldinger MD, Olivier B,
Oosting RS. The serotonin transporter plays an important role
in male sexual behavior: A study in serotonin transporter
knockout rats. J Sex Med 2011;8:97–108.
41 Bradley KC, Meisel RL. Sexual behavior induction of c-Fos in
the nucleus accumbens and amphetamine-stimulated locomo-
tor activity are sensitized by previous sexual experience in
female Syrian hamsters. J Neurosci 2001;21:2123–30.
42 Pontieri FE, Tanda G, Di Chiara G. Intravenous cocaine,
morphine, and amphetamine preferentially increase extracel-
lular dopamine in the “shell” as compared with the “core” of
the rat nucleus accumbens. Proc Natl Acad Sci U S A
1995;92:12304–8.
43 Nisell M, Marcus M, Nomikos GG, Svensson TH. Differen-
tial effects of acute and chronic nicotine on dopamine output in
the core and shell of the rat nucleus accumbens. J Neural
Transm 1997;104:1–10.
44 Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu
S, Cadoni C, Carboni E. Drug addiction as a disorder of
associative learning. Role of nucleus accumbens shell/extended
amygdala dopamine. Ann N Y Acad Sci 1999;877:461–85.
45 Di Chiara G. Nucleus accumbens shell and core dopamine:
Differential role in behavior and addiction. Behav Brain Res
2002;137:75–114.
46 Carelli RM, Ijames SG, Crumling AJ. Evidence that separate
neural circuits in the nucleus accumbens encode cocaine vs.
“natural” (water and food) reward. J Neurosci 2000;20:4255–
66.
47 Piazza PV, Le Moal ML. Pathophysiological basis of vulner-
ability to drug abuse: Role of an interaction between stress,
glucocorticoids, and dopaminergic neurons. Annu Rev Phar-
macol Toxicol 1996;36:359–78.
48 Mitchell JB, Stewart J. Facilitation of sexual behaviors in the
male rat associated with intra-VTA injections of opiates. Phar-
macol Biochem Behav 1990;35:643–50.
49 Mitchell JB, Stewart J. Facilitation of sexual behaviors in the
male rat in the presence of stimuli previously paired with
systemic injections of morphine. Pharmacol Biochem Behav
1990;35:367–72.
50 Fiorino DF, Phillips AG. Facilitation of sexual behavior and
enhanced dopamine efflux in the nucleus accumbens of male
rats after D-amphetamine-induced behavioral sensitization. J
Neurosci 1999;19:456–63.
51 Diana M, Melis M, Muntoni AL, Gessa GL. Mesolimbic
dopaminergic decline after cannabinoid withdrawal. Proc Natl
Acad Sci U S A 1998;95:10269–73.
52 Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL.
Profound decrement of mesolimbic dopaminergic neuronal
activity during ethanol withdrawal syndrome in rats: Electro-
physiological and biochemical evidence. Proc Natl Acad Sci U
S A 1993;90:7966–9.
53 Melis M, Spiga S, Diana M. The dopamine hypothesis of drug
addiction: Hypodopaminergic state. Int Rev Neurobiol
2005;63:101–54.
54 Kippin TE, Szumlinski KK, Kapasova Z, Rezner B, See RE.
Prenatal stress enhances responsiveness to cocaine. Neuropsy-
chopharmacology 2008;33:769–82.
55 Hull EM, Dominguez JM. Getting his act together: Roles of
glutamate, nitric oxide, and dopamine in the medial preoptic
area. Brain Res 2006;1126:66–75.
56 Dominguez JM,Hull EM.Dopamine, themedial preoptic area,
and male sexual behavior. Physiol Behav 2005;86:356–68.
57 Stewart J, Rajabi H. Estradiol derived from testosterone in
prenatal life affects the development of catecholamine systems
in the frontal cortex in themale rat. BrainRes 1994;646:157–60.
58 Putnam SK, Sato S, Riolo JV, Hull EM. Effects of testosterone
metabolites on copulation, medial preoptic dopamine, and
NOS-immunoreactivity in castrated male rats. Horm Behav
2005;47:513–22.
59 Sanderson NS, Le B, Zhou Z, Crews D. Preoptic neuronal
nitric oxide synthase induction by testosterone is consistent
with a role in gating male copulatory behavior. Eur J Neurosci
2008;27:183–90.
60 Singh R, Pervin S, Shryne J, Gorski R, Chaudhuri G. Castra-
tion increases and androgens decrease nitric oxide synthase
activity in the brain: Physiologic implications. Proc Natl Acad
Sci U S A 2000;97:3672–7.
61 Sato S, Braham CS, Putnam SK, Hull EM. Neuronal nitric
oxide synthase and gonadal steroid interaction in the MPOA of
male rats: Co-localization and testosterone-induced restora-
tion of copulation and nNOS-immunoreactivity. Brain Res
2005;1043:205–13.
62 Montorsi F, Salonia A, Deho F, Cestari A, Guazzoni G, Rigatti
P, Stief C. Pharmacological management of erectile dysfunc-
tion. BJU Int 2003;91:446–54.
63 Montorsi F, Perani D, Anchisi D, Salonia A, Scifo P, Rigiroli
P, Deho F, De Vito ML, Heaton J, Rigatti P, Fazio F. Brain
activation patterns during video sexual stimulation following
the administration of apomorphine: Results of a placebo-
controlled study. Eur Urol 2003;43:405–11.
64 Miner MM, Seftel AD. Centrally acting mechanisms for the
treatment of male sexual dysfunction. Urol Clin North Am
2007;34:483–96, v.
65 Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G,
Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley
I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS,
McVary K, McCullough A, Nehra A, Porst H, Schulman C,
Seftel A, Sharlip I, Stief C, Teloken C. Pharmacotherapy for
erectile dysfunction. J Sex Med 2004;1:128–40.
66 Hatzimouratidis K, Hatzichristou D. Testosterone and erectile
function: An unresolved enigma. Eur Urol 2007;52:26–8.
67 Traish AM, Goldstein I, Kim NN. Testosterone and erectile
function: From basic research to a new clinical paradigm for
managing men with androgen insufficiency and erectile dys-
function. Eur Urol 2007;52:54–70.
68 Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichris-
tou D, Montorsi F, Vardi Y, Wespes E. Guidelines on male
sexual dysfunction: Erectile dysfunction and premature ejacu-
lation. Eur Urol 2010;57:804–14.
1974 Oliveira et al.
J Sex Med 2011;8:1965–1974
76
! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
 
Discussion 
 
77
! 
78
!3. DISCUSSION 
 
 
The present work aimed to assess the programming effects of the acute 
prenatal exposure to corticosteroids in the adult brain and its impact on 
anxiety and fear behaviors. Initially, a behavioral characterization was 
performed (Chapter 2.1); this first study revealed a hyperemotional 
phenotype in animals treated with prenatal dexamethasone (DEX). Thus, 
in a subsequent study we performed a structural, neurochemical and 
molecular analysis of brain regions associated with the control of these 
functions (BNST and amygdala) (Chapter 2.2). In addition, given 
previous data from our lab showing an impoverished dopaminergic 
innervation of the mesolimbic pathways (Leao et al., 2007; Appendix 1), 
an assessment of adult male addictive behavior (Appendix 2) and sexual 
behavior was performed; the latter was correlated with neurochemical 
and molecular data from hypothalamus and nucleus accumbens 
(Chapter 2.3). 
 
 
3.1. Animal model of antenatal corticosteroid exposure 
 
The glucocorticoid (GC) milieu, both in utero and in the early postnatal 
period, is crucial for neurodevelopment not only because of its 
activational effects, but also through its important brain programming 
effects. Increasing evidence suggests that early life exposure to GC 
triggers undesired metabolic, cardiovascular, neuroendocrine and 
behavioral phenotypes in adulthood (Mesquita et al., 2009; Appendix 3). 
In this work, we aimed to understand the effects of a clinical relevant 
dose of GCs administered during pregnancy in a short-term basis. Thus, 
in our animal model of prenatal short-term exposure to GCs, we decided 
to use 1mg/kg of DEX, a dosage that was previously shown to have 
physiological effects in rodents (De Souza and Adlard, 1973).  
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To compare the effects of synthetic versus natural corticosteroids we 
also used in some of our studies a short-term administration of 
corticosterone (CORT) to pregnant dams. There is a paucity of studies 
regarding the dosages of CORT needed to exert similar physiological 
effects as DEX; however, given that DEX is 25 times more potent than 
CORT on GC receptor binding, we have used a 25mg/kg dose of CORT in 
our experiments. Importantly, both drugs (at the dosages used) seem to 
have similar physiological effects in both humans and rodents. In fact, 
animal studies have confirmed the efficacy of synthetic and natural 
corticosteroids in these relative dosages in promoting fetal lung 
maturation (Jobe et al., 2003). Moreover, human data supports the 
efficacy of both drugs in promoting lung maturation (Dluholucky et al., 
1976; Roberts and Dalziel, 2006).  
 
It is relevant to note at this point that the neurodevelopment processes 
in rodents and humans are not totally coincident. In contrast to humans, 
in which the phase of maximal fetal brain growth begins at 28–36 weeks 
(80% of gestation), maximal brain growth in rats does not occur until 
the first postnatal week (Dobbing and Sands, 1970, 1979). Therefore, in 
order to implement a model of late gestational exposure to GCs, 
pharmacological administration was performed during the final days of 
gestation, in order to better assess the effects on the developing fetal 
brain. At this point, it is important to highlight that our model proved to 
be efficient as it induces activational effects (e.g. differences in body 
weight) but also triggers relevant brain programming effects (see below) 
that persist throughout adulthood. 
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!3.2 Behavioral assessment of anxiety and BNST structural correlates 
 
The studies presented (Chapters 2.1 and 2.2) demonstrate that 
antenatal exposure to DEX results in increased anxiety-like behavior in 
adulthood. These conclusions are supported by data collected from 
different behavioral tests: two tests based on conflict behavior, the 
elevated plus maze (EPM) and the open-field (OF) tests, but also in a 
behavior paradigm, the acoustic startle response (ASR), that is 
independent on the animals’ motivation to explore new contexts.  
 
Among the different tests used to measure anxiety in rodents, the EPM 
has been thoroughly validated by both physiological and 
pharmacological measures (Pellow et al., 1985; Lister, 1987; Cruz et 
al., 1994; File, 2001), being considered by many as the gold-standard 
test to measure anxiety in rodents. The test recreates natural stimuli 
known to induce anxiety in humans, which are considered to be 
ethologically valid. In the EPM, the animals face the conflict of exploring 
a novel and well lit open narrow platform raised above the floor or to 
stay on a darker narrow alley with high walls protecting from potential 
threats (Dawson and Tricklebank, 1995). When tested in the EPM, rats 
exposed to anxiolytic drugs spend an increased percentage of time and 
entries in the open arms, reflecting the value of the test in the 
assessment of anxiety rather than exploration. The EPM is considered to 
rely on neuronal pathways related with processment of diffuse stimuli 
and not with specific cues; these include the BNST, but not the 
amygdala (Davis et al., 1997; Pego et al., 2008).  
 
In our work, decreased ratio of open arm time and number of open arm 
entries were observed in DEX exposed rats. Interestingly, a group of 
rodents exposed to the non-synthetic GC, CORT, displayed an 
intermediate phenotype, possibly reflecting a different susceptibility of 
the developing nervous system to the activation of different 
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!corticosteroid receptors. Our findings are supported by previous studies 
on the exposure to DEX during the last third of gestation (Welberg et al., 
2001), even though other authors failed to replicate these findings 
(Hauser et al., 2009). Besides different dosage (0,1mg/kg/day) and 
duration of drug exposure (last gestational week), the latter authors 
suggest that the anxiogenic effects of prenatal DEX could be more easily 
visible under stressful background conditions only, since, in their work, 
the test was performed under the dark phase of the light/dark cycle; 
according to them, light could emphasize a DEX induced 
hypersensitivity to stress. 
 
Herein we showed that the hyperanxious phenotype triggered by 
prenatal short-term exposure to DEX is also evident in the acoustic 
startle, an expression of unconditioned emotional behavior. The startle 
is a fast protective mechanism of the organism in response to a sudden 
and intense stimulus, being considered an indicator of anxiety-like 
behavior (Koch, 1999). In this test, the reflex response of the organism 
to loud noises, characterized by a sequential contraction of the skeletal 
musculature, is recorded and reflects the activation of a trisynaptic 
circuit: 1) auditory inputs from several brainstem nuclei (dorsal cochlear 
nucleus, cochlear root nucleus, ventral cochlear nucleus, lateral superior 
olive and ventrolateral tegmental nucleus) are conveyed to a main 
sensorimotor interface, 2) the caudal pontine reticular nucleus, which 
then projects to 3) spinal motor neurons to trigger the motor response 
(Lee et al., 1996; Koch, 1999). Thus, the assessment of anxiety through 
the acoustic startle reflex, by characterizing the impairment of a specific 
neuronal circuit, is thought to be more precise and less influenced by 
environmental and experimental conditions known to interfere with the 
EPM performance (Izidio et al., 2005; Lewejohann et al., 2006; 
Wahlsten et al., 2006). In our work (Chapter 2.2), DEX exposed subjects 
displayed increased startle amplitudes at different intensities and a 
more rapid increase in startle amplitudes as a function of stimulus 
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!intensity, when compared to controls. Few studies had assessed the 
impact of prenatal GC exposure in the ASR, but recent data on the effect 
of prenatal DEX on female offspring (0.2 mg/kg, gestational days 14-21) 
also showed an increase in basal startle response, but only when an 
additional stressor was applied (e.g. by performing blood sampling 
three months before) (Hougaard et al., 2005; Kjaer et al., 2011).  
 
Of notice, it was demonstrated that the response of stressors upon the 
ASR is modulated by a direct projection from the BNST to the caudal 
pontine reticular nucleus, but also by an indirect one via the CeA (Davis 
et al., 1997). Thus, the BNST and the CeA are the common regions of 
the brain that might influence the phenotype observed in the EPM and in 
the ASR in animals treated with prenatal GCs. Taking that into account, 
we decided to perform a better characterization of these brain regions in 
order to understand the underlying mechanisms of the DEX-induced 
programming of anxiety behavior. Moreover, it is well established the 
role of anxiogenic stimulus in the autonomic activation, including a 
stimulation of the HPA axis and subsequent elevation of corticosteroid 
levels (File et al., 1988). Such adaptative response allows coping when 
novel and potential threatening situations are presented; however, a 
sustained activation of the HPA axis may disrupt these stress-responsive 
systems and result in a permanent activation of these systems. The 
BNST is one, probably the most important, of the relay stations that 
conveys inputs from stress-sensitive areas of the cortex and limbic 
system both to the HPA axis but also to brain stem nuclei implicated in 
several emotional behaviors (Herman and Cullinan, 1997); its role on 
HPA axis modulation is largely exerted through inhibition of the PVN. 
 
Impact of prenatal DEX on BNST morphology 
 
Taking into consideration the role of the BNST in anxiety, and namely its 
modulatory effects in the ASR through projections to the caudal pontine 
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!reticular nucleus (Davis et al., 1997), and the control it exerts over the 
HPA axis, a neuromorphological assessment of the BNST was 
mandatory. Interestingly, antenatal exposure to DEX affected both the 
volume and dendritic arborization of the anteromedial division of the 
BNST (BNSTam). This topographic specificity must be highlighted 
particularly in stress-induced anxiety. In fact, there is substantial 
evidence for the presence of numerous cell bodies that synthesize 
corticotropin releasing factor (CRF) (Ju et al., 1989; Phelix and Paull, 
1990; Sahuque et al., 2006), a mediator of anxiety and stress-like 
responses (Bale and Vale, 2004) in this division of the BNST. Moreover, 
the BNSTam projects intensely to brainstem and hypothalamic regions 
(Cullinan et al., 1993; Moga and Saper, 1994; Spencer et al., 2005; 
Dong and Swanson, 2006) modulating neuroendocrine, autonomic, and 
behavioral responses associated with preservation of homeostasis. Of 
particular relevance to this work are the BNSTam projections to the 
paraventricular nucleus of the hypothalamus (Dong and Swanson, 
2006), which participates in the modulation of peripheral corticosteroid 
levels. In fact, while electrical stimulation of the BNSTam results in 
increased plasma corticosterone levels (Dunn, 1987), its lesion 
produces a decrease of the plasmatic levels of these hormones (Choi et 
al., 2007). 
 
Herein we described an increase in BNST total volume, an effect largely 
due to increased volumes in anteromedial division of the BNST, without 
significant impact on total cell numbers. Additionally, a remodeling of 
dendritic arborizations was identified, with prenatal DEX exposure 
resulting in an increase of total dendritic length of neurons in the 
BNSTam when compared to controls; however, no effects were identified 
in spine densities. Our findings of a general hypertrophy of dendrites in 
the neurons of this brain area are in accordance with data from studies 
on the effects of stress in adulthood (Vyas et al., 2003; Pego et al., 
2008). Interestingly, the plastic changes observed in the BNSTam of 
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!DEX-exposed animals are paralleled with alterations in the expression 
levels of NCAM, a molecule important for neuronal plasticity (Nacher et 
al., 2002; Bisaz and Sandi, 2010). In addition, the increased levels of 
synapsin, a protein involved in the regulation of neurotransmitter release 
(Rosahl et al., 1995), are also suggestive of an increased 
neurotransmission, and possibly overactivation, of this brain region 
following antenatal DEX exposure. Such molecular changes confirm a 
stress-induced enhanced plasticity in these brain regions, as suggested 
by the increased dendritic arborization of these animals.  
 
A brief note to highlight that besides the increased anxiety-behavior, 
animals exposed to DEX in pregnancy also displayed increased 
depressive-like behavior in adulthood (Chapter 2.1). It is known that 
increased anxiety may prompt individuals to develop depression 
(Strohle and Holsboer, 2003). The overlap between the emotional 
alterations observed in anxiety and depressive disorders (Hettema, 
2008) is supported by animal studies (Bessa et al., 2009), and suggests 
shared psychopathological pathways for both behaviors. Interestingly, in 
this work (Chapter 2.1), we observed that despite prenatal exposure to 
either CORT or DEX did not affect the baseline performance in the 
forced swimming test (FST), these animals were more susceptible to the 
development of depressive-like symptoms following additional exposure 
to a chronic mild stress protocol during adulthood. These observations 
of increased immobility in the FST were subsequently replicated in other 
labs (Kjaer et al., 2010), but in some only in female progeny that was 
reared by DEX-exposed dams (Hauser et al., 2009). A final note to 
highlight that a very recent study showing that daily restraint stress 
during late gestation resulted in offspring depressive-like behavior later 
in life, demonstrated that this phenotype was associated with reduced 
dendritic complexity and spine density of neonatal-generated granule 
cells (Tamura et al., 2011). These data support the role of hippocampal 
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!neuronal network disruption in prenatally induced depressive disorders, 
whose characterization could also be of interest in our research model. 
 
At this point, it becomes clear that the exposure of pregnant dams to 
DEX induces a programming structural effect in the BNST of their 
progeny, which renders them more anxious and prone for depressive-
like behavior in adulthood. It is also important to note that we also 
found a hyperresponsive HPA axis in these animals (Chapter 2.1) that 
led to increased levels of circulating corticosteroids in adulthood. This 
fact might be relevant to explain the hyperemotional phenotype, as the 
increase of circulating corticosteroids might further promote the 
activation of the BNST as it is known that these hormones are 
implicated in the neuroanatomical changes observed in this brain region 
(Pego et al., 2010). 
 
 
3.3 Behavioral assessment of fear and correlates in the structure of 
the amygdala 
 
Following the data supporting a hyperanxious phenotype in the adult 
offspring of short-term DEX exposed dams, we also decided to perform 
an assessment of fear conditioning in these animals (Chapter 2.2). 
Surprisingly, our work suggests that DEX exposure impairs fear 
conditioning in adulthood. 
 
As a result of triggering a wide range of defensive behaviors, conditioned 
fear becomes a key survival-related function when a potential threat is 
presented to the individual. The most popular measures of conditioned 
fear include freezing and fear-potentiated startle (Fendt and Fanselow, 
1999). Considering the neuronal circuits involved in the fear-potentiated 
startle, visual or auditory, but also shock, pathways project via the 
thalamus and insular or perirhinal cortex to the BLa. The latter then 
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!projects to the CeA and MeA, which send outputs to the pathway of the 
acoustic startle in the brainstem. Specifically, the CeA either projects 
directly or via mesencephalic reticular formation and deep layers of 
superior colliculus, while the MeA sends indirect projections via 
ventromedial hypothalamus and ventral periaqueductal gray (Davis, 
2006). Thus, the different projections to the caudal pontine reticular 
nucleus are responsible for the increase in startle amplitude induced by 
fear conditioning to a previous neutral stimulus. Previous data supports 
that while baseline startle amplitudes are not affected by interference 
with these connections, the response to fear conditioning is. 
 
 
Our finding of impaired fear conditioning in adulthood following 
antenatal DEX exposure (Chapter 2.2) favors the hypothesis of defective 
amygdalar function and memory consolidation for emotionally arousing 
experiences. Supporting our findings, recent studies showed that 
prenatally stressed animals displayed a reduced ability to learn the 
predictive nature of a stimulus (Markham et al., 2010). Impairment of 
fear memory consolidation was also observed in maternally stressed 
male mouse offspring (from gestational day 8 to 20) (Lee et al., 2011). 
These findings, along with data showing an impairment on context-
induced fear conditioning in adult male rats following early life stress 
(neonatal isolation between postnatal days 2-9) (Kosten et al., 2006), 
support that adverse early life events can, indeed, modulate fear 
conditioning. Conversely, other authors suggested an enhanced fear-like 
behavioral profile in adult male offspring from pregnant females 
submitted to immobilization from day 14 of pregnancy until birth (8–9 
days), as they presented an impairment in fear extinction; however, such 
effect was only present if additional prolonged stress protocol was 
applied in adulthood (Green et al., 2011). 
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!Impact on the morphology of the amygdala 
  
Several studies have contributed to the elucidation of the role of the 
amygdala and its divisions, particularly the CeA and BLa, in fear. A 
disruption of fear-potentiated startle has been observed following 
different types of CeA lesion (Hitchcock and Davis, 1987; Campeau and 
Davis, 1995; Walker and Davis, 1997). Electrolytic lesions of the CeA 
completely blocked the expression of fear-potentiated startle in rats 
(Kim and Davis, 1993). Moreover, the differential role of the BNST and 
the amygdala was supported, as only light enhanced startle, but not 
fear-potentiated startle, was disrupted by inactivation of BNST (Walker 
and Davis, 1997; Gewirtz et al., 1998). Interestingly, inactivation of the 
BLa impaired both behaviors. Nonetheless, recent data suggests that 
the lateral division of the BNST may tonically inhibit the fear-potentiated 
startle, probably via projections to the CeA (Meloni et al., 2006). 
 
Considering the established role of the amygdala in fear conditioning, 
and the observed impairment in fear behavior, a neuromorphological 
assessment of the amygdala appeared essential. According to our data 
(Chapter 2.2), brief prenatal DEX-exposure results in decreased volumes 
in the CeA and BLa (but not in the lateral division of the amygdala), 
without affecting the total cell numbers. Indeed, the volumetric 
reduction observed in these amygdalar divisions largely results from 
dendritic atrophy. It is interesting to note that the described dendritic 
atrophy in the BLa (but not in the CeA) is in accordance with previous 
observations on the effects of chronic unpredictable stress during 
adulthood (Vyas et al., 2002); however, others have failed to show any 
effect on the volumes of cerebral cortex, corpus callosum, 
hippocampus, dentate gyrus or amygdala following a single course of 
betamethasone at postnatal day one (Yossuck et al., 2006). Several 
technical issues may explain this divergence, namely the time of the 
exposure and the nature of insults, as different windows of vulnerability 
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!to the programming effects of different stimuli seem to occur. In fact, 
the effects of stress in the neuronal morphology of specific brain regions 
are remarkably distinct throughout life. While chronic juvenile stress 
seems to induce a general hypertrophy on amygdalar dendritic 
arborization (Eiland et al., 2011), adult stress seems to have no impact 
(Pego et al., 2008). However, it is important to mention that others have 
reported an increase in dendritic growth in the BLa and no changes in 
the CeA (Vyas et al., 2002; Vyas et al., 2003) in response to stress. 
Obviously, these apparent divergent results illustrate the complexity of 
the structural phenomena taking place in the amygdala in response to 
stress/glucocorticoids and further studies are needed to better 
understand these differences. 
 
The relevance of dopamine for emotional behavior 
  
The next step in our work was to establish the neurochemical correlates 
for our behavioral and structural findings. Amongst several 
neurotransmitters, we decided to evaluate dopamine (DA) in light of 
previous findings of our laboratory in this (Leao et al., 2007; Appendix 
1) and similar (Mesquita et al., 2009; Appendix 3) animal models, but 
also on its relevance for the function of the amygdala. Indeed, DA is 
believed to play a facilitative role in the amygdalar function, specifically 
via VTA efferents (Asan, 1997). In vitro studies support that dopamine 
modulates the excitability of amygdalar, namely BLa, neurons (Kroner et 
al., 2005) and it was demonstrated the blockade of fear-potentiated 
startle by lesion of the VTA (Borowski and Kokkinidis, 1996). The 
facilitator effect of DA on affective behaviors may be explained, at least 
partially, by its actions at the cellular level on BLa neurons. DA receptor 
activation could simultaneously facilitate the BLa output in response to 
strong inputs that cause spike firing, while suppressing weaker inputs 
via activation of GABAergic interneurons. In our work, the observation of 
a hypodopaminergic status in the amygdala following prenatal DEX-
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!exposure (Chapter 2.2) seems of particular relevance if we consider the 
impairments in fear memory observed in these animals. In fact, this is in 
line with previous observations in models of DA-deficient mice, in which 
restoration of DA levels in the BLa was required for the formation of 
fear-related memory (Fadok et al., 2010). According to our data, the 
decreased amygdalar levels of dopamine are associated with increased 
expression of D2 receptor mRNA in DEX-exposed subjects. This is 
consistent with recent data showing that conditioned fear is modulated 
by D2 receptor pathway connecting the VTA and BLa, where freezing 
behavior and increased dopamine levels in the BLa in response to a 
conditioned stimulus were both inhibited by intra-VTA administration of 
a D2-agonist (De Oliveira et al., 2011); moreover, according to the same 
study, intra-BLa injection of a D2-antagonist resulted in inhibition of 
FPS. 
 
 
3.4 Implications of antenatal DEX-exposure for sexual behavior  
 
The final behavior phenotype that proved to be altered in DEX-exposed 
animals was male sexual behavior. The most important period in brain 
sexual differentiation of rodents comprises the last gestational week and 
the first two weeks of postnatal life (Segarra et al., 1991), making it 
particularly vulnerable to insults, including stress and high 
corticosteroid exposure. Actually, it has been reported that prenatal 
stress disrupts the normal maternal hormonal milieu, and suppresses 
the fetal testosterone peak on gestational days 18 and 19 required for 
the expression of male sexual behavior in adulthood (Ward and Weisz, 
1984; Lalau et al., 1990). An impact in the function of the hypothalamic-
pituitary-gonadal (HPG) axis is suggested to occur as a result of 
disturbing the normal maturation of the HPA axis, as both axes share 
central and peripheral mechanisms of regulation (Page et al., 2001). In 
addition, previous studies reported that both prolonged prenatal stress 
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!or corticosteroids-exposure result in reduced peripheral testosterone 
levels and impairments in adult male sexual behavior (Ward, 1972; 
Gerardin et al., 2005; Piffer et al., 2009), further supporting the need to 
clarify the potential effects of a brief prenatal corticosteroid exposure 
that better mimics the daily clinical practice. 
 
When assessing male sexual behavior, two distinct patterns of behavior, 
initially described by Wallace Craig, are classically considered: 1) 
appetitive and 2) consummatory (Craig, 1917; Ball and Balthazart, 
2008). While appetitive behaviors are variable and reflect the 
motivational status driving the individual to respond to a stimulus, 
consummatory behaviors are more stereotyped and species-specific 
(Pfaus, 1996; Hull and Rodriguez-Manzo, 2009). The analysis of several 
behavioral parameters differentiates the appetitive and consummatory 
components of male rat sexual behavior. Briefly, male rat sexual 
behavior is characterized by a succession of mounts, either with or 
without vaginal penetration (intromission), that eventually lead to 
ejaculation (Hull and Dominguez, 2007). Appetitive aspects and sexual 
motivation are inferred from latency to first mount (Hull et al., 2006), 
while consummatory components of copulatory behavior are reflected 
by intromission and ejaculation latencies but also mount and 
intromission frequencies (Pfaus et al., 1990a; Agmo, 1999).  
 
According to our data (Chapter 2.3), brief prenatal DEX-exposure 
impaired mainly sexual motivation, as reflected by increased mount and 
intromission latencies, but also reduced number of mounts; notably, 
these differences were more striking in animals exposed to DEX than to 
CORT. Previous studies, using less detailed sexual behavioral 
assessment, reported impaired adult male sexual behavior following 
prenatal restraint stress (GD 18-22) (Gerardin et al., 2005) or 
aromatase inhibitor exposure (GD 21-22) (Gerardin et al., 2008). A 
transient impairment in male sexual behavior was also reported after 
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!prolonged prenatal exposure to DEX or restraint stress, but not CORT 
(GD 14-21) (Holson et al., 1995); importantly, in the latter study the 
authors only measured “lordosis quotient” and ejaculations. While 
opposite results were reported by others following neonatal DEX-
exposure (0,3mg/kg/day, from postnatal day 1-3), with animals showing 
increased sexual motivation and intromission behavior in the bi-level 
chamber (Kamphuis et al., 2004), the behavioral parameters assessed 
in our work are somewhat reproduced in a detailed report on the impact 
prolonged prenatal stress (GD 14-21) (Meek et al., 2006). Thus, in 
conclusion it seems that most reports in literature point to an 
impairment in male sexual performance after exposure to DEX in late 
pregnancy. This conclusion led us to search for the underlying 
mechanisms of this behavioral dysfunction, particularly the decrease in 
sexual motivation. 
 
 
The hypodopaminergic status and its implications in the central control of 
sexual behavior 
 
Taking into account the central role of the nucleus accumbens (NAcc) 
and DA in sexual behavior, particularly in sexual motivation, but also 
data from our group describing an impoverished dopaminergic 
innervation of the NAcc following brief prenatal DEX-exposure (Leao et 
al., 2007; Appendix 1), we decided to assess the impact of such 
exposure on the dopaminergic circuits in adulthood. 
 
Dopamine (DA) is the common key player in all the three major 
integrative systems that regulate sexual motivation and genital and 
motor responses (Hull et al., 2004). This neurotransmitter favors sexual 
motivation, copulatory proficiency, and genital reflexes (Giuliano and 
Allard, 2001). Among these systems: 1) the mesolimbic system is 
critical for appetitive behavior and reinforcement; 2) the medial preoptic 
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!system contributes to genital reflexes, sexual motivation and motor 
patterns of copulation; and 3) the nigrostriatal system enhances the 
motoric readiness to respond to stimuli. The neuronal circuits 
underlying sexual excitation involve the activation of 
incertohypothalamic and mesolimbic dopamine transmission that 
targets the hypothalamic medial preoptic area (mPOA) and NAcc, 
respectively (Pfaus, 2009). Therefore, during male rat sexual behavior 
increased DA release is observed in the NAcc. After a small augment 
following presentation of a receptive female, a sharp increase in 
dopamine transmission is observed during copulation, that steadily 
declines on female removal (Pfaus et al., 1990b).  
 
In our work (Chapter 2.3), we established an interesting neurochemical 
link with the findings in impaired sexual behavior of the male GC-
exposed progeny, as we reported decreased dopamine in hypothalamus 
and NAcc of animals briefly exposed to prenatal corticosteroids. This is 
in accordance with a prior simultaneous behavioral and microdialysis 
sampling study linking the absence of copulatory behaviors in prenatally 
stressed male rats who failed to increase extracellular levels of 
dopamine and its metabolites in the NAcc (Wang et al., 1995), thus 
supporting the potential impact of intense environmental stressors in 
NAcc dopamine release. The findings of decreased dopamine levels in 
the NAcc are also pertinent if we consider descriptions correlating a 
delayed onset of copulation and ejaculation with a diminished release of 
this neurotransmitter in the mesolimbic tract (Hull et al., 2004). 
 
Apparently, these changes are related to a general impoverished of the 
dopaminergic innervation of the NAcc as suggested by our observations 
of decreased density of tyrosine hydroxylase-positive fibers in this area 
following prenatal short-term exposure to DEX (Leao et al., 2007; 
Appendix 1). The existence of a hypodopaminergic status in these 
animals is further supported by the report of increased dopamine D2 
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!receptors mRNA in the NAcc, possibly as a compensatory mechanism 
for the low dopamine levels (Appendix 2). Considering the different 
response of the two regions comprising the NAcc, core and shell, to 
natural reinforcers, it would have been of interest to assess the 
differential impact of DEX-exposure on them. In fact, whereas increased 
c-fos expression is observed in the core of the NAcc during sexual 
behavior, it remains unchanged in the shell (Bradley and Meisel, 2001).  
 
The mesolimbic reward circuit, in which the VTA-NAcc pathway is the 
central component, is an essential element when understanding the 
impact of the prenatal DEX-induced hypodopaminergic status on 
behavior. In fact, dopamine is released in the NAcc in response to 
consummatory behaviors such as sex and food, but also drugs of abuse 
(Piazza and Le Moal, 1996). Therefore, besides impaired sexual 
behavior, other behavioral consequences should be expected, since 
adequate dopamine input to the NAcc is essential for feeding, reward 
and addiction. In fact, the individual’s cycles of drug-seeking 
behavior/abuse and response to natural rewards are tightly regulated by 
the balance between hypo- and hyperdopaminergic states in the 
mesolimbic circuit, and particularly in the NAcc. Therefore, while 
motivational or rewarding properties of drugs of abuse appear to be 
potentiated by hyperdopaminergic states, hypodopaminergic states 
seem to increase drug-seeking behavior along with a decline in the 
motivational impact of ‘natural’ rewards such as food and sex (Diana et 
al., 1993; Diana et al., 1998; Melis et al., 2005). The reduced dopamine 
levels in the NAcc and concomitant impaired appetitive sexual behavior 
observed in the DEX-exposed progeny further support this hypothesis. In 
addition, as reported in other models of early life stress (Kippin et al., 
2008), it would also be also reasonable to assume a differential 
susceptibility to addiction. Actually, our group recently reported an 
increased preference for opiates and ethanol, along with simultaneous 
hyperresponsiveness to the psychostimulatory actions of morphine 
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!following brief prenatal exposure to DEX (Appendix 2). These behavioral 
findings are in accordance with previous studies showing cross-
sensitization between repeated exposures to pharmacological agents 
and natural motivated behaviors such as sex (Mitchell and Stewart, 
1990b, a; Fiorino and Phillips, 1999).  
 
Besides its role in the mesolimbic circuit, DA in the hypothalamus, 
particularly in the mPOA, is vital for genital reflexes, motor patterns of 
copulation, and (probably) sexual motivation (Hull and Dominguez, 
2006). Thus, and despite our data relies on the whole hypothalamic 
area, and not the mPOA specifically, the decreased hypothalamic levels 
of dopamine exhibited following DEX might be of relevance. Of notice is 
the fact that antenatal CORT-exposure did not produce a similar 
reduction in hypothalamic DA levels nor had impact on D1 receptors 
mRNA levels, which might be relevant to explain the differential 
neuroendocrine and behavioral effects of CORT from DEX.  
 
Given that the facilitative role of increased levels of DA in the mPOA on 
sexual behavior is considered to be mediated by testosterone 
(Dominguez and Hull, 2005), which can activate androgen receptors, 
either directly or via stimulation of estrogen receptors following 
aromatization to estradiol (Stewart and Rajabi, 1994), we also assessed 
the levels of androgens and its receptors in the hypothalamus. We found 
an augment in androgen receptor mRNA in the hypothalamus of DEX 
progeny, which possibly reflects the decreased circulating androgens; 
interestingly, estrogen receptors were unaffected. These findings are of 
relevance as an androgen-dependent female-stimulated DA raise is 
required for efficient mating (Putnam et al., 2005). Furthermore, 
testosterone is considered essential to regulate nNOS transcription in 
the mPOA, with the consequent influence in nitric oxide production, and 
modulation of DA release (Sanderson et al., 2008).  
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!While it is clear the involvement of changes in the DAergic circuits and 
of hypothalamic androgens as underlying causes of the altered sexual 
behavior displayed by the adult male DEX-exposed progeny, there are 
several aspects that need further clarification to better understand this 
dysfunctional behavior, namely a greater topographic and molecular 
specificity of the reported changes in the NAcc and, mainly, in the 
hypothalamus. These are some of the aspects currently under analysis 
in our lab. 
 
 
3.5 The selective effect of antenatal DEX exposure 
 
At this point, one might wonder if all behaviors would be affected by 
antenatal DEX-exposure, or whether there is some specificity in the 
behavioral changes. Certainly, the latter seems to be the answer. 
Indeed, in the present work, we failed to show any deficit in spatial 
memory (Chapter 2.1). Such fact supports the view that brain structures 
may be subject to differential programming by corticosteroids during 
specific time windows; in this specific case it seems that neuronal 
circuits regulating emotionality (primarily, the BNST and amygdala) are 
vulnerable, whereas spatial memory systems (primarily, the 
hippocampus) are not. However, other authors described impaired 
spatial learning following prolonged prenatal stress (Markham et al., 
2010) or DEX-exposure (Brabham et al., 2000), during the last 
gestational week (and not E18 and E19, as we did); moreover, in the 
latter study, changes were only observed in subjects reared by exposed 
mothers, possibly due to altered maternal behavior. Nonetheless, data 
from our lab does not confirm the presence of major changes in pup-
directed or self-directed behaviors following short-term DEX-
administration (Appendix 2). It is also relevant to note, that studies from 
our lab also demonstrate cognitive deficits if rats are exposed to 
stress/GCs in the first week of postnatal life (Mesquita et al., 2009; 
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!Appendix 3). Thus, it seems most likely that the selective impact of 
prenatal GCs exposure on emotional and sexual behavior, without 
apparently affecting cognition, is due to the specific time period of the 
exposure to DEX, an aspect that can be ascribed to the different 
temporal maturation of brain circuits namely in what regards the 
expression of GR and MR (Rosenfeld et al., 1993; Owen and Matthews, 
2003). 
 
Also noticeable is the absence of changes in the prepulse inhibition test 
following DEX exposure (Chapter 2.2). In this test, which assesses the 
sensorimotor gating mechanisms, the amplitude of startle response is 
reduced when a non-startling acoustic stimulus is previously presented; 
due to its nature, this test is considered of relevance to schizophrenia. 
Acoustic prepulses are processed via ascending auditory pathway, 
including the inferior colliculus and then activating the superior 
colliculus, which also receives other acoustic, tactile and visual inputs. 
Projections from the latter to the pedunculopontine tegmental nucleus 
mediate the inhibition of startle response through a cholinergic 
projection to the caudal pontine reticular nucleus (Fendt et al., 2001). 
The absence of an effect on acoustic startle response to inhibitory 
prepulse described in our study is in accordance with previous data 
(Hauser et al., 2006), and suggests that GR antenatal programming is 
not of clear relevance to the neurodevelopmental hypothesis of 
schizophrenia. 
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!4. CONCLUSIONS AND FUTURE PERSPECTIVES 
 
 
In summary, we report the deleterious effects of prenatal exposure to 
DEX in emotional behavior, namely fear and anxiety. Moreover, 
neuromorphological, neurochemical and molecular programming 
changes in the brain areas related with these behaviors, namely in the 
amygdala and in the BNST, seem to underlie the hyperanxious and fear 
pathology in adulthood. These findings are also associated with the 
reprogramming of the HPA axis, leading to a hyperresponsive axis. 
Notably, the impact on emotional behavior appears to extend beyond 
anxiety and fear, being associated with increased susceptibility to 
develop depressive-like behavior following exposure to chronic stress.  
In parallel, we demonstrate an impairment in adult male sexual 
behavior, mainly in its motivation-related aspects. This behavioral 
dysfunction was also associated to a hypodopaminergic status in both 
the NAcc and the hypothalamus. In the latter region, we also found 
changes in androgen signaling.  
Interestingly, despite not being the main purpose of this thesis, our data 
points out the possibility of a less deleterious impact of the exposure to 
natural GCs, namely corticosterone. These findings, with potential 
clinical implications, further support the concerns raised on the impact 
of the excessive or repeated prenatal use of synthetic corticosteroids 
and call for the need of a re-appraisal of its therapeutic regimens and 
certainly for its parsimonious use. 
 
As in every scientific work, at the end there seems to be more questions 
to be addressed than answers given… this is the driving force of science. 
Future work should aim the establishment of functional correlates of the 
described behavioral and neuromorphological phenotypes. Also, the 
impact of the HPA axis impairment on specific neuronal networks 
involved in emotional behavior should be further clarified by additional 
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!molecular and neurochemical studies on its main neurotransmitter 
systems. 
 
 
Several strategies could be considered to achieve these goals: 
 
1) The behavioral, structural and molecular findings that emphasize 
the changes in BNST functionality could benefit from 
electrophysiological studies in this region. 
 
2) The regulatory influence of the BNST on the HPA axis via PVN 
projections should be further clarified, namely through molecular 
studies on CRF receptors and tracer studies on CRF neurons. In 
parallel, the study of the GABAergic system, the main 
neurotransmitter system of the BNST, could further elucidate the 
regulatory influence this region over the HPA axis. 
 
3) The described decrease in amygdalar DA levels together with the 
increased D2 receptor gene expression should be further 
explored. Tracer studies on the dopaminergic input to the BLa 
from the VTA could be of interest. 
 
4) Given the described impairment in motivation-related aspects of 
sexual behavior, detailed neurochemical studies on NAcc core and 
shell and mPOA could better clarify the impact of prenatal 
exposure to corticosteroids in the brain dopaminergic systems. 
 
5) The addictive phenotype reversion evidenced by L-dopa 
administration (Appendix 2) highlights the potential role of the 
dopaminergic system at least in part of the observed changes, 
namely in male sexual behavior. Would the observed impairments 
in sexual motivation also be reverted by L-dopa administration? 
114
!And which side effects could be expected from its long-term 
administration? 
 
Hopefully, in a near future answers to these questions will be available. I 
hope to be able to contribute to the elucidation of some of them. 
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ABSTRACT Elevated glucocorticoids, during pregnancy, alter emotionality and
increase propensity to drug abuse later in life, albeit through substrates and mecha-
nisms are largely unknown. In this study, we examined whether antenatal glucocorti-
coid exposure induces enduring structural changes in the nucleus accumbens (NAcc),
an important relay point in the reward limbic circuitry. To this end, rat dams were
exposed to the synthetic glucocorticoid dexamethasone (DEX) on days 18 and 19 of
gestation, and stereological tools were used to assess the total volume of, and neuronal
numbers in, the NAcc, as well as the density of mesencephalic dopaminergic inputs
from the ventral tegmental area (VTA) to the NAcc in their adult offspring. Further,
we used measures of bromodeoxyuridine incorporation into NAcc cells to examine
whether DEX-induced effects on cell proliferation represent another mechanism
through which glucocorticoids alter the structure of mesolimbic pathways and might
influence addictive behavior. Our studies show that exposure to DEX during late ges-
tation results in significantly reduced volumes and cell numbers in the NAcc. The lat-
ter measure correlated strongly with a reduced rate of cell proliferation in DEX-
exposed animals. Moreover, the treatment resulted in a decreased number of cells
expressing tyrosine hydroxylase in the VTA and an impoverished dopaminergic inner-
vation of the NAcc. These observations, which identify glucocorticoid-sensitive struc-
tures and neurochemical targets within the developing ‘‘reward pathway,’’ pave way
for future studies designed to understand how early life events can predispose individ-
uals for developing drug dependence in adolescent and adult life. Synapse 61:40–49,
2007. VC 2006 Wiley-Liss, Inc.
INTRODUCTION
The fetus is highly sensitive to perturbations of its
chemical environment during critical developmental
windows. However, the fetal brain is not only sensi-
tive to teratogenic agents; for example, exposure to
high levels of adrenal corticosteroids (CSs) can set
long-term programs in behavior by altering brain
chemistry and morphology. As we recently demon-
strated in rats, pharmacologically induced hypercorti-
calism during late pregnancy leads to increased emo-
tionality, a feature which persists throughout life (Oli-
veira et al., 2006). Moreover, exposure to excess levels
of CSs during late fetal stages are thought to lead to
increased susceptibility to a variety of neurological
and psychiatric disorders during childhood and adult
life (Boska and El-Khodor, 2003; Lewis and Levitt,
2002; Weinstock et al., 1988), including increased sus-
ceptibility to drug abuse (Meaney et al., 2002; Tha-
dani et al., 2004). The latter is thought to be associ-
ated to disturbances in either emotional or mood
states, or both (Regier et al., 1990).
The nucleus accumbens (NAcc) is a heterogeneous
structure belonging to the ventral division of the
striatum. Histological and neurochemical studies
reveal two anatomically distinct regions: a core and a
shell (Zahm and Brog, 1992). Both core and shell
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receive inputs from the amygdala, globus pallidus,
and ventral pallidum. However, they differ in the
density of their cortical afferents; the core receives
projections predominantly from the prelimbic, ante-
rior cingulate, and dorsal agranular insular cortex,
whereas the shell receives projections predominantly
from the infralimbic, ventral agranular insular, and
piriform cortex (Zahm, 2000). Furthermore, and per-
haps more importantly, these divisions innervate dis-
tinct areas; the core projects to the conventional basal
ganglia circuitry including the ventral pallidum, glo-
bus pallidus, and the substantia nigra, whereas the
shell projects to subcortical limbic structures such as
the lateral hypothalamus and the ventral tegmental
area (Zahm and Brog, 1992). These patterns of connec-
tivities indicate that the two NAcc divisions may be
involved in different aspects of the motivation-reward
processes (Ikemoto and Panksepp, 1999) and the tim-
ing of the initiation of response patterns originating in
the frontal corticostriatal loop systems (Groenewegen
et al., 1999; Kelley et al., 2005).
The NAcc receives major dopaminergic inputs from
the VTA. Importantly, the central dopaminergic sys-
tems, especially those in the NAcc that are crucial to
the regulation of reward behavior, appear to be particu-
larly vulnerable to perinatal insults. For example,
maternal stress in late gestation (Berger et al., 2002;
Diaz et al., 1998; Henry et al., 1995) or repeated periods
of maternal separation during early postnatal develop-
ment (Meaney et al., 2002) alter the pattern of DA re-
ceptor expression and decrease the dopamine trans-
porter availability in the NAcc, later in life. Interest-
ingly, Meaney and collaborators (2002) showed that
postnatal maternal separation produces increased be-
havioral responses to stress and cocaine. In addition,
there is evidence that prenatal and early postnatal
stress results in decreased DA drive to the medial pre-
frontal cortex (Brake et al., 2000), a feature commonly
associated with psychiatric disorders thought to have a
neurodevelopmental basis (Lewis and Levitt, 2002).
The mechanisms through which stress alters NAcc
function have not been fully investigated. On the pre-
mise that elevation of glucocorticoids is one of the
most overt physiological manifestations of stress and
that the brain is more sensitive to organization by
glucocorticoids during early development, this initial
study evaluated the potential impact of antenatal glu-
cocorticoid administration upon NAcc structure and
its dopaminergic innervation. Our results show that
exposure of the fetus to dexamethasone (DEX) during
late gestation leads to a reduction in both the volume
and the number of cells in the NAcccore and NAccshell
of males, and volumes and number of neurons in the
NAccshell in females. These changes could be partly
attributed to antenatal DEX-induced inhibition of cell
proliferation in NAcc. Further, we report an associa-
tion between fetal exposure to DEX and reduced
numbers of tyrosine hydroxylase (TH)-positive cells in
the adult VTA, paralleled by a markedly reduced den-
sity of dopaminergic inputs to the NAcc.
MATERIALS AND METHODS
Animals and treatments
Adult pregnant Wistar rats (Charles River Laborato-
ries, Barcelona, Spain) were individually housed under
standard laboratory conditions (light/dark cycle of 12/
12 h with lights on at 08:00; 228C); food and water
were provided ad libitum. Subcutaneous injections of
dexamethasone (DEX, 0.1 mg/kg; n ¼ 4) or saline
(CONT, 1 ml/kg; n ¼ 4) were administered on E18 and
E19 days of pregnancy. Other groups of CONT- and
DEX-treated mothers (n ¼ 3) were given a single injec-
tion of bromodeoxyuridine (BrdU, 50 mg/kg, i.p.) on
E18/19, to birthmark neurons in the offspring. On
postnatal day 21, progeny were separated according to
antenatal treatment and gender. All manipulations
were done in accordance with local regulations (Euro-
pean Union Directive 86/609/EEC) and NIH guidelines
on animal care and experimentation.
Tissue preparation
Groups of male and female rats born to mothers
exposed to either saline or DEX (derived from four dif-
ferent litters) on E18 and E19 of pregnancy were
deeply anesthetized and transcardially perfused with
4% paraformaldehyde (PFA) when 60 days old. Brains
were removed and the cerebral hemispheres were sep-
arated by a longitudinal cut in the midsagittal plane.
Blocks containing the NAcc were washed in tap water
and dehydrated through a graded series of ethanol sol-
utions, before being embedded in glycolmethacrylate
(Tecnovit 7100, Heraeus Kulzer, Wehrheim, Germany).
Microtome sections (30 mm) were placed on slides
Fig. 1. Photomicrographs of Giemsa-stained glycolmethacrylate-
embedded coronal sections of the NAcc shell and core divisions used
for the cell counting with the SteroInvestigator software. LV, lateral
ventricle; ac, anterior commissure. Scale bar ¼ 200 mm.
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coated with Entellan-new, before staining with Giemsa
stain. The outline of the NAcc, including its core and
shell areas (Zahm and Brog, 1992), was defined in
each section using established landmarks (Fig. 1).
Another subset of male rats (derived from four differ-
ent litters) was prepared for TH immunocytochemistry.
Every 8th (30-mm thick) section, which included the
NAcc and VTA, was treated with 3% H2O2 in PBS to
eliminate endogenous peroxidase activity and blocked
with 4% bovine serum albumin (BSA, Sigma) in PBS.
Sections were then incubated overnight at 48C in rabbit
anti-TH serum (1:2000; Affinity Reagents, Exeter, UK),
in blocking solution. Antigen visualization was carried
out by sequentially incubating with biotinylated goat
antirabbit antibody, ABC1 (Vector, Burlingame, CA),
and diaminobenzidine (DAB, Sigma) (Fig. 2).
Serial coronal cryosections, covering the entire length
of the NAcc and VTA, were prepared from 3-day old
pups (derived from three different litters) whose moth-
ers had been treated with BrdU (Fig. 3). Every 2nd
section from this series was mounted on poly-L-lysine-
coated slides and stained for BrdU after fixation in 4%
PFA (30 min), permeabilization (0.2% Triton X-100 in
Tris buffer saline, 10 min), microwave treatment for
antigen retrieval (20 min in 0.1 M citrate buffer), acidi-
fication with 2 M HCl, peroxidase and nonspecific
blocking (3% H2O2 and 4% BSA, respectively). The
BrdU antibody was a mouse monoclonal from Dako,
Fig. 2. Representative light
microscopic photomicrographs of
TH-positive immunocytochemistry
in NAcc and VTA. Illustration of
dopaminergic innervation of NAcc
in control- (A) and DEX-treated
(B) animals. Magnification of con-
trol- (A1) and DEX-treated (B1).
Boxes represent the areas illus-
trated in (A) and (B), respectively.
TH immunocytochemistry in con-
trol (C,C1) and DEX-treated (D,
D1) in the VTA. LV, lateral ventri-
cle; ac, anterior commissure. (A–D)
– Scale bar ¼ 200 mm and (A1–D1)
– Scale bar ¼ 5 mm.
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(Glostrup, Denmark) (1:50). Antigen visualization was
carried out using a universal detection system (Bio-
Genex, San Ramon, CA) and DAB. Specimens were
lightly counterstained with hematoxylin.
Stereology
Estimates of NAcccore and NAccshell region volumes
and cell numbers were obtained using StereoInvestiga-
tor1 software (MicroBrightfield, VT) and a camera
(DXC-390, Sony, Japan) attached to a motorized micro-
scope (Axioplan 2, Carl Zeiss, Germany). Cavalieri’s
principle was used to assess the volume of each region.
Every 8th section was used, and the cross-sectional
area was estimated by point counting (final magnifica-
tion !112). We used a test point system in which the
interpoint distance, at the tissue level, was 75 mm.
The volume of the region of interest (ROI) was then
calculated from the number of points that fell within
its boundaries and the distance between the systemati-
cally sampled sections. Average cell numbers were esti-
mated using the optical fractionator method as
described elsewhere (West et al., 1991). Briefly, a grid
of virtual 3D-boxes (30 mm ! 30 mm ! 15 mm) was
superimposed on every 8th section of the ROI, spaced
as for the volumetric estimation. An estimate of total
number of cells was then derived from the number of
cells falling inside the boxes, the volume of each box,
Fig. 3. Photomicrographs de-
monstrating BrdU immunoreactive
cells in NAcc of controls (A,A1), VTA
control (C,C1), DEX-treated (B,B1),
and VTADEX-treated (D,D1) in rats
ofPND3. (A–D)–Scalebar¼200mm;
(A1–D1)–Scalebar¼5mm
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Fig. 4. Stereological data. Average volumes of NAcc regions in males (A,C) and females (E,G). Total
number of neurons inNAcc divisons inmales (B,D) and females (F,H). *P< 0.05; **P< 0.01; ***P< 0.001.
44 P. LEA˜O ET AL
Synapse DOI 10.1002/syn
125
box spacing, and total number of boxes. Coefficients of
error were automatically computed according to the
formulas of Gundersen et al. (1999) for cell numbers
and Gundersen et al. (1987) for volume estimations.
Glial cells were not included in the estimations, and
the discrimination between neuronal and glial cell
body profiles was based on the criteria described by
Ling et al. (1973) and Peinado et al. (1997).
The density of TH-positive fibers impinging upon the
NAcc was estimated using a ‘‘staggered’’ cycloid test sys-
tem (Baddeley et al., 1986; Emre et al., 1993; Issacs
et al., 1993). The total number of intersections of the
cycloid arcs with the stained fibers was obtained on ran-
domly selected sections containing the core and shell
regions. In addition, the number of TH-positive (VTA)
and of BrdU-positive (NAcc and VTA) cells per unit area
was estimated using StereoInvestigator software. To
complement these measurements, a densitometric analy-
sis of TH immunoreactivity in the NAcc (core and shell)
was performed using NIH Image 1.52 software; the unit
sampling area for these measurements was 1.0 mm2,
and measurements were made in three randomly-
selected regions within core and shell of the NAcc.
Statistical analysis
Differences between groups were determined by a
nonparametric procedure (Mann–Whitney) that does
not assume normality or equal variance. For statistical
analysis, the ‘‘n’ ’ of each experiment group is the num-
ber of litters from which individuals were derived. The
results are expressed as group means6 standard error.
Differences were considered to be statistically signifi-
cant when P < 0.05.
RESULTS
Sustained effects of antenatal DEX on NAcc
cytoarchitecture
The male progeny of DEX-treated dams displayed
reduced volume (P ¼ 0.03) and cell number (P ¼ 0.001)
in the NAcccore (Figs. 4A and 4B). NAcccore male controls:
total number of cells ¼ 352,000 (SEM¼ 8155, n¼ 4), vol-
ume ¼ 1.75 mm3 (SEM ¼ 0.13, n ¼ 4); male DEX: total
number of cells ¼ 235,600 (SEM ¼ 19,050, n ¼ 4), vol-
ume ¼ 1.35 mm3 (SEM ¼ 0.03, n ¼ 4). Similar observa-
tions, albeit of smaller magnitude, were made in their
female counterparts (volume: P ¼ 0.001; cell number: P
¼ 0.004; Figs. 4E and 4F). NAcccore female controls: total
number of cells¼ 306,400 (SEM¼ 11,720, n¼ 4), volume
¼ 1.49 mm3 (SEM ¼ 0.03, n ¼ 4); female DEX: total
number of cells ¼ 231,500 (SEM ¼ 12.160, n ¼ 4), vol-
ume¼ 1.27 mm3 (SEM¼ 0.048, n¼ 4).
Prenatal DEX also significantly reduced the volume
(P ¼ 0.04) and number of cells (P ¼ 0.02) in the NAccshell
of males (Figs. 4C and 4D). NAccshell male controls: total
number of cells ¼ 252,000 (SEM ¼ 4121, n ¼ 4), volume
¼ 0.12 mm3 (SEM¼ 0.055, n¼ 4); male DEX: total num-
ber of cells ¼ 199,600 (SEM ¼ 17,290, n ¼ 4), volume ¼
0.9 mm3 (SEM ¼ 0.03, n ¼ 4). In contrast, there was no
significant effect of antenatal DEX treatment in the
shell region of the NAcc in females (volume: P ¼ 0.7; cell
number: P ¼ 0.4) (Figs. 4G and 4H). NAccshell female
controls: total number of cells ¼ 234,700 (SEM ¼ 1649,
n ¼ 4), volume ¼ 1.1 mm3 (SEM ¼ 0.03, n ¼ 4); female
Fig. 5. Number of BrdU-positive cells in NAcc regions (A,B) and
VTAs (C) in PND3. **P < 0.01; ***P < 0.001.
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DEX: total number of cells ¼ 214,200 (SEM ¼ 16,780, n
¼ 4), volume¼ 1.02 mm3 (SEM¼ 0.04, n¼ 4).
Inhibition of cell proliferation in the
NAcc and VTA
The total number of cells in a given tissue is deter-
mined by the dynamic balance in cell proliferation and
cell death (cell turnover). In view of the reduced number
of cells in the NAcc core and shell of male progeny of
DEX-treated mothers, as well as the known inhibitory
effects of stress and glucocorticoids on neurogenesis, in
this first study, we examined the possible contribution of
altered cell proliferation on total NAcc cell numbers in
male animals. As shown in Figures 5A and 5B, exposure
to antenatal DEX resulted in a significant inhibition of
BrdU incorporation (assessed at postnatal day 3) in the
NAcc core (P ¼ 0.004) and shell (P ¼ 0.0003) regions, as
well as in the VTA (P ¼ 0.0001) (Fig. 5C).
Fig. 6. Decreased TH content in the NAcc divisions of the progeny, after treatment with prenatal
DEX. Densitometric (A,B) and stereological (C,D) data in core and shell, respectively. *P < 0.05;
**P < 0.01; ***P < 0.001. Pearson correlation of both densitometric and stereologic quantifications of
TH immunoreactive fibers in NAcc core (E) and shell (F).
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Reduced dopaminergic innervation of the NAcc
after prenatal exposure to DEX
Densitometric and stereological measurements in
the two divisions of the NAcc revealed significantly
reduced densities of TH-positive fibers in the progeny
of DEX-treated dams (by densitometry: core, P ¼ 0.04
(Fig. 6A), and shell, P ¼ 0.001 (Fig. 6B); by stereol-
ogy: core, P ¼ 0.03, (Fig. 6C) and shell, P ¼ 0.003
(Fig. 6D). The correlation coefficient (Pearson analy-
sis) between the two methods of estimation for core
was r ¼ 0.97 and P < 0.01 (Fig. 6E); shell: r ¼ 0.95
and P < 0.01 (Fig. 6F).
Supplementing the earlier findings, we observed that
the number of TH-positive cells per surface unit of the
VTA was significantly reduced in animals that had
received DEX during prenatal life (P ¼ 0.0003) (Fig. 7).
DISCUSSION
Stressful experience during uterine or early post-
natal life is thought to predispose individuals to
addictive habits, as well as to increased risk for devel-
oping mental disorders such as schizophrenia and
major depression (Hougaard et al., 2005; McClure
et al., 2004). Motivation and the ability to respond
to rewarding stimuli are key elements in all of
these conditions. Work over the last two decades has
identified the mesolimbic ‘‘reward pathway,’’ of which
the NAcc and VTA are crucial components (Wise,
2004a,b). Importantly, the VTA projects dopaminergic
terminals to the NAcc (Jonjen-Relo et al., 1994). Since
the NAcc plays a significant role in the timing of the
initiation of response patterns originating in the fron-
tal corticostriatal loop systems (Groenewegen et al.,
1999), its implication in drug addiction and anhedo-
nia (Di Chiara, 2002; Salamone et al., 2003) is not
surprising.
Increased CS secretion is a key feature of the
response to stress. CSs are small, lipid-soluble mole-
cules; these characteristics allow them easy access to
the brain, where they elicit both rapid and long-last-
ing changes in neural activity and behavior. Numer-
ous studies from our own and other laboratories have
demonstrated that GC can induce structural changes
in various brain regions including the prefrontal cor-
tex (Brown et al., 2005; Cerqueira et al., 2005), hippo-
campus (Donohue et al., 2006; Sousa et al., 1999,
2000), and striatum (Copeland et al., 2005; Haynes
et al., 2001).
Recently, McClure et al. (2004) reported a reduc-
tion in the volume and number of neurons in the
NAcc of rats born to mothers that had received an
injection of saline during late pregnancy; they puta-
tively attributed these structural changes to injection
stress-induced CS secretion. The results of the pres-
ent study largely confirm the supposition by McClure
et al. (2004). We show that the adult offspring of rat
dams that had been exposed to the synthetic CS
DEX during the late stage of pregnancy have signifi-
cantly decreased NAcccore volumes and total neuronal
numbers. Similar observations were made in the
NAccshell of the male, but not female, progeny of
DEX-treated mothers. While the significance of this
sex difference is not known at present, it is interest-
ing to note that males show greater susceptibility to
early life events (McClure et al., 2004; Simon and
Volicer, 1976) and that, in humans and animals, the
two sexes display differences in their propensity to
develop addictive behavior, and mood and other affec-
tive disorders (Simon and Volicer, 1976). Further, the
two sexes differ significantly in their basal CS secre-
tory profiles and endocrine responses to stress
(Patchev et al., 1997), as well as in their hormonal
and behavioral responses to prenatal stress (Bowman
et al., 2004). Our finding that CS influences the
structure of the NAccshell (but not NAcccore) in a sex-
specific fashion calls for the establishment of the
relationship between sex, stress, and the regulation
of specific components of the motivation-reward cir-
cuit. Current views hold that the NAccshell is respon-
sible for anticipatory responses (Chang et al., 1994),
while the NAcccore participates in the timing of the
initiation of response patterns originating in the
frontal corticostriatal loop systems; it will be inter-
esting to know whether these processes are differen-
tially regulated between the sexes and to what extent
their different susceptibilities to antenatal CS (and
presumably stress) translates into sex differences in
behavior.
The changes in NAcc volume and neuronal numbers
in animals exposed to antenatal CS were accompanied
by significant reductions in the dopaminergic innerva-
tion of the NAcc by the VTA (confirming a recent
report by McArthur et al., 2005), as well as by reduced
numbers of dopaminergic cell bodies in the VTA (not
observed by McArthur et al., 2005). Interestingly, these
Fig. 7. TH-positive cells per surface unit of the VTA. ***P <
0.0001.
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changes appear to result from antenatal DEX-induced
alterations in cell proliferation: our results record, for
the first time, that CS can significantly reduce post-
natal neurogenesis in both, the VTA and NAcc. The in-
hibitory actions of CS on neuronal proliferation in the
postnatal brain, especially in the hippocampus (Gould
et al., 1991), have been extensively described, but their
ability to interfere with neurogenesis during prenatal
life have been recognized only recently (Lemaire et al.,
2000). CS receptors are expressed in many areas of
the rat brain, including the basal ganglia striatum and
brainstem nuclei, from embryonic day 15.5 (Diaz et al.,
1998); since the NAcc and VTA undergo considerable
structural organization during late gestation (Hynes
and Rosenthal, 1999), our antenatal CS paradigm on
E18/19 is likely to have had a major impact on this
process.
The NAcc seems to be one of the most important brain
centers in determining drug-addiction behavior. When
stimulated by DA, neurons in NAcc produce feelings of
pleasure and satisfaction; in normal conditions, such
response keeps the subject focused on basic biological
goals. However, genetic as well as natural and pharma-
cological interventions can modulate dopaminergic drive
upon the NAcc. The decrease in basal dopaminergic in
the NAcc after prenatal DEX treatment (associated with
an impoverishment structural complexity in this nu-
cleus) may determine an increase susceptibility to drug-
seeking behavior. Thus, the results of the present study
lend support to the view that early exposure to stress or
CS might ‘‘program’’ the mechanisms and neural sub-
strates governing reward-seeking behavior throughout
the lifespan (Marinelli and Piazza, 2002; Piazza et al.,
1998).
Importantly, the implications of the present results
are plausibly also relevant to our understanding of
the biological basis of schizophrenia, since there are
reports that cell losses contribute to volumetric reduc-
tions in the NAcc of schizophrenic patients (Pakkenberg,
1990). Moreover, CS released during stress might con-
tribute to the neurodevelopmental anomalies that
underlie schizophrenia (Boksa and El-Khodor, 2003);
in support to this hypothesis, Koenig et al. (2005) have
shown that two parameters used for the validation of
animal models of schizophrenia—diminution of the
prepulse inhibition of the acoustic startle response and
disruption of auditory sensory gating—are modulated
by prenatal stress. In addition, our findings that ante-
natal CS exposure leads to decreased DA input to the
NAcc and reduced numbers of TH-positive cells in the
adult VTA show that CS may be important determi-
nants of mesolimbic function in the adult. Lastly, our
observations that antenatal exposure to CS can have
enduring effects on the cytoarchitecture and neuro-
chemistry of the VTA and NAcc are important in the
light of the common use of CS in the prevention of pre-
term birth in women.
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Mechanisms of initiation and reversal of drug-seeking
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Stress and exposure to glucocorticoids (GC) during early life render individuals vulnerable to
brain disorders by inducing structural and chemical alterations in specific neural substrates.
Here we show that adult rats that had been exposed to in utero GCs (iuGC) display increased
preference for opiates and ethanol, and are more responsive to the psychostimulatory actions
of morphine. These animals presented prominent changes in the nucleus accumbens (NAcc),
a key component of the mesolimbic reward circuitry; specifically, cell numbers and dopamine
(DA) levels were significantly reduced, whereas DA receptor 2 (Drd2) mRNA expression levels
were markedly upregulated in the NAcc. Interestingly, repeated morphine exposure signifi-
cantly downregulated Drd2 expression in iuGC-exposed animals, in parallel with increased
DNA methylation of the Drd2 gene. Administration of a therapeutic dose of L-dopa reverted
the hypodopaminergic state in the NAcc of iuGC animals, normalized Drd2 expression
and prevented morphine-induced hypermethylation of the Drd2 promoter. In addition, L-dopa
treatment promoted dendritic and synaptic plasticity in the NAcc and, importantly, reversed
drug-seeking behavior. These results reveal a new mechanism through which drug-seeking
behaviors may emerge and suggest that a brief and simple pharmacological intervention can
restrain these behaviors in vulnerable individuals.
Molecular Psychiatry (2011) 0, 000–000. doi:10.1038/mp.2011.126
Keywords: DNA methylation; dopamine receptor 2; levodopa; nucleus accumbens; mesolimbic
circuit; prenatal glucocorticoids
Introduction
Stressful events during critical developmental peri-
ods have long been considered as etiological factors in
psychiatric disorders such as schizophrenia, depres-
sion and drug-seeking behavior.1–4 The programming
effects of stress are most likely mediated by endogen-
ous glucocorticoids (GC), whose ability to produce
structural re-organization and dysfunction of the
neural substrates that underpin these stress-related
pathologies are well known.1,5–7 Although adminis-
tration of prenatal GC does not mimic prenatal stress,
synthetic GC such as dexamethasone (DEX) are
widely used in obstetrics, for example, to ensure
fetal lung maturation during late pregnancy in
humans.8 DEX is not biodegraded in the same way
as its naturally occurring congeners, and crosses the
maternal-placental barrier to a greater extent than
endogenous GC;9,10 it can thus pose additional risk for
the developing brain.
We previously demonstrated that fetal exposure to
GC leads to hyper-emotionality in adulthood.11 In
addition, we showed that prenatal DEX/GC targets
the mesolimbic dopaminergic system;12 this system
comprises projections from the ventral tegmental area
(VTA) to the nucleus accumbens (NAcc) and is
strongly implicated in motivational and reward
aspects of addictive behaviors.13–15 Specifically, the
NAcc of adult rats exposed to GC in utero (iuGC)
display reduced neuronal numbers and fewer dopa-
mine (DA) inputs from the VTA.12 Further, early life
stress is known to influence DA receptor expression
in the adult NAcc16,17 and changes associated
with increased behavioral responses to stress and
cocaine.1,4,18,19 Together, these observations suggest
that prenatal exposure to elevated levels of GC can
program the mesolimbic circuit. In the present study,
a multimodal analysis was used to further define the
molecular neurobiological mechanisms that underlie
the initiation and reversibility of drug-seeking beha-
vior by prenatal exposure to GC.
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Materials and methods
Animals and behavioral tests
Pregnant Wistar rats were individually housed under
standard laboratory conditions (light/dark cycle of 12/
12h with lights on at 08:00h; 22 1C); food and water
were provided ad libitum. Subcutaneous (s.c.) injec-
tions of DEX at 1mgkg!1 (DEX; iuGC animals) or
saline (control) were administered on gestation days
18 and 19. All manipulations were done in accor-
dance with the local regulations (European Union
Directive 2010/63/EU) and NIH guidelines on animal
care and experimentation.
Male offspring (nX8) derived from four different
litters were subjected to behavioral tests when they
were 3–4 months old.
Open field
Locomotor behavior was investigated using the open-
field test. Briefly, rats were placed in the center of
an arena (MedAssociates, St Albans, VT, USA) and
their ambulation was monitored online over a period of
15min. Total distances traveled were used as indicators
of locomotor activity. Animals were injected with
saline or morphine and tested 30min after injection.
Conditioned place preference (CPP)
The place preference apparatus consisted of two
compartments with different patterns on floors and
walls, separated by a neutral area (MedAssociates).
Animals were placed in the central neutral area and
allowed to explore both compartments, allowing
definition of the preferred compartment (day 1).
During the conditioning phase (day 2–4), rats were
confined to the pre-test preferred compartment for
20min after saline injection (1ml kg!1, s.c.) and, after
a 6-h gap, to the other compartment for 20min after
injection of morphine (10mgkg!1, s.c.). CPP was
assessed on day 5 (20min) when all compartments
were accessible to the animal. Results are expressed
as the difference of time spent in the drug-paired to
saline-paired side.
Ethanol consumption
The two-bottle choice protocol was carried out for
15 days as described previously.20 Briefly, after 3 days
of taste habituation (one bottle with 10% ethanol
and other with 5% sucrose), rats were offered both
bottles. Each bottle was weighted daily; bottle posi-
tions were changed every day to control for position
preference. Corrections were made for daily evapora-
tion and spillage.
Cross-fostering and maternal behavior
For cross-fostering experiments, litters from five
control and five DEX-treated mothers were exchanged
on postnatal day 1. Maternal behavior was assessed
every second day, over a period of 30min. Both, pup-
directed (nursing, non-nutritive contact, licking
and nest building) and self-directed (self-grooming,
resting, vertical activity and carrying) behaviors were
registered.
Drugs
Morphine hydrochloride (Labesfal Pharmaceutical,
Campo de Besteiros, Portugal) was administered s.c.
at a dose of 10mgkg!1; sesame oil was used as the
vehicle. L-dopa/carbidopa (Sinemet, Merck, NJ, USA)
at a dose of 36.0/9.0mg/kg (in water) was adminis-
tered daily by oral gavage.
Tyrosine hydroxylase (TH) immunohistochemistry
Animals were deeply anesthetized and transcardially
perfused with 4% paraformaldehyde. Cerebral hemi-
spheres were separated by a longitudinal cut in the
midsagittal plane. Sections of 30 mmwere treated with
3% H2O2 and blocked with 4% bovine serum albumin
in phosphate-buffered saline. Sections were then
incubated overnight at 4 1C with rabbit anti-TH serum
(1:2000; Affinity Reagents, CO, USA). Antigen visua-
lization was carried out by sequentially incubating
with biotinylated goat anti-rabbit antibody, ABC1
(Vector, Burlingame, CA, USA) and diaminobenzidine
(DAB, Sigma). The density of TH-positive fibers
impinging upon the NAcc was estimated as pre-
viously described.12
Structural analysis
Rats were transcardially perfused with 0.9% saline
under deep pentobarbital anesthesia and processed as
described previously.21 Briefly, brains were removed
and immersed in Golgi–Cox solution22 for 14 days;
brains were then transferred to a 30% sucrose
solution (7 days), before being cut on a vibratome.
Coronal sections (200mm thick) were collected and
blotted dry onto cleaned, gelatin-coated microscope
slides. They were subsequently alkalinized in 18.7%
ammonia, developed in Dektol (Kodak, Rochester,
NY, USA), fixed in Kodak Rapid Fix (prepared as per
package instructions with solution B omitted), dehy-
drated through a graded series of ethanols, cleared in
xylene, mounted and coverslipped. For each selected
neuron, all branches of the dendritic tree were
reconstructed at " 600 magnification, using a motor-
ized microscope with oil objectives (Axioplan 2,
Carl Zeiss, Thornwood, NY, USA) that was attached
to a camera (DXC-390, Sony, Tokyo, Japan) and
Neurolucida software (Microbrightfield, Williston,
VT, USA). A 3D analysis of the reconstructed neurons
was performed using NeuroExplorer software (Micro-
brightfield). Twenty neurons were studied in each
animal, and results from the same animal were
averaged. To assess differences in the arrangement
of dendritic material, a 3D version of a Sholl
analysis23,24 was performed. For this, we counted
the number of intersections of dendrites with con-
centric spheres positioned at radial intervals of 20mm;
in addition, we also measured dendritic tree lengths
located between two consecutive spheres. The meth-
od for sampling dendritic branches for spine density
was designed as follows: only branches that (1) were
either parallel or at acute angles to the coronal surface
of the section and (2) did not show overlap with other
branches that would obscure visualization of spines
AQ1
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were considered. Because treatment-induced changes
in the apical dendritic branches varied with distance
to soma, segments were randomly selected in the
proximal parts of the tree; selection of basal dendrite
was done at radial distances between 50 and 100 mm.
To assess treatment-induced changes in spine mor-
phology, spines in the selected segments were
classified according to Harris et al.25 in mushroom,
thin, wide and ramified categories. Thin spines were
considered immature, whereas the other spine types
were considered to be mature spines.
Macrodissection
Animals were anesthetized, decapitated, and heads
were immediately snap-frozen in liquid nitrogen.
Brain areas of interest were rapidly dissected on ice
under a stereomicroscope, observing anatomical land-
marks. Samples were snap-frozen (dry ice) and stored
at !80 1C until use.
Neurochemical evaluation
Levels of catecholamines were assayed by high-perfor-
mance liquid chromatography, combined with electro-
chemical detection (HPLC/EC) using a Gilson instru-
ment (Gilson, Middleton, WI, USA), fitted with an
analytical column (Supleco Supelcosil LC-18 3mM,
Bellefonte, PA, USA; flow rate: 1.0mlmin!1). Samples
were stored overnight in 0.2N perchloric acid
at !20 1C, sonicated (5min on ice) and centrifuged at
5000 g. The resulting supernatant was filtered through
a Spin-X HPLC column (Costar, Lowell, MA, USA) to
remove debris and 150ml aliquots were injected into
the HPLC system, using a mobile phase of 0.7M
aqueous potassium phosphate (pH 3.0) in 10%
methanol, 1-heptanesulfonic acid (222mg l!1) and
Na-EDTA (40mg l!1). A standard curve using known
concentrations of all catecholamines was run each day.
Molecular analysis
For real-time PCR analysis, total RNA was isolated
using Trizol (Invitrogen, Carlsbad, CA, USA) and
DNase treated (Fermentas, Burlington, Canada) fol-
lowing recommended protocols. Two mg of RNA was
converted into cDNA using the iSCRIPT kit (Biorad,
Hercules, CA, USA). Reverse transcription PCR
was performed using Quantitec SyberGreen (Qiagen,
Venlo, The Netherlands) and the Biorad q-PCR CFX96
apparatus. Hprt was used as a housekeeping gene.
Relative quantification was used to determine fold
changes (control vs iuGC), using the DDCT method.
Primer sequences are shown in Supplementary Table 1.
For western blotting procedures, ice-cold lysis
buffer (50mM Tris-HCl pH 7.4, 50mM NaCl, 1mM
phenylmethylsulfonyl fluoride, complete protease
inhibitors (Roche, Basel, Switzerland)) was added to
each frozen area. After disruption of the tissue using a
23G needle, 0.1% SDS and 1% Triton X-100 was
added to each sample. After incubation on ice for 1 h,
samples were centrifuged at 13 000 r.p.m. for 10min at
4 1C; the supernatant was quantified using the
Bradford method. Forty mg of total protein was loaded
into SDS-polyacrylamide gel electrophoresis and then
transferred to nitrocellulose membranes. After incu-
bation with the primary antibodies: rabbit anti-
Dopamine receptor D1 (1:2500, ab20066, Abcam,
Cambridge, UK), rabbit anti-Dopamine receptor
D2 (1:2000, ab21218, Abcam) and mouse anti-
alpha-tubulin (1:200, DSHB, Iowa, USA); the second-
ary antibodies were incubated at a 1:10 000 dilution
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA).
Detection was done using ECL kit (Pierce, Rockford,
IL, USA). Band quantification was performed using
ImageJ (http://rsbweb.nih.gov/ij/) as advised by
the software manufacturers, using a-tubulin as the
loading control. At least six animals per group were
analyzed.
For epigenetic analysis, four animals per group
were analyzed. Genomic DNA of 2 mg were bisulfite-
converted (EZDNA Methylation Kit, Zymo Research,
Irvine, CA, USA) and amplified with primers CpG-
Drd2_F and CpG-Drd2_R (designed using Methpri-
mer), using AmplitaQ Gold (Applied Biosystems,
Carlsbad, CA, USA). Bands were purified using
innuPREP Gel extraction kit (Analytik Jena, Jena,
Germany). After elution, 2 ml of product were used in
a TOPO cloning reaction (Invitrogen) following
recommended procedures. XL1-blue competent cells
were transformed with the TOPO reaction and plated
onto LB–50mgml!1 kanamycin plates, suplemented
with X-GAL (5-bromo-4-chloro-3-indolyl-beta-D-ga-
lacto-pyranoside). A total of 10 clones were isolated
per animal; plasmid DNA was purified using innu-
PREP Plasmid Mini Kit. Plasmids were sequenced
using standard M13 primers.
Results
In utero GC exposure triggers increased drug-seeking
behavior in adulthood
To test the hypothesis that prenatal GC exposure
would increase drug preference, we compared all
experimental groups in a CPP paradigm. As compared
with controls, iuGC-treated animals developed a
stronger preference for morphine, spending more
time in the compartment previously associated with
morphine reward (Figure 1a; t=4.623, P=0.0036).
Whereas control and iuGC animals did not differ in
their intake of sucrose solution (Supplementary
Figure S1), iuGC animals demonstrated an approxi-
mately two-fold greater preference than controls for
ethanol in a two-bottle free-choice paradigm over a
period of 2 weeks (Figure 1b; t=3.523, P=0.0048). As
locomotor activity is considered to predict suscept-
ibility to drug abuse,1,26 it was interesting to note that
morphine stimulated locomotor activity (open-field
arena) to a greater extent in iuGC animals than in
controls (B160% vs B35%; F(3,15) = 67.94, P<0.0001;
Figure 1c). To exclude the potentially confounding
effects of inadequate maternal care, itself a suspected
etiological factor in stress-related psychiatric disor-
ders,27–29 we analyzed the maternal behavior of
control and GC-treated dams, and also performed a
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cross-fostering experiment. Neither self- nor pup-
directed behaviors were significantly influenced by
GC treatment (Supplementary Figure S2). Identical
behaviors were observed when iuGC offspring raised
by natural and fostered mothers were compared in the
CPP (Figure 1a; t=6.877, P<0.0001) or ethanol
consumption (Figure 1b; t=12.58, P<0.0001) tests.
Although the hypolocomotor profile observed in non-
fostered iuGC animals in the open field test was not
seen in cross-fostered iuGC rats (Figure 1c), morphine
elicited a hyperlocomotor response in both cross-
fostered and non-fostered iuGC animals as compared
with control rats raised by foster mothers (Figure 1c;
t=2.737, P=0.021). Collectively, these findings
indicate that exposure to prenatal GC increases
vulnerability to drug-seeking behavior.
Morphological and neurochemical changes in the
NAcc after in utero GC exposure
Increased sensitivity to the psychomotor-stimulatory
actions of drugs such as morphine reflects increased
DA release into the NAcc.1,26 Furthermore, the
dopaminergic system seems particularly sensitive to
the effects of GCs.5,12,30 Thus, we next assessed
the impact of prenatal GC upon the number of
TH-positive fibers, DA and DA metabolite levels,
as well as DA turnover in the NAcc (Figure 2).
The number of TH-positive fibers in both the core and
shell divisions of the NAcc were significantly
reduced in iuGC animals (Figure 2a, shell: t=2.827,
P=0.022; Figure; core: t=10.48, P<0.0001; Supple-
mentary Figure S3), in parallel with markedly
reduced NAcc levels of DA (t=2.567, P=0.0247)
and the DA metabolite 3,4-dihydroxyphenylacetic
acid (DOPAC; t=2.362, P=0.0376; Figure 2c); inter-
estingly, the levels of norepinephrine and epinephr-
ine, two other catecholamine transmitters whose
synthesis indirectly depends on TH, as well as of
the unrelated monoamine serotonin (5-HT), were not
affected by prenatal GC exposure. Importantly, besi-
des the reduced availability of DA in the NAcc,
iuGC-treated animals also displayed increased DA
turnover (Figure 2d; t=2.835, P=0.0196). Moreover,
as no remarkable neurochemical changes were obser-
ved in the VTA or other DA projection fields (pre-
frontal cortex, hippocampus; data not shown), the
Figure 2 Prenatal glucocorticoid (GC) reorganizes dopaminergic innervation and dendritic structure in the nucleus
accumbens (NAcc). In utero GC-exposed (iuGC) animals presented reduced tyrosine hydroxylase (TH)-positive fibers in the
shell (a) and core (b) subdivisions of the NAcc when adults. (c) High-performance liquid chromatography (HPLC)
measurements confirmed reduced levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanilic acid
(HVA) in the NAcc of iuGC animals in comparison with controls in parallel with increased turnover of DA in this brain
region (d). Stereological assessment revealed a volumetric atrophy (e) in the NAcc shell in iuGC animals together with
reduced number of cells (f). We observed no changes in dendritic length (g), but there was an increase in the total number of
spines in the medium spiny neurons of iuGC animals when compared with controls (h), as a result of increased number of
immature spines (i). (j) Representative reconstruction of medium spiny neurons of NAcc shell in control and iuGC animals.
The NAcc core of iuGC animals also presented volumetric atrophy (k) and reduced number of cells (l), but preserved
dendritic length; spine numbers and mature/immature spine ratio (m–o). (p) Representative reconstruction of a medium
spiny neuron from NAcc core in control and iuGC animals. Data is presented as mean±s.e.m. CONT, controls; NE,
norepinephrine; EPI, epinephrine; 5-HT, serotonin. *P<0.05, **P<0.01,*** P<0.001.
Figure 1 Prenatal in utero glucocorticoid (iuGC) exposure enhances drug-seeking behaviors. (a) In the contingent
conditioned place preference paradigm (CPP), iuGC animals spend significantly more time in the morphine-associated
compartment than controls. (b) In the non-contingent two-bottle preference paradigm, total ethanol consumption was higher
in iuGC animals than in controls. Similar results were obtained for cross-fostered animals in both paradigms. (c) Locomotor
activity was assessed in the open field. Although in basal conditions, iuGC animals presented reduced locomotor activity,
after morphine administration (MOR), iuGC rats displayed increased locomotor activity when compared with controls.
Cross-fostered iuGC-animals no longer present the basal hypolocomotor phenotype, but after MOR, they still presented
increased locomotor activity. Data is presented as mean± s.e.m. CONT, controls; MOR, morphine (10mgkg!1) s.c. injection.
*P<0.05, **P<0.01,*** P<0.001.
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NAcc is seemingly most sensitive to the effects of
prenatal GC.
Extending our previous finding that prenatal GC
treatment leads to reduced neuronal proliferation in
the NAcc,12 we now report that iuGC results in
volumetric atrophy (Figure 2e, shell: t=4.340,
P=0.0025; Figure 2k, core: t=5.906, P=0.0004) and
a reduction of total cell numbers in both the shell and
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core divisions of the NAcc in iuGC adult animals
(Figure 2f, shell: t=3.018, P=0.0166; Figure 2l, core:
t=3.760, P=0.0055). Subsequent 3D morphological
analysis of dendrites and spines showed that whereas
prenatal GC did not influence dendritic lengths of
neurons in the NAcc (Figure 2g and m), the treatment
produced significant increases in the number of
spines within the shell (Figure 2h; t=3.775,
P=0.0069), but not the core division (Figure 2n).
The increase in spine number was accompanied by a
significant increase in the relative number of im-
mature spines in the shell (Figure 2i; t=3.108,
P=0.017), which, presumably, serve to compensate
for the loss of cells in the NAcc and for the reduced
amounts of DA reaching the NAcc from the VTA.
Notably, although iuGC treatment was associated
with increased total spine numbers in the VTA,
the treatment did not alter the ratio of immature to
mature spines in this region (Supplementary Figure
S4). These morphological data, together with the
neurochemical data described above, suggest a link
between a hypodopaminergic state in the NAcc
and the behavioral phenotype observed in animals
exposed to prenatal GC.
Altered expression of DA receptor 2 (Drd2) is
associated with differential methylation of Drd2 gene
in iuGC-treated animals
We next used quantitative reverse-transcription PCR
and immunoblotting to identify molecules that might
be responsible for the observed behavioral, morpho-
logical and neurochemical phenotypes. Expression
levels of the mRNAs encoding the GC receptor and
corticotropin releasing factor receptors 1 and 2 (all
implicated in the neuroendocrine adaptation to stress
as well as in drug-seeking behavior1), did not differ
between controls and iuGC subjects (Supplementary
Figure S5). Likewise, no significant differences were
found in the expression levels of the synaptic
plasticity-related genes Bdnf, synapsin-1, Cdk5, Creb
and NCAM (Supplementary Figure S5). However,
there was a significant upregulation of Drd2 mRNA
(Figure 3a; t=2.764, P=0.028) and DRD2 protein
(Figures 3b and c; 35 kDa precursor, t=3.740,
P=0.0028; 47kDa isoform, t=3.372, P=0.005; 72 kDa
glycosylated DRD2, t=2.177, P=0.050) in the NAcc of
iuGC animals. Prenatal GC exposure did not influence
either Drd1 or Drd3-5 mRNA expression levels
(Figure 3a) or the levels of DRD1 protein (50 kDa
and glycosylated 74 kDa isoforms; Supplementary
Figure S5). In the VTA of iuGC animals, Drd5 levels
were downregulated (Supplementary Figure S5), but
the expression of other DA receptors was unchanged
(data not shown).
Strikingly, repeated exposure to morphine and
ethanol in prenatal GC-treated adult rats led to a
significant decrease in the expression of Drd2 mRNA
in the NAcc (Figure 3d; morphine: t=2.346, P=0.043;
ethanol: t=3.330, P=0.0021). As recent studies
reported that psychostimulant treatment induces
epigenetic changes in the NAcc,31–33 we next analyzed
the pattern of methylation (strongly correlated with
transcriptional repression) in a conserved (human
and rodent) CpG island within the Drd2 gene, cover-
ing part of the promoter region and exon 1 (Figure 3e).
Our analysis shows that whereas the general DNA
methylation profile did not differ between controls
and iuGC subjects under basal conditions, overall
methylation of the CpG island was significantly
increased after chronic morphine administration in
adult iuGC-treated animals (Figure 3f–h; t=3.085,
P=0.0215). These changes in DNA methylation are
consistent with the finding that Drd2 expression is
downregulated after morphine treatment (Figure 3d).
Further, the observation that voluntary ethanol con-
sumption (Figure 3d) also downregulates Drd2 sug-
gests Drd2 DNA methylation as a potentially
important mechanism in response to substances of
abuse.
Restoration of DA levels reverts the molecular,
cellular and behavioral phenotype of iuGC animals
The results presented up to this point indicate a
strong association between the hypodopaminergic
state that prevails in the NAcc of iuGC-exposed
subjects and their likelihood to seek drugs of abuse.
We next examined whether the phenotype produced
by iuGC could be rescued using a simple pharmaco-
logical approach. To this end, we administered
the DA precursor L-dopa (together with carbidopa
to prevent peripheral degradation) for 3 days. This
treatment regimen resulted in concomitant increases
in DA levels (Figure 4a; F(3,21) = 23.79, P<0.0001)
and correspondingly, decreases in Drd2 expression
(Figure 4c; t=2.982, P=0.038) in the NAcc of
controls and iuGC-treated animals. Interestingly, the
dynamic Drd2 response to morphine was normalized
after restoration of DA in the NAcc by L-dopa treat-
ment, with iuGC-treated and control animals showing
similar patterns of Drd2mRNA expression (Figure 4c)
and Drd2 promoter methylation (Figure 4d–f). Inter-
estingly, the neurochemical adjustments induced
by L-dopa were accompanied by signs of structural
plasticity in the NAcc. These were particularly
marked in the core division of the NAcc, where
L-dopa-treated animals displayed increased den-
dritic lengths (more pronounced in iuGC-exposed
animals; Figure 4j; F(3,12) = 4.587, P=0.023) and
spine numbers (Figure 4k; F(3,12) = 10.01, P=0.0014),
though the type of spines were similar between the
two groups (Figure 4l). In contrast, increased spine
numbers was the only noticable morphological
change observed in the NAcc shell (Figure 4h;
F(3,10) = 14.86, P=0.0005).
Remarkably, acute (3 days) L-dopa treatment also
reversed the vulnerability of iuGC-exposed animals to
drug-seeking behaviors, in both contingent (t=1.851,
P=0.101) and non-contingent (t=0.0192, P=0.985)
paradigms (Figures 4m and n), and rescued the
hyperlocomotor phenotype displayed by iuGC-treated
animals after morphine administration (Figure 4o;
t=2.292, P=0.05). Reversal of these behaviors by
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acute L-dopa administration however proved to be
only transient; the reversal was not sustained when
animals were tested 3 weeks after the last dose of
L-dopa (Supplementary Figure S6). On the other
hand, when the L-dopa treatment regimen was exten-
ded to 3 weeks, reversal of the behavioral, morpho-
logical and molecular anomalies associated with
a hypodopaminergic state was observable for at
least 3 weeks after discontinuation of the drug
(Supplementary Figure S6).
Discussion
Work over the last two decades has identified the
dopaminergic mesolimbic ‘reward pathway,’ of which
the NAcc is a crucial component, as essential for
drug-seeking behaviors.13,14,34,35 The central role of DA
released into the NAcc in the generation of enhanced
feelings of pleasure and satisfaction15 and, thus, in
the timing of the initiation of response patterns (e.g.,
drug-seeking behavior) within the frontocortico-
Figure 3 Impaired dopamine receptor 2 (Drd2) response in in utero glucocorticoid-exposed (iuGC) animals under basal
conditions and after exposure to substances of abuse. (a) Drd2 mRNA expression was augmented in iuGC animals when
compared with controls, but no changes were found in the expression of other dopamine receptors. (b) Representative
immunoblot of DRD2 in five control and five iuGC animals. The levels of the putative DRD2 percursor (35 kDa), the non-
glycosylated form (B50 kDa) and the glycosylated receptor (74 kDa) were higher in iuGC animals (c). (d) Although in a basal
situation, Drd2was upregulated in iuGC animals, after four injections of morphine (MOR) or 15 days of ethanol consumption
(EC), the levels of this receptor were significantly lower in iuGC animals when compared with controls. (e) Scheme of the rat
Drd2 CpG island that covers part of the promoter, and exon 1 and respective amplicon with the 16 potential methylation sites
are marked (small squares). Also shown is the sequence conservation in humans and mouse (chr8: rat chromosome 8; bp:
base pairs). (f) Percentage of total Drd2 CpG methylation in the NAcc of control and iuGC animals revealed a trend for a
reduction in the methylation pattern of Drd2 CpG island in basal conditions, but in opposite pattern after exposure to
morphine. (g) Percentage of methylation of each dinucleotide in the Drd2 CpG island in a basal situation. (h) After drug
exposure, iuGC animals presented an increase in the methylation status of several dinucleotides. Data is presented as
mean±s.d. CONT, controls; *P<0.05, **P<0.01.
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striatal loop,36 is well established. Current views
suggest that repetitive exposure to drugs of abuse
evolve from goal-directed behaviors into habit-based
actions.37,38 We previously demonstrated that stress,
associated with increased GC secretion, alters the
structure of the corticostriatal loops and steers the
development of instrumental behavior into habitual
behavior.39 The present demonstration of GC-induced
programming of the structure and function of the
NAcc provide, on the other hand, new insights into
the mechanisms that underlie the transfer of condi-
tioned behavior to instrumental behavior. Notably, the
NAcc (the core in particular) is a crucial deter-
minant of the efficiency of response-outcome
associative learning40 and thus, of the rewarding
effects of drugs of abuse;34 the NAcc modulates
motivational drive (‘wanting of a reward’) and thus,
drug-craving. In all these processes, DA seems to have
an essential role.
An intricate relationship between stress, the GC
released in response to stress, and dopaminergic tone
in the regulation of vulnerability to drug and
substance abuse has been suggested.1,5,14,26,41 Stress
and drugs of abuse appear to activate dopaminergic
synapses in a similar manner,41 culminating in DA
release in the NAcc.1,4,42 Stress induces sensitization
to the psychomotor effects of a number of drugs of
abuse and GC have been shown to have an essential
role in this process.1 Specifically, GC are known to
modulate the reinforcing properties of drugs and, in
fact, have positive reinforcing properties of their
own.43 Adding a new perspective, the present study
demonstrates that iuGC triggers an impoverishment in
dopaminergic inputs and DA levels in the NAcc,
leading to increased drug-seeking behavior in adult-
hood; notably, hypodopaminergic status is a hallmark
of the ‘addicted brain.’44,45 Associated with their
lower intra-NAcc levels of DA, animals exposed to
prenatal GC expressed more Drd2 in the NAcc,
potentially indicating a compensatory mechanism in
this structure. The finding that morphine and ethanol
downregulated Drd2 expression is consistent with the
DA-releasing abilities of these substances. The fact
that this downregulation is more pronounced in iuGC
subjects most likely reflects receptor hypersensitivity
due to the hypodopaminergic state previously in-
duced by iuGC.
The regulation of Drd2, implicated in different
phases of addiction, is seemingly complex;44 although
the short DRD2 isoform interacts with DA transporters
and functions as a presynaptic autoreceptor to
regulate dopaminergic tone, the long DRD2 isoform
is largely localized in postsynaptic targets and
mediates the effects of psychostimulants.46 The
present study reveals that vulnerability to substance
abuse depends on the dynamic range response of
Drd2 to increased DA release in the NAcc, rather than
simply on the expression of Drd2 at a given time
point. Such dynamic regulation is likely to depend on
different levels of transcriptional control.
Epigenetic mechanisms are being increasingly im-
plicated in the stable programming by early life
events of a spectrum of psychopathological states,
including anxiety and depression,29 impaired cogni-
tion47 and drug abuse,31–33,48,49 and transient epige-
netic modifications have been shown to underlie
neural processes such as learning and memory.50
Such epigenetic changes could imprint dynamic
environmental experiences on the unchanging gen-
ome, resulting in stable and adaptive alterations in
the phenotype. Our results demonstrate that exposure
to high GC levels during uterine development
increase the risk of drug-seeking behavior in associa-
tion with altered methylation status of a conserved
CpG island in Drd2 gene and therefore, interfering
with the dynamics of Drd2 expression. Further, they
show that repeated administration of morphine to
iuGC animals results in marked epigenetic modifica-
tions of the Drd2 gene promoter. These modifications,
together with the induced hypodopaminergic state in
iuGC-exposed animals, may be considered as key
mechanisms that underpin increased susceptibility to
drug abuse on one hand, and the dysregulated Drd2
response to drugs of abuse on the other.
Intriguingly, we found that reduced levels of Drd2
expression are not necessarily coupled to hyper-
methylation of Drd2 gene. Although Drd2 expression
was downregulated after morphine administration in
Figure 4 Restoration of dopamine (DA) levels by L-dopa reverts the molecular, structural and behavioral phenotypes of
in utero glucocorticoid (iuGC) animals. (a) Acute (3 days) treatment with L-dopa increased DA levels in the nucleus
accumbens (NAcc) of both experimental groups; although iuGC animals still exhibited less DA than controls. In fact, iuGC
animals given L-dopa presented DA levels similar to those of controls without treatment. (b) No differences were found in DA
turnover after L-dopa treatment in iuGC animals. (c) Dopamine receptor 2 (Drd2) expression was diminished after L-dopa
treatment both in a basal situation and after morphine exposure (values normalized to controls given water). (d) L-dopa
treatment did not change Drd2 methylation status in a basal situation (e), but was able to revert the increased methylation in
iuGC animals after morphine exposure (f). L-dopa supplementation had no significant effect on NAcc shell dendritic length
(g), but triggered an increase in the number of spines, albeit similarly in control and iuGC animals, and reverted the altered
ratio of mature to immature spines observed in iuGC animals (h and i). (j) In contrast, L-dopa treatment increased dendritic
length in the NAcc core of both groups. An increase in the number of spines was also observed in both groups with no
changes in the type of spines (k and l). (m) L-dopa treatment reverted the higher vulnerability of iuGC animals to morphine-
induced CPP and also reverted the ethanol preference displayed by these animals (n). (o) In agreement, the higher locomotor
pattern after morphine displayed by iuGC rats was completely reverted by L-dopa treatment. No differences were found in
the locomotion between L-dopa treated control and iuGC animals in a basal situation. Data is presented as mean±s.e.m.
CONT, controls; MOR, after morphine injection 10mgkg!1; 3d: 3 days; *P<0.05, **P<0.01,***P<0.001.
Drug-seeking behavior induced by prenatal exposure to GC
AJ Rodrigues et al
8
Molecular Psychiatry
140
Drug-seeking behavior induced by prenatal exposure to GC
AJ Rodrigues et al
9
Molecular Psychiatry
141
both control and iuGC animals, Drd2methylation was
observed to a greater extent in the iuGC group. This
observation suggests that DNA methylation is not the
sole mechanism involved in transcriptional repres-
sion of Drd2 gene. Consistent with this, recent studies
have demonstrated interdependence and cooperation
between DNA methylation and histone modifications
in the regulation of gene silencing and activation.51
More extensive studies are needed to decipher the
precise mechanisms underlying the ‘epigenetic po-
tential’ of iuGC animals, namely the complex regula-
tion of Drd2 gene expression, which facilitates
adaptation to specific physiological states and
demands.
In exploring whether the dynamic epigenetic
mechanisms that regulate susceptibility to drug-
seeking behavior can be exploited in a therapeutic
context, we found that systemic administration of
L-dopa reverts drug-seeking behavior in iuGC-treated
animals. The latter occured in association with
morphological plasticity and significant decreases in
Drdr2 expression levels in the NAcc. Accordingly, we
suggest that susceptibility to drug-seeking behavior by
iuGC exposure results from the sequential depletion
of DA, upregulation of Drd2 and synaptic impover-
ishment of dopaminoceptive neurons in the NAcc
(Supplementary Figure S7). In this scenario, when
DA levels are stimulated by substances of abuse,
increased methylation of the Drd2 gene results in
downregulation of Drd2 expression albeit only in
iuGC animals. Strikingly, restoration of DA in the
NAcc of iuGC-treated animals also normalizes their
Drd2 responses to subsequent morphine and ethanol
exposure, a finding that most likely underlies the
above-mentioned reversion of drug-seeking behavior.
If translatable to humans, our findings suggest that a
simple reinstatement of dopaminergic homeostasis
may be sufficient to control addictive behaviors in
vulnerable individuals.
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s u m m a r y
Epidemiological evidence links exposure to stress hormones during fetal or early postnatal development
with lifetime prevalence of cardiac, metabolic, auto-immune, neurological and psychiatric disorders. This
has led to the concept of ‘developmental programming through stress’. Importantly, these effects
(specifically, hypertension, hyperglycaemia and neurodevelopmental and behavioural abnormalities) can
be reproduced by exposure to high glucocorticoid levels, indicating a crucial role of glucocorticoids in
their causation. However, there can be important differences in outcome, depending on the exact time of
exposure, as well as duration and receptor selectivity of the glucocorticoid applied. The mechanisms
underlying programming by stress are still unclear but it appears that these environmental perturbations
exploit epigenetic modifications of DNA and/or histones to induce stable modifications of gene expres-
sion. Programming of neuro- and behavioural development by glucocorticoids and stress are important
determinants of lifetime health and should be a considerationwhen choosing treatments in obstetric and
neonatal medicine.
! 2008 Elsevier Ltd. All rights reserved.
1. Introduction
Endogenous corticosteroids have a wide spectrum of physio-
logical functions throughout early development, including the
regulation of surfactant production by the lungs, salt-water
homeostasis, lipid and carbohydrate metabolism, muscle growth
and development, immune responses1 and, as will be discussed,
neuro- and behavioural development. Exogenous corticosteroids
are indicated in obstetric and pediatric care and are widely used in
childhood to treat allergic and/or dermatological symptoms.
Corticosteroids are classified as mineralocorticoids or glucocorti-
coids (GCs), given their respective contributions to ion and water
transport in the kidney or in the mobilisation of glucose, respec-
tively. Aldosterone is the prototypic endogenous mineralocorticoid,
while cortisol and corticosterone represent the major circulating
GCs in humans and rodents, respectively.
Adrenal production of GCs and mineralocorticoids is governed
by the secretion of pituitary adrenocorticotropin, controlled by
corticotropin-releasing hormone and arginine vasopressin neurons
within the paraventricular nucleus (PVN) of the hypothalamus. This
top-down sequential activation of the adrenal cortex is tightly
regulated through the negative feedback actions of GCs at the
pituitary and hypothalamus,2,3 as well as in higher brain centres,
such as the hippocampus and prefrontal cortex (PFC).4 The hypo-
thalamic–pituitary–adrenal (HPA) axis, like most physiological
processes, displays a robust circadian rhythm of activity, but its
activation upon perception of a threatening physical, physiological
or psychological stimulus (stress) plays a particularly important
role in survival. Noxious stimuli occur unpredictably, often at times
of the day when the HPA axis is at ‘rest’. Mounting an adequate and
balanced behavioural and physiological response to adverse stimuli
demands finely tuned homeostatic mechanisms that can go awry
(transiently or in a protracted fashion) and lead to various brain and
other pathologies.
While recent evidence suggests that corticosteroids may
produce rapid non-genomic cellular effects5 via putative
membrane-bound receptors,6 corticosteroids are classically
considered to exert their biological action through two ligand-
activated transcription factors, mineralocorticoid receptors (MRs)
and glucocorticoid receptors (GRs). Ligand binding results in the
translocation of the receptor–ligand complexes to the nucleus,
where they bind to glucocorticoid response elements (GREs) in the
promoter region of target genes to influence gene transcription.
Mapping studies have revealed that whereas GRs are ubiquitously
distributed, MRs have a more discrete distribution; for example, in
the brain MR expression is mainly restricted to one hypothalamic
nucleus (the PVN), certain hippocampal subfields and the septum.
These patterns of distribution, as well as the pharmacological
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profiles of each receptor, to some extent explain the wide spectrum
of physiological and behavioural homeostatic functions that are
subject to regulation by corticosteroids. Nevertheless, certain
enigmas still surround how specificity of actions may be attained
given that hippocampal neurons, for example, co-localise both
receptors, share presumably identical GREs, and bind the same
ligand (cortisol/corticosterone) in the brain; moreover, MRs and
GRs differ in affinity by only some 10-fold.7 Recent attempts to
examine whether nuclear co-regulatory proteins may be differen-
tially recruited by the two receptors provided some promise for
resolving this important issue.8,9
There are convincing links between exposure to GC during early
life and the subsequent development of metabolic syndrome
(a cluster of cardiovascular risk factors including hypertension,
insulin resistance and hyperlipidaemia)10,11 as well as susceptibility
to auto-immune12 and neurological13 and psychiatric disorders.14
According to the increasingly popular concept of developmental
programming through stress and GCs, stimuli or insults that occur
during critical periods of development can permanently alter tissue
structure and function, producing effects that may persist
throughout life. The shaping of brain and other physiological
functions through endogenous and exogenous signals (stress, GC)
at critical periods of development may be compared to the well-
known ‘organisational’ effects of sex steroids during sexual differ-
entiation of the brain.15,16
2. Programming of neuro- and behavioural development
by glucocorticoids during early life
2.1. Antenatal period
The placenta and most fetal tissues express GRs from mid-
gestation onwards.17 The expression of MRs is more restricted and,
at least in rodents, is only detectable during late gestation.18 In the
fetus, steroid hormones are typically involved in organ develop-
ment and maturation (e.g. lungs, heart, liver, gut and kidneys) and
their action during this time has long-term (organisational) effects
on the function of the organ in later life. As exogenous GCs can
accelerate these processes, they are used therapeutically in preterm
labour as well as in the perinatal period, in particular to help lung
maturation.19 Given their small size and lipophilicity, GCs can
access the brain; the magnitude of their damaging effects in the
brain depends largely on the particular stage of development when
exposure occurs,20 indicating that there are ‘critical windows’ of
sensitivity to the detrimental effects of GCs on brain tissue; again,
these windows of sensitivity may be analogous to those described
for sexual differentiation of the brain through the actions of sex
steroids.15
Spatio-temporal fine-tuning of GC levels during ontogeny is
mandatory for appropriate organ maturation while avoiding
undesirable side-effects. The fetus has only limited capacity to
degrade steroids, especially synthetic (xenobiotic) GCs, which
means that even low levels of GCs can have prolonged access to
sensitive tissues. This can have detrimental effects especially in
tissues undergoing rapid proliferation and differentiation, e.g. the
brain. Here, it should be noted that although endogenous GC can
bind both GRs and MRs, their effects (at least in the brain) may be
regulated in a rheostatic manner, depending on their relative
occupation of each receptor21,22; on the other hand, the typical GCs
used in obstetrics and neonatology (e.g. dexamethasone, betame-
thasone) tend to be have a greater affinity for GRs which, as will be
discussed later, appear to mediate many of the undesired actions of
GCs in the brain. In this context, it should be mentioned that fetal
GC levels are much lower than those found in the maternal circu-
lation, as a consequence of the action of the enzyme 11b-hydrox-
ylase 2 (11b-HSD2), which regulates the conversion of active GCs
(cortisol and corticosterone) into their inactive 11-keto metabolites
(cortisone and 11-dehydrocorticosterone, respectively).23,24
11b-HSD2 is present in the syncytiotrophoblast, the site of
maternal–fetal exchange, where it is well-positioned to serve as the
barrier for GC transfer and, consequently, to protect the fetus from
the adverse effects of excessive maternal GC. However, this mech-
anism does not provide complete protection; studies in rats and
humans indicate considerable variations in placental 11b-HSD2
activity towards the end of pregnancy,25 possibly explaining why
stress-induced increases in GC secretion in the mother may
surmount the placental barrier and produce deleterious effects in
the developing fetus. The fetal brain transiently expresses high
levels of 11b-HSD2; levels decline after mid-gestation in a manner
that varies from one brain area/neuronal population to another.26
Experimentally, the effects of increased GC load on the fetal
brain have been studied by exposing pregnant rodent dams either
to exogenous natural or synthetic GCs or to various stressors (e.g.
repeated immobilisation) from the last week of gestation (typically,
from embryonic day 14 [E14], with delivery at E21/22, corre-
sponding, approximately, to the second trimester of human preg-
nancy).27 It should be noted however, that differences in maternal
care28 may be an important confounding factor in the interpreta-
tion of results involving such paradigms, especially those pertain-
ing to brain maturation and eventual psychopathology.
Synthetic GC (e.g. dexamethasone) administration to pregnant
rat or mouse dams is frequently used to experimentally increase
the foetus’ exposure to GC. If at all, exogenous GCs are poor
substrates for 11b-HSD2, and they therefore readily cross the
placenta.29 Rats receiving acute dexamethasone (selective GR
agonist) during the last third of pregnancy display an anxious
phenotype and signs of impaired GC negative feedback in adult-
hood; such signs are not seen in animals receiving corticosterone
(binds to MR and GR) at an equivalent dosage, indicating the
differential effects of GR vs MR occupation in the programming of
behavioural functions.30 Interestingly, not all behavioural domains
are differently affected by corticosterone and dexamethasone,
suggesting that the neurochemical and anatomical substrates
which mediate anxiety behaviour might be differentially sensitive
to corticosteroids at different developmental stages due to the
relative temporal availability of GR and MR in a specific brain
area.31 Prenatal stress affects mood and emotional behaviour in
a manner similar to that observed with exogenous GC: as adults,
animals that experienced stress in utero display depression-like32
and hyper-emotional (anxious) phenotypes.33 The underlying
anatomical and neurochemical correlates of these altered behav-
iours remain ambiguous, but a variety of neurotransmitter
systems and signalling cascades can be expected to be affected by
antenatal GC exposure. Interestingly, some of the stress-induced
behavioural symptoms can be normalised with antidepressants,34
a finding that matches reports that antenatal GC exposure reduces
5-HT1A receptor expression,35 a phenomenon causally related to
depression-like behaviour.
Apart from these well-known behavioural effects of inappro-
priate antenatal GC exposure and their clinical projections for the
pathogenesis of mood and anxiety disorders, accumulating
evidence suggests that other behavioural functions are also subject
to GC-mediated programming. Prenatal stress reportedly also
results in reduced exploratory behaviour, presumably a reflection
of their reduced motivational drive.36 Locomotor behaviour has
been frequently assessed in animals that were exposed to prenatal
stress or exogenous GC, but the findings for this behavioural
endpoint have been somewhat controversial. Locomotor activity
after acute adult pharmacological or environmental challenges in
prenatally stressed or GC-treated animals reflects the malprog-
ramming effects of stress/GCs on motivational and appetitive
functions. For instance, amphetamine-stimulated locomotion was
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found to be accentuated in adult rats that had been stressed during
prenatal life, but interestingly, these effects were only manifest
when these animals were exposed to an acute stressor in adult-
hood.37 These patterns have been attributed to stress-induced
alterations in catecholaminergic systems.38 The behavioural
patterns observed in animals are similar to those seen after acute
amphetamine application in unmedicated schizophrenic patients;
striatal dopaminergic transmission is disturbed in such patients
who are characterised by their impaired ability to discriminate
between relevant (signal) and irrelevant (noise) signals in the pre-
pulse inhibition (PPI) test.39 Importantly, there are strong links
between maternal stress in human pregnancy and the incidence of
schizophrenia in the offspring.40
Addictive behaviour represents another behavioural domain
that seems to be susceptible to GC programming during early life.
An increasing number of studies indicate that the experience of
high GC levels during late gestation can predispose individuals for
developing drug dependence in adolescent and adult life. In
trying to identify the neuromorphological correlates of these
behavioural changes, we recently evaluated the impact of prenatal
GC exposure on the structure and function of the nucleus
accumbens (NAcc), a crucial relay point in the limbic circuitry of
reward. We observed that the volume and number of cells in the
NAcc were significantly reduced in the adult progeny of dams
treated with dexamethasone during their last trimester of preg-
nancy; these findings were paralleled by reduced rates of cell
proliferation in the ventral tegmental area (VTA, an area that
sends dopaminergic projections to the NAcc) as well as in the
shell and core of the NAcc. In addition, prenatal GC treatment
resulted in reduced dopaminergic innervation of the NAcc.41
Previously, major structural reorganisation of the NAcc and VTA
were described during late gestation42; the data from Lea˜o et al.41
therefore indicate that GC may interfere with this process,
producing structural and neurochemical alterations that predis-
pose to drug-seeking behaviour.
Most psychiatric disorders (depression, anxiety and schizo-
phrenia) associated with gestational stress are characterised by
cognitive impairments. The hippocampus, which is critical for
learning andmemory, has an abundant population of corticosteroid
receptors.21 A very robust finding in the literature is that hippo-
campal volumes and numbers of neurons and synaptic contacts are
reduced in prenatally stressed rats.43 Moreover, the adult offspring
of mothers subjected to stress during gestation show significant
impairments in spatial learning44 and long-term potentiation, the
electrophysiological correlate of memory45; these physiological
and behavioural impairments most likely occur secondarily to the
above-mentioned morphological changes. Nevertheless, and
despite many published studies on the association between ante-
natal stress and reduced cognitive performance in animals, we and
others failed to observe deficits in learning ability and memory in
the offspring of rats born to mothers that were either stressed or
exposed to exogenous corticosteroids during pregnancy.30,46 Such
discrepancies could arise from the quality of the postnatal envi-
ronment (including health status of the mother); for example, rats
born to dexamethasone-treated mothers, but reared by vehicle-
treated mothers, were found to display normal spatial learning and
enhanced sensitivity to GC negative feedback, compared with
animals born to, and raised by, dams that were given dexametha-
sone during pregnancy.47 Thus, the early postnatal environment
seems to play a critical role in the determination of behavioural and
neuroendocrine outcomes.48 Importantly, these findings also point
to the reprogrammability of events initiated during prenatal life by
postnatal experience; this reprogramming will, presumably, be
compromised by any stressful experience after birth, and it is likely
to be limited to periods after birth when neuronal plasticity (within
and between brain regions) is still dynamic.
2.2. Neonatal period
Behaviour is critically dependent on brain development,
including appropriate neuron numbers and synapses, as well as
connectivity between different brain areas. Despite this, there is
a notable paucity of information available about how stress and GC
experience during early postnatal life affect behaviourally relevant
brain structures. Early studies described hippocampal atrophy
following exposure to stress or exogenous corticosteroids during
early life. This atrophy can be accounted for by dendritic/axonal
changes,49 and a decrease in neuronal number50; the latter could be
a consequence of changes in neuronal survival and plasticity as
a result of reduced neurogenesis and increased apoptosis51 and
altered neurotrophin expression.52 Since the hippocampus plays
a critical role in learning and memory and connects to other brain
regions that are involved in the regulation of mood and emotion-
ality, as well as neuroendocrine regulation, these permanent
changes can be expected to have a major impact on behaviour and
physiology. One such region is the PFC which is implicated in the
regulation of cognition, mood, emotion and motivation. Braun and
collaborators found that early life stress results in a decrease in
dendritic spine density and number of pyramidal neurons in the
anterior cingulate cortex, and an increase in these measures in the
dorsal part of the PFC,53 although the functional significance of
these findings remains to be elucidated.
The programming effects of stress in early postnatal life (first
week of life in rodents corresponds, roughly, to late pregnancy in
primates) have been extensively assessed. Most studies employed
the so-called maternal separation (MS) stress paradigm, which is
based on interference with the mother–infant interaction. Even
though phenotypic outcomes are not always easy to compare
between studies, possibly due to subtle differences in experimental
protocols (e.g. frequency and duration of MS, age at which the
paradigm is first applied, level of social deprivation, as well as the
quality of the post-separation and post-weaning environments),
most studies report behavioural aberrations that may be related to
many aspects of mental illness in humans, such as mood and
anxiety disorders as well as schizophrenia. For instance, Ellenbroek
and colleagues54 showed that separation of rat pups from their
mothers for a single 24 h session results in attention deficits and in
a disruption of PPI which, as previously mentioned, suggests
schizophrenia-like dysfunction. Interestingly, this behavioural
phenotype was only expressed after puberty,54 thus resembling the
temporal profile observed for the onset of schizophrenic symp-
tomatology in patients and in line with the concept that the impact
of early-life stress on sensorimotor gating depends on the age at
which the stress is experienced.54,55 The mechanisms through
which early-life stress induces these behavioural abnormalities
remain unclear at present; however, their responsiveness to anti-
psychotic drugs54 indicates hypersensitivity in the dopaminergic
system. In addition, MS-stressed rats (A.R. Mesquita, unpublished
data) and mice56 display, as adults, signs of increased learned
helplessness, a sign of depressive-like behaviour that can be pre-
vented by antidepressant administration at the end of the MS
paradigm.57 In these types of experiments too, narrow periods of
sensitivity to the deleterious effects of GCs or MS have been
observed. However, these ‘windows of vulnerability’ may differ
from one behavioural domain to another. For example, prenatal
manipulations of the GC milieu do not influence learning and
memory30; nevertheless, significant impairments of these
measures of cognition have been observed in MS-stressed rats
(unpublished data).
Variations in maternal care may serve an important role in
determining the behavioural outcome of early-life stress. For
instance, Liu et al.58 found that the learning impairments induced
by MS were greater in the adult offspring of animals reared by
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poor-caring vs those fostered by good-caring mothers. Similar
reports exist with respect to quality of maternal care and MS-
induced deficits in sensorimotor gating, mood and anxiety.59,60
Besides the behavioural programming described above, early-
life events are known to affect somatic well-being on measures of
body mass and growth. However, their impact on the timely
reaching of critical milestones has not been studied extensively.
Recent studies in our laboratory61 have shown that MS on postnatal
days 2–15 delays the acquisition of neurological reflexes that are
dependent on vestibular and cerebellar function. On the other
hand, MS-treated animals showed earlier eye and ear opening,
indicating advanced physical maturation. Similarly, Neal62 reported
that dexamethasone administration during the first postnatal week
leads to retardation of acquisition of the above-mentioned neuro-
logical reflexes. While some authors have suggested that delayed
myelination can account for these neurological deficits,63–65 we
recently found that the serotoninergic system might also be
involved61; specifically, MS-experienced rats showed increased
serotonin turnover in the dorsal raphe nucleus.
It is important to note that the neurochemical bases of MS are
poorly understood. Importantly, GCs do not seem to be directly
responsible for any of the above-mentioned effects since GCs are
not secreted in response to stress in the rodent neonate66; this so-
called stress hyporesponsive period is confined to about the first
two weeks of the rodent’s postnatal life. The fact that MS and
postnatally administered GCs may lead to similar behavioural and
neuroendocrine outcomes, suggests possible redundancy of signals
that converge on stress-sensitive neural substrates. Resolution of
this issue remains a challenge for future research.
3. Are animal studies translatable into clinical practice?
In its 2001Mental Health Report, theWorld Health Organization
observed that, ‘Contrary to popular belief, mental and behavioural
disorders are common during childhood and adolescence. Inade-
quate attention is paid to this area of mental health’. The Report
went on to point out that, ‘Mental and behavioral disorders of
childhood and adolescence are very costly to society in both human
and financial terms. The aggregate disease burden of these disor-
ders has not been estimated, and it would be complex to calculate
because many of these disorders can be precursors to much more
disabling disorders during later life’. Happily, these concerns are
currently being addressed,67 and some of the results discussed
above indicate that the various experimental paradigms and animal
models may be relevant to human health.
Glucocorticoids are indicated in obstetric and paediatric condi-
tions, such as infection, connective tissue and allergic disorders,
and are commonly used in obstetric practice to accelerate lung
maturation in cases of threatened preterm labour; the latter affects
up to 10% of pregnancies. While GC therapy makes a significant
contribution to the reduction of infant mortality,68 there is
considerable debate about which GC should be used, and according
to what regimen, for a particular underlying condition, so as to
induce the minimum degree of damage. Only a few studies have
assessed the impact of perinatal GC exposure in humans and there
is usually sparse follow-up information available. The significant
findings that have so far emerged may be summarised as follows:
(i) children exposed to dexamethasone and whowere born at term,
had increased emotionality, unsociability/social withdrawal and
general behavioural problems69 as well as persistent impairments
in tests of verbal working memory70; (ii) the offspring of women
given multiple doses of antenatal GCs because of risk of preterm
delivery have reduced head circumferences, and show significantly
increased aggressive/violent behaviour and attention deficits.71
Likewise, maternal stress has been shown to induce long-term
programmes in the fetus that prevail at least until middle
childhood72 and, as shown by recent work from Rachel Yehuda’s
laboratory, children of mothers with post-traumatic stress disorder
display altered cortisol levels that are accompanied by signs of
behavioural distress during the first nine months of life.73 In
addition, the stress-induced release of striatal dopamine is reduced
in subjects that had experienced poor parental bonding, indicating
dysregulation of neurotransmitter systems by stressful experiences
during early life.74
These clinical reports reveal a pattern similar to that observed in
experimental animal models, but which itself is insufficient to
allow immediate extrapolation to humans. Taken together, they do,
however, point to the long-term negative impact that high GC
levels can have on the development of the brain and behaviour.
However, one should consider that risk–benefit judgements are
confounded by the fact that subjects born preterm are already at
risk for delayed neurodevelopment. A recent systematic review
concluded ‘. prenatal steroids reduce the occurrence and severity
of . health problems in the first few weeks of life .. However,
these benefits are associated with a reduction in some measures of
weight and head circumference at birth, and there is still insuffi-
cient evidence on the longer-term benefits and risks’.75
4. Mechanisms of programming by stress and glucocorticoids
Stable alterations of gene expression that are independent of
changes of the DNA sequence can be caused by epigenetic mech-
anisms. Covalent modifications, e.g. through methylation of DNA at
cytosine residues of CpG dinucleotides or through various histone
modifications, are among the best known of these. Work by Avi-
shai-Eliner et al.76 and Liu et al.58 showed that social environmental
cues, such as postnatal handling, promote maternal care, resulting
in long-lasting increases in GR expression in the hippocampus of rat
pups raised by high-caring mothers. Recently, pioneering work in
the laboratories of Michael Meaney and Moshe Szyf demonstrated
that demethylation at the nerve growth factor1A (NGFI-A, also
known as Egr1, zif268 or Krox 24) binding site may underlie the
increased expression of GRs; NGFI-A is a key transcription factor in
the GR promoter, activating transcription at the GR 17
promoter.77,78 Studies in vitro and in vivo demonstrated that
demethylation at the NGFI-A binding site in the rat GR 17 promoter
is initiated by enhanced serotonin input and activation of 5-HT7
receptors which, in turn, activate the cAMP/protein kinase
A pathway, increasing NGFI-A expression; NGFI-A binding to its
recognition element in the 17 GR promoter initiates cytosine
demethylation and leads to the recruitment of a histone acetylase
(cyclic AMP response element-binding protein), an event that could
potentially explain enhanced transcription of the GR.78 Interest-
ingly, cross-fostering studies revealed a direct effect of maternal
care, rather than genetic inheritance, suggesting trans-generational
transmission of these epigenetically programmed traits.79 While
pointing to mediation through serotonin, it should be mentioned
that GCs themselves have been shown to have the potential to
induce epigenetic changes in non-neural tissues; for example,
chronic treatment of rat hepatoma cells with GC induces fast
chromatin remodelling in an enhancer region of the GR target gene
tyrosine aminotransferase, an event followed by recruitment of the
transcription factor hepatic nuclear factor-3 (HNF3) and slow, but
persistent DNA demethylation at GC-responsive units within the
enhancer.80,81
5. Conclusions
An abundance of data in rodents and humans indicates that
exposure to GC at specific time-points during ante- and postnatal
development can induce undesired cardiovascular, metabolic,
neuroendocrine and behavioural phenotypes in adulthood. The
A.R. Mesquita et al. / Seminars in Fetal & Neonatal Medicine 14 (2009) 130–135 133
150
concept that stress and GCs act by reprogramming the genetically
determined phenotype through epigenetic mechanisms is
becoming increasingly popular; more intriguing is the evidence
that some of these acquired changes may be transmitted across
generations. Improvements in our understanding of these latter
two mechanisms are a major challenge for researchers in this field;
in particular, it will be of interest to discover ways in which human
health can be improved by over-writing these changes.
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